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Unlike the mammalian digestive tract that has been developed into distinct
regions for different functions, fish have a relatively simple intestine and many
fishes have no recognizable stomach. We used the zebrafish microarray ap-
proach to characterize its intestine. By dividing the zebrafish intestine into
seven segments along its length, we found that the first five segments resem-
ble the mammalian small intestine and the last two segments resemble the
mammalian large intestine. We then investigated the role of Notch signaling
and found that a specific group of glycogen-rich fibroblasts were involved in
the Notch-mediated cell fate decision process. Further, we studied the effects
of radiation and found an interesting pattern of regeneration in the intestine.
Moreover, the number of intestinal stem cells was investigated through a novel




A systemic study of adult zebrafish intestine has been carried out in this thesis
project integrating morphological, histological, molecular and computational
approaches.
Morphologically, the zebrafish intestine is organized as an inverted Z shape
in vivo. Dilation of the intestinal tube at its anterior is frequently seen contain-
ing ingested food, especially after feeding; while compaction of stools is often
observed in its posterior region. Histologically, villi are present almost along
the whole intestine with expcetion in the very posterior region (segment S7).
Interestingly, crypts are absent along the whole intestine. Our transcriptomic
analysis has shown that the zebrafish mucosa only resembles the mouse villi
but not the crypts, supporting the absence of crypts in zebrafish.
cDNA microarray has been performed to profile the region-specific tran-
scriptomes along the anterior-posterior axis. Transcriptomic analysis shows
segments S1-S5 are very similar to each other, while S6 and S7 shows major
difference. This is consisten with our qRT-PCR results and in situ hybridiza-
tion results. Expression of fabp2, the well known marker gene of the small
intestine, is switched off in the proximal region of S5. Similar results are seen
for villin, another marker gene of the small intestine.
vii
Based on our results, we like to propose that the zebrafish intestine re-
gionalizes into the small intestine and the large intestine. The small intestine
connects to the large intestine through a transitional region, while the large
intestine further regionalizes into a proximal part and a distal part. There is
no stomach or cecum found. The pepsin gene locus, conserved in most verte-
brate species, seems evolutionarily lost in zebrafish genome. In the mean time,
trypsin and chymotrypsin are synthesized by the intestinal cells.
Perturbation to Notch signaling shows that Notch influences the fate de-
termination of the bipotent precursor cells toward an absorptive or secretory
lineage. Inhibition of Notch signaling has led to precocious differentiation of
the precursor cells along the secretory lineage with involvement of a glycogen-
rich intestinal subepithelial myofibroblasts.
Gamma-radiation has allowed us to study the regenerative process of ze-
brafish intestine. Despite degeneration of villi after radiation, regeneration are
observed and the intestinal functions are sustained, which partially explains
the survival of fish after radiation. Our discovery that zebrafish intestine expe-
riences multiple waves of tissue regeneration has shed new light on our current
unserstanding of the nature of the intestinal organ with potential therapeutic
values.
viii
Computational analysis suggests that the number of stem cells is about
2 to 4 per section of an inter-villi pocket in the small intestine of zebrafish.
Interestingly, this number seems to remain similar in the small intestines of
other species including mouse and human, despite the vast difference in their
villous size. Transient responses during restitution of the intestinal epithelium,
however, appear to be following different strategies in different species.
ix
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1.1 Introduction to the digestive system
The digestive tract, also known as the alimentary canal, is present in all multi-
cellular organisms. It takes in food, digests it to extract energy and nutrients,
and expels the remaining waste [1, 2]. The digestive tract differs substan-
tially from organism to organism. In its simplest form, it is a more or less
uniform tube from mouth to anus opening. In human, it consists of mouth,
pharynx, esophagus, stomach, small intestine, large intestine, rectum and anus
(Fig.1.1A). The small intestine is further divided into duodenum, jejunum and
ileum, while the large intestine is further divided into ascending colon, trans-
verse colon and descending colon.
Apart from the digestive tract, several other organs also form part of the
digestive system, including the liver, pancreas and gall bladder [1]. These
organs, together with the digestive tract and several auxiliary parts such as
the saliva glands and the tongue, form one of the largest systems in the human
body.
The human digestive system is amazing in many aspects. In a normal
human adult, the digestive tract is approximately 7-9 meters long [3] and the
large intestine is about 1.5 meters long [4]. It processes about 500 kilogram of
food each year. In one square inch of human small intestine, there are about
2
20,000 units of epithelial projections termed villi and ten billion microvilli [5].
The epithelium lining the inner surface of the intestine is constantly under
abrasion and in the mean time, is constantly being renewed. The epithelium
lining will be renewed following a cycle of 2 to 7 days. In other words, the
intestinal epithelium will go through several thousand rounds of renewal during
the human lifespan, representing the most rapidly renewing tissue in the human
body [6].
3
Figure 1.1: Human digestive system and intestinal architecture
(A) The human digestive system. It consists of the liver, pancreas, gall
ladder and the digestive tract running from mouth, pharynx, esopha-
gus, stomach, small intestine, large intestine to anus opening. Panel A
is from http://kidshealth.org/misc/movie/bodybasics/digestive-system.html
and panel B from ref. [7] (top to bottom). (B) Architecture of the small intes-
tine. From innermost to outermost, it includes mucosa, submucosa, mascularis
and serosa.
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1.2 Tissue architecture and cell types of the
intestinal epithelium
The intestinal epithelium has been best characterized in mammals. Architec-
turally, several layers are observable in a cross-section of the small intestine,
including mucosa, submucosa, muscularis and serosa (from innermost to out-
ermost). The muscularis further consists of two layers: circular smooth muscle
and longitudinal smooth muscle (Fig.1.1 B).
In the small intestine, the epithelial lining invaginates to form numerous
crypts and larger, finger-shaped projections called villi. In the colon, there are
again numerous villi, with regional variations in size. The intestinal epithelium
harbors four major types of epithelial cells, including columnar cells, mucin-
secreting cells, endocrine cells, and, in the small intestine, Paneth cells [8, 9].
Other less common cell lineages are also present, such as caveolated cells and
M (membranous or microfold) cells, but are less well characterized [10, 11].
Columnar cells represent the most abundant epithelial cells with microvilli
structures along the apical membrane. They are called enterocytes in the
small intestine and colonocytes in the large intestine. Mucin-secreting cells,
or goblet cells, are named due to their goblet shape and presence of mucus
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granules to produce a swollen theca. Endocrine, also called neuroendocrine or
enteroendocrine, cells represent a minor cell population distributed through-
out the intestinal epithelium. They secrete peptide hormones in an endocrine
or paracrine manner from the neurosecretory granules. Paneth cells are lo-
cated almost exclusively at the crypt base of the small intestine and ascending
colon. Paneth cells contain large apical secretory granules and express a num-
ber of proteins, including lysozyme, tumor necrosis factor, and the antibacterial
cryptins [11].
1.3 Turnover of the intestinal epithelium
The intestinal epithelium represents one of the most rapidly renewing tissues
of the human body [6]. The epithelial cells of the intestine undergo apoptosis
at the tips of villi, and the sloughed cells are replaced by neighboring cells
migrating upward. In the crypts, new cells are generated by stem/progenitor
cells to maintain the epithelial homeostasis. Turnover of the epithelial cell
lineages within the gastrointestinal tract is a constant process, occurring every
2-7 days in normal homeostasis and increasing after damage [10]. Renewal of
epithelium maintains tissue homeostasis and may also serve functions like ex-
pulsion of intestinal parasites [12]. Rapid renewal of the epithelium tissue over
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the whole lifespan of the host organism, however, has aroused wide scientific
interests in regulation of cell differentiation, tissue homeostasis, the mainte-
nance of genome integrity, gene mutations and development of cancer, which
will be further discussed below.
1.4 Significance of the study of the digestive
system
Dysfunction of the digestive system may yield a wide range of digestive, nutri-
tional or metabolic problems. The digestive system itself may be vulnerable
to diseases such as gastroenteritis, inflammation, infection, ulcer and even for-
mation of cancer.
According to recent surveys on human cancers, both gastric and colorectal
cancers are among the leading cancers in modern societies, with 21,500 new
cases for gastric cancer and 148,810 new cases for colorectal cancer as estimated
for the United States in 2008 [13]. According to statistic data released by the
National Cancer Institute (Bethesda, US), colorectal cancer has been one of
the most frequent human cancers, with an incidence much higher than that
in many other organs including the stomach and it has a mortality of 30-50%
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in five years after diagnosis [14]. According to a survey released in Singapore,
colorectal cancer has been ranked the most frequent cancer (gastric cancer in
the third place), which has hit 4899 patients from 1993-1997, with 2621 deaths
during the same period [15]. Thus, efforts toward a better understanding of the
digestive tract and cancer formation have great significance in both research
and clinical applications.
1.5 Intestinal stem cells
The intestine has been a fascinating organ for biologists due to the spatial
organization of the sequential cellular events including proliferation, differenti-
ation and apoptosis. In the mouse, proliferation of the intestinal epithelium is
restricted to the crypts and apoptosis is restricted to the tips of villi. Loss of
cells are thus being constantly replenished by newly generated cells from the
lower region of crypts [16, 9, 17].
Leblond and Cheng (1974) proposed a unitarian hypothesis, stating that
all the cell types of the intestinal epithelium, including absorptive enterocytes,
goblet cells, enteroendocrine cells and Paneth cells, arise from the same source
of stem cells [18]. Following that, increasing attention has been drawn to
this field of research due to the potential medical importance [19]. Evidence
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in support of the existence of intestinal stem cells and their multipotency has
been ever growing.
1.5.1 Location of intestinal stem cells
Historically, there have been two schools of thought regarding the location of
intestinal stem cells. One school believes that the stem cells are located at
the so-called +4 position, just sitting above the Paneth cells. In this school
of thought, the finding of cells with long-term retention of tritiated thymidine
or BrdU labelling [20, 21, 22] led to the hypothesis that stem cells in the
intestine, as well as in epidermis or hair follicle, protect their genome against
DNA-replication-induced errors through selective DNA strand segregation by
retaining an immortal DNA strand [23, 24, 25]. It was found that these label-
retaining cells often appeared at the position +4 from the very bottom of
the crypt, sitting above the differentiated Paneth cells, thus this position was
proposed to be the location of intestinal stem cells [26, 27]. This view seems
to be supported by the recent report that Bmi1 expression specifically marks
the cells at the +4 position of the crypt and these cells are able to generate the
four major epithelial cell types (columnar cells, goblet cells, enteroendocrine
cells and Paneth cells) in mouse small intestine [28].
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The second school believes that the stem cells are sandwiched between the
post-mitotic Paneth cells near the bottom of the crypts based on the identifi-
cation of crypt base columnar (CBC) cells, which are small, undifferentiated,
cycling cells hidden between the Paneth cells [18, 29, 30, 31, 32]. Originally
based on morphological considerations, but more recently also based on clonal
analysis through N-nitroso-N-ethylurea(NEU)-induced mutations in the Dlb-1
gene [31, 33], these CBC cells are believed to represent the true stem cells.
This seems to be supported by the recent reports that both Lgr5 and Ascl2
mRNAs mark the CBC cells in the crypt, which are able to generate the four
major epithelial cell types in mouse intestine [34, 35, 36].
Proof of pluripotency of the intestinal stem cells based on lineage tracing
in genetically modified mice has been equally successful in support of either
school of thoughts [28, 37, 34, 36]. Current results, therefore, appear to support
the presence of two populations of intestinal stem cells, which differ in their
location, cell number and molecular profiles. In view of their apparently equal
power of regeneration, questions arise regarding the necessity of maintaining
two populations of stem cells, their potential interactions and the roles they
play during tissue homeostasis. Is it possible that one population of stem cells
are descendants of the other population? Or are all of them derived from a
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single stem cell at different phases? Unfortunately, the answers remain unclear
today. Insights that we may gain from studies in other species like zebrafish
would definitely be a plus to further our understanding of the nature of the
intestinal biology.
1.5.2 Intestinal stem cell number
The number of intestinal stem cells is under tight regulation under normal
physiology. Excessive stem cells are believed to cause crypt division or fis-
sion, thereby maintaining the desired number of stem cells within each crypt.
Stem cells are sensitive to irradiation and irradiation-induced DNA damage
will cause the stem cells to undergo apoptosis in an altruistic manner to pre-
vent passing the DNA damage to their daughter cells. Loss of stem cells will
be compensated by expansion of the remaining stem cells or their immediate
daughter cells that still possess stemness property or with colonogenic poten-
tial. Due to unavailability of molecular makers, the number of stem cells has
not been verified for a long time, though it is estimated to be 4-6 in each crypt
of mouse small intestine [38, 39, 16].
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1.5.3 Intestinal stem cell marker
It has been one of the major goals to identify specific molecular markers for
intestinal stem cells. At the time when the thesis project was initiated in 2005,
there were no gene markers identified for intestinal stem cells. Several gene
markers were proposed in literature, including Msi-1 [40, 41], BMPR1a [42],
phospho-PTEN [42], DCAMKL1 [43], Eph receptors and integrins [44]. How-
ever, no convincing data are available to prove the pluripotnecy of these cells.
Recently, a few other markers, including Lgr5 [34, 45], Ascl2 [36], Bmi1 [28, 46]
and Prominin1 [47], have been published with rigorous proof of the pluripo-
tency of the identified stem cells.
The recent identification of intestinal stem cell gene markers has led to a
sudden flourish in this field of research. For example, Lgr5 not only marks stem
cells in the small intestine, but also marks stem cells in the hair follicle [48]. It is
also suggested to mark stem cells in the stomach and mammary gland [34, 45].
Like Lgr5, Ascl2 has also been identified to mark intestinal stem cells in a more
specific manner [36]. Transcriptome of intestinal stem cells have been probed
by microarray [36] and culture of the stem cells has been reported to be able
to grow villus-like structures even without support of mesenchymal cells [37].
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1.6 Intestines of different vertebrate models
1.6.1 Mouse intestine
The digestive tract of mouse traverses from mouth to pharynx, esophagus,
stomach, small intestine, large intestine till anus opening. Due to its similarity
to human intestine, the mouse intestine has been a popular model for studying
human intestine.
Development of mouse intestines has been described previously [49]. About
12 days after fertilization, the duodenum shows the epithelium, with its round
or slightly elliptical internal and external contours. The epithelium is 1-2 cells
thick and surrounded by a loose mesenchymal layer. One day later, the outer
profile of the epithelium is still elliptical. The lumen has a slit-like appearance
or sometimes a triangular shape. Along with development, the epithelium
forms elevations projecting into the lumen, but there are no indications of the
presence of previllous ridges as described for the chick (see below). Around
14 dpf, degenerating cells appear at the top of the epithelial elevations. These
cells become rounded and are extruded into the lumen.
Adult mouse features presence of crypts and villi in the small intestine, but
only crypts in the large intestine [34]. Each crypt contains a monoclonal popu-
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lation of cells [50, 51] derived from multipotent stem cells [52]. After a phase of
rapid amplification, the clonal descendants undergo terminal differentiation to
four principal cell types during a bipolar migration [52]: columnar and goblet
cells arise as they are rapidly translocated in vertical coherent bands to the
apical extrusion zone [53]. Paneth cells differentiate as they descend to the
crypt base, while enteroendocrine cells arise as they migrate out of the prolif-
erative zone. Of these cell types, the columnar cells are most abundant (about
80% of the whole epithelial population), followed by the goblet cells (about 10-
15% in the small intestine, often in the crypts; the population is bigger in the
large intestine). The Paneth cells fall into minority and the enteroendocrine
cells are rare. Organization of the cellular events in well demarcated anatomic
units provides a unique opportunity for us to infer the biological properties of
stem cells [54] and investigate the regulatory mechanisms of cell proliferation,
commitment and differentiation.
1.6.2 Chicken intestine
The digestive tract of chicken runs from mouth/beak through esophagus, crop,
proventriculus (glandular stomach), gizzard, small intestine, ceca, large intes-
tine, cloaca to the vent [55, 56, 57]. The most prominent feature is the presence
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of the gizzard, which temporarily stores food intake and mechanically breaks
the food particles into smaller sizes to make the work of the enzymes eas-
ier. The crop buffers the food passage and moistens it before it traverses into
the proventriculus. Chicken also possesses two ceca that are essentially non-
functional, proximal to its cloaca that functions as a common chamber for the
gastrointestinal tract and the urinary tract.
Development of chicken intestine demonstrates some interesting features.
During early embryonic development, the epithelium of chicken intestine un-
dergoes three stages, including the circle, ellipse and triangle stages, to estab-
lish the first three previllous ridges [58, 59]. Following that, new previllous
ridges will form in the location occupied by the valley between two established
ridges. After this period, ridge formation becomes more irregular. There will
be about eight previllous ridges by eleven days and sixteen by thirteen days.
Epithelium proliferation in the chicken intestine, however, occurs both in the
crypts and along the villus [60], which differs from that in mouse intestine
where proliferation is restricted to the crypts only [9].
Similar to mouse, adult chicken also features presence of crypts and villi
in the small intestine, but only crypts in the large intestine [61]. Vacuolated
columnar cells, mucin-secreting goblet cells and peptide-synthesizing enteren-
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docrine cells are present along the villus axis [62, 60, 63, 64, 65]. But the
presence of the Paneth cells has not been reported in chicken intestine [66].
1.6.3 Frog intestine
The digestive tract of frog proceeds from mouth to esophagus, stomach, small
intestine, large intestine and anus opening. The frog is prominently featured by
its metamorphosis during development, where significant changes occur to its
organs, including its intestine [67]. During metamorphosis, undifferentiated
cells appear at stage 60 (the start of metamorphic climax) as small islets
between the larval epithelium and connective tissue. They actively proliferate
and finally differentiate into the secondary or adult epithelium. In the mean
time, all of the larval epithelial cells undergo apoptosis on and after stage
60 and are gradually replaced by the adult epithelial cells. An interesting
difference between frog and most other vertebrate species, however, is the
absence of villous structures in frog intestine till the metamorphic stage [67, 68].
Following the metamorphosis, adult frog intestine features presence of both
villi and crypts (also called crests and troughs, respectively). The intestinal
epithelium contains columnar cells, goblet cells and enteroendocrine cells [69,
70]. The columnar cells are most abundant and the goblet cells take up about
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10% of the epithelial population [70]. But the presence of the Paneth cells has
not been reported in frog intestine.
1.6.4 Zebrafish intestine
The digestive tract of zebrafish starts with mouth and proceeds to pharynx,
esophagus, intestine and ends with the anus opening. During development,
the time period between 26 hpf and 76 hpf represents a critical period where
the entire intestinal endoderm remains highly proliferative [71, 7]. At 26-30
hpf, the cells give rise to the primitive gut comprising a continuous thin layer
of endoderm just above the dorsal surface of the yolk at the midline of the
embryo. The endoderm cells then adopt a bilayer configuration and form small
cavities to make an intestinal lumen. Later the endoderm cells polarize and
differentiate into distinct cell lineages. Enteroendocrine cells are identifiable
first at 52 hpf in the caudal region of the intestine. By 74-76 hpf, the entire
digestive tract is a hollow tube. The mouth has opened and a single continuous
lumen from mouth to anus is formed, but the anus remains closed till a day
later. The differentiation of mucin-containing goblet cells is first evident at 100
hpf and is restricted to the middle segment of the intestine, where enterocytes
with large supranuclear vacuoles are also present. Meanwhile, expansion of
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the lumen in the rostral intestine forms the intestinal bulb. The epithelium
elaborates folds and proliferating cells become progressively restricted to a
basal compartment analogous to the crypts of Lieberku¨hn in mammals.
Similar to its mammalian counterparts, the epithelium of zebrafish intes-
tine contains columnar cells, goblet cells and enteroendocrine cells [71]. But
zebrafish intestine has demonstrated some differences from their mammalian
counterparts. Previous studies have suggested the absence of a stomach based
on gross morphological observations in cyprinids [72], though this is not well
grounded at the molecular level. The absence of crypts and the Paneth cells
has also been reported in larval zebrafish intestine [71]. These differences be-
tween species have triggered interests into questions like how the gastric func-
tions may be carried out in the intestine and how the zebrafish intestine may
be regionalized to carry out different functions like mammalian small/large
intestines.
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1.7 Establishing zebrafish as a vertebrate model
for study on intestine
Since its introduction to the scientific research community in the early 1970’s
by Professor George Streisinger of University of Oregon, the zebrafish has been
widely employed as a vertebrate model in a broad range of studies including
developmental studies, genetic studies, modeling of human diseases and drug
screening [73, 74]. Nowadays, zebrafish has become one of the most popular
animal models for molecular research and the zebrafish community has been
growing.
In recent years, the zebrafish has become an increasingly popular experi-
mental model with its own advantages. It is a vertebrate model with rapid
development. Ex utero development and optical transparency of its embryos
greatly facilitate developmental analysis and imaging. Its genome data is now
publicly accessible.
Due to the advantages of zebrafish as a model for molecular research, it has
begun to be used for studies on intestinal biology. To characterize zebrafish
intestine, several pioneer reports have probed the developmental process of ze-
brafish intestine. From morphology, cell type and tissue renewal, zebrafish in-
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testine demonstrates similarity to mammalian intestines [71, 75, 76]. To model
human intestinal cancer, pioneering work has been done to produce tumors in
zebrafish intestine by manipulating the Wnt/beta-catenin pathway [77, 78].
However our current understanding of zebrafish intestine generally remains
fragmented. For example, the molecular and functional difference along the
anterior-posterior axis of zebrafish intestine remains unclear. Its similarity
to human intestines is also unclear. Current work aims to unravel the general
characteristics of adult zebrafish intestine from morphological, histological and
molecular aspects. Features of small intestine and large intestine will be ex-
plored and molecular similarity between regions of zebrafish intestine and their
mammalian counterparts will be investigated. Research goals of the thesis work
are briefly outlined in the next section.
1.8 Research goals of the current work
The current thesis work aims to have a better understanding of the region-
alization and characteristics of adult zebrafish intestine. We have integrated
morphological, histological and molecular approaches toward this end.
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1.8.1 Morphological and histological features of zebrafish
intestine
Previous work on zebrafish has been largely carried out in larval fish where
the intestinal organ is still developing. Mature zebrafish intestine distinguishes
itself from the developing intestine in morphology, histology as well as func-
tional specialization. These characteristics of adult intestine have not been
adequately studied so far. Here we want to address these aspects starting with
morphology and histology.
1.8.2 Characterization of regionalization of zebrafish in-
testine through genome-wide gene expression anal-
ysis
Functional specialization and regionalization of adult zebrafish intestine remain
poorly understood today. There is no definitive morphological, histological or
architectural demarcation to help us identify the functional transition along the
intestinal tract. Thus gene expression features may become necessary for this
purpose. In this project, genome-wide gene expression profiles will be probed
in a region-specific manner along the adult fish intestine. Any analogy between
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zebrafish intestine and the mammalian intestines will thus be determined by
analysis using these gene expression profiles.
1.8.3 Study of the cell fate decision in zebrafish intes-
tine
Several signaling pathways serve important roles in the cell fate decision pro-
cess in the intestines and one of them is the Notch pathway. Though it has
been shown to influence the cell fate specification in larval or juvenile zebrafish
intestine [79], we want to examine its role in adult intestine and to further un-
derstand its relationships with other signaling pathways that are also known
to be important in the intestine, such as Wnt signaling, BMP signaling, GATA
transcription factors as well as mesenchymal cell activities.
1.8.4 Responsive nature of intestine during regenera-
tion
The responsive nature of the intestine upon perturbation is yet to be further
explored. As the intestinal stem cells are known to be very sensitive to radia-
tion [80], we expect to see drastic changes taking place in the intestine upon
high dose radiation. So we will use high dose whole body radiation to investi-
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gate the responsive dynamics of intestine during tissue regeneration and find
out how events of cell proliferation, apoptosis and renewal are orchestrated to
re-establish homeostasis.
1.8.5 Computational analysis of intestinal stem cells and
their adaptive changes
Due to absence of specific molecular markers for intestinal stem cells in ze-
brafish, we aim to investigate the number of pluripotent intestinal stem cells
present in each inter-villi pocket and their adaptive changes through computa-
tional analysis. A generalized mathematical model will be developed to inves-









The surface of the intestine epithelium is the site where nutrients are absorbed
into the body. This absorption function is aided by expanding the surface
area of the gut into villi at the tissue level and microvilli at the cellular level.
Consequently, the mouse and human intestine has become a model for studying
how this large surface develops during embryogenesis, the role of stem cells in
the renewal of the epithelium, and development of colorectal cancer [81, 9, 82].
However, these complex problems can be studied in a simpler system, the
zebrafish (Danio rerio), which has emerged as an important vertebrate model
for study of not only human development but also disease [73, 83, 78, 84, 85]. In
comparison with the mouse or human intestine, the zebrafish intestine shares
structural and functional similarity at the tissue level but is structurally simple
and develops rapidly [7, 86, 71].
So far, morphological development of zebrafish intestine has been relatively
well characterized in embryos and larvae [7, 71]. However, the organization and
physiology of digestive tract has not been specifically documented for adult
zebrafish although several books are available for description of general fish
intestine anatomy [72]. Zebrafish, like many fish, lacks a morphologically and
functionally distinct stomach and does not express genes that encode specific
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gastric functions [78, 87, 88, 79]. Sections of intact zebrafish embryos and
juveniles and microCT tomography reveal the digestive tract from pharynx
and esophagus to the three sections of the folded intestine and anus. Previous
studies have described the zebrafish intestine as a tapered tube that begins at
the esophageal junction and is folded into three sections, the large diameter
rostral intestinal bulb, the mid-intestine, and the small diameter caudal intes-
tine. However, it is not known whether these regions are functionally distinct or
whether their functions correspond to the mammalian stomach, small intestine
or large intestine. In this study, we characterized the anterior-posterior axis of
adult zebrafish intestine at tissue, cellular and molecular levels. By compar-
ing the morphological and molecular characteristics, we identified structurally
and functionally distinct areas that correspond to the small intestine and large
intestine but not stomach.
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2.2 Materials and Methods
2.2.1 Maintenance of zebrafish and dissection of zebrafish
intestine
Danio rerio of about one year old were maintained following established proto-
cols [89] and in compliance with Institutional Animal Care and Use Committee
(IACUC) guidelines. Zebrafish were euthanized by 0.1% 2-phenoxyethanol and
their intestines were isolated and cut into seven segments along the anterior
and posterior axis, as shown in Fig.2.1B. The seven segments were labeled S1,
S2, S3, S4, S5, S6 and S7, respectively.
2.2.2 Paraffin sectioning of zebrafish intestine
Intestinal segments were fixed in 4% paraformaldehyde in phosphate buffered
saline at room temperature overnight. Then the intestine samples were de-
hydrated in 70% ethanol overnight and further dehydrated in ethanol with
increasing gradients (75%, 90%, 95% and 100%). The samples were cleared in
100% Histoclear II (National Diagnostics, US) for 30 min twice, embedded in
liquid paraffin at 58oC for 30 min, then changed into fresh paraffin for final
embedding at 58oC overnight. Finally, the samples were sectioned at 7 µm on
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a Reichert-Jung 2030 microtome (Leica, Germany) and collected onto Fisher
SuperFrost slides. The slides were left on a heating block at 42oC overnight
before further assays were conducted.
2.2.3 Hematoxylin and eosin and alcian blue staining
Tissue sections were stained by Meyer’s hematoxylin for 10 min, rinsed in
tap water, stained by eosin for 1 min, followed by dips in acidic ethanol and
rinse in tap water. They were stained by alcian blue (Biogenex, US) for 10
min and rinsed in tap water. Finally, the slides were dehydrated in ethanol
of increasing gradients (75%, 90%, 95% and 100%), cleared by HistoClear
II (National Diagnostics, US), mounted with DePeX (EMS, US) mounting
medium and covered by cover slips. Images were taken using a Zeiss Axiovert
imaging system.
2.2.4 Quantitative real-time PCR (qRT-PCR)
Quantitative real-time PCR was carried out in 96-well plates on a LightCycler
480 system (Roche, Swiss). The PCR reaction was set up according to the
manufacturer’s protocol with optimization of primer-specific annealing tem-
perature and extension time. PCR products were labeled by SYBR Green
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dye. All gene expression levels were measured and normalized against the
level of house-keeping gene actin beta 2 expression.
2.2.5 Microarray experiments
Intestines were isolated from male adult zebrafish, quickly rinsed in 1x phos-
phate buffered saline/diethylpyrocarbonate, and cut into seven segments ac-
cording to Fig.2.1B. To maintain a more homogeneous molecular background,
only male fish were used for microarray analyses. The same segments from
every 10 fish were pooled as one biological replicate and they were kept in
liquid nitrogen till extraction of RNA. Two rounds of extraction of RNA were
performed using Trizol (Invitrogen, USA). A total of five replicates were pre-
pared for each segment. For each replicate, 10 µg RNA was reverse-transcribed
into cDNA with incorporation of aminoallyl-dUTPs. Later the samples were
hybridized onto in-house spotted microarray chips with labeling by Cy5 as de-
scribed previously [90]. RNAs from whole fish were used as reference for all ex-
periments and labeled by Cy3. After hybridization, the microarray chips were
scanned and graded, and raw data were normalized using LOWESS method
implemented in Gene Cluster 3.0 during the pre-processing stage.
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2.2.6 Identification of differentially expressed genes from
the microarray data
Pre-processed microarray data were visualized and subjected to one-way ANOVA
test using MeV MultiExperiment Viewer software [91]. One-way ANOVA test
was performed using a critical p-value of 0.1 with standard Bonferroni cor-
rection for all seven intestinal segments. The selected genes were used for
clustering and expression pattern analysis to compare the similarity and dif-
ferences in the seven segments.
2.2.7 Gene ontology (GO) analysis by GO Tree Machine
Up-regulated genes were selected for each individual segment based on the
fold changes of their expression levels (at least two told up against the RNA of
pooled adult zebrafish and FDR adjusted p-value ≤ 0.05). Gene ontology was
carried out using GO Tree Machine, which is a web-based tool developed by
the Vanderbilt University to analyze gene ontology for a given set of genes [92].
It compares the distribution of genes in the gene set of interest in each GO
category to those in the reference gene set, i.e. the transcriptome of zebrafish
in our case. Gene information was retrieved from GeneKeyDB, a database that
integrates gene information from Ensembl, Swiss-Prot, HomoloGene, Unigene,
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Gene Ontology Consortium and Affymetrix etc. Statistical tests were used for
the assessment of enrichment of each gene category.
2.2.8 Pathway analysis using WebGestalt
WebGestalt is web-based software package developed by the Vanderbilt Uni-
versity, including gene ontology analysis, KEGG (Kyoto Encyclopedia of Genes
and Genomes) pathway analysis, intersection of gene sets and so on [93]. In
this work, the KEGG pathway analysis was used and the program took a set of
genes of interest as input, retrieved information about pathways and their asso-
ciated genes from the GeneKeyDB. The gene set of interest was compared to a
reference gene set for the proportion of genes in the pathway. Hypergeometric
test or Fishe’s exact test was used to assess the statistical significance. Since
the pathway database only accepted mouse and human genes, thus zebrafish
genes were first mapped to their mouse homologs prior to pathway analysis.
Zebrafish genes were mapped to their mouse homologs using the web-based
tool developed by the Genome Institute of Singapore using DR build #115-63
(http://giscompute.gis.a-star.edu.sg/∼govind/unigene db/).
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2.2.9 Gene Set Enrichment Analysis
GSEA is a computational method that determines whether a priori defined set
of genes shows statistically significant, concordant differences between two bi-
ological samples; it calculates an enrichment score using a running-sum statis-
tic through a ranked list of gene expression data set [94]. In this work, the
software GSEA2.0 developed by the Broad Institute [94] was used. The statis-
tical significance of the enrichment score was estimated by using an empirical
phenotype-based permutation test procedure. A false discovery rate was pro-
vided by introducing adjustment of multiple hypothesis testing.
2.3 Results
2.3.1 Architectural differences along the zebrafish in-
testinal tract
The anterior-posterior axis of the embryonic, juvenile, and adult zebrafish
digestive tract has been described in several atlases [95, 96, 97]. In summary,
the adult digestive tract consists of the mouth, pharynx, esophagus, intestine,
and anus (Additional file 1). However, the zebrafish belongs to the group of
stomach-less fishes in which the intestine transits directly from esophagus. In
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adult fish, it is folded into three sections: the rostral intestinal bulb, mid-
intestine and caudal intestine (Fig.2.1A). When dissected from the animal and
freed of the surrounding mesentery, the intestine remains folded by two turns
into three straight regions that correspond anatomically to the three portions
as observed in vivo (Fig.2.1B). Their diameters decrease along the anterior-
posterior axis (Fig.2.1B).
To characterize intestinal function, we subdivided the intestinal bulb, mid-
intestine, and caudal sections into seven segments, S1-S7 (Fig.2.1B) and exam-
ined their architecture under a light microscope. We observe that the zebrafish
intestine surface in segments S1-S6 is covered by ridges that are oriented cir-
cumferentially across the intestine axis (Fig.2.1C-I). The ridges are densely
packed and highly branched. In segment S6 the ridges are shorter and broader
than the anterior segments. Segment S7 is morphologically distinguished from
the other six segments by a smooth surface devoid of any folds or villus-type
structures (Fig.2.1I).
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Figure 2.1: Morphology of adult zebrafish intestine
(A) A partially dissected 6-month-old zebrafish shows the anterior, medial,
and posterior portions of the intestine (green-outlined). RIB: rostral intestinal
bulb; MI: mid-intestine; CI: caudal intestine. (B) Division of a dissected ze-
brafish intestine into seven equal-length segments (green lines), S1 to S7, along
the anterior-posterior axis. (C-I) Surface views of segments S1-S7 showing the
folding of the mucosal surface into ridges. Scale bars, 500 µm.
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Cross-sections of the intestinal segments reveal a simple architecture for
the zebrafish digestive tract of a mucosa, muscularis externa and serosa layer
(Fig.2.2). The intestinal mucosa consists of a simple epithelium of enterocytes
and mucous-secreting goblet cells and an underlying lamina propria containing
blood capillaries, lymphatic vessels, muscle fibres and mesenchymal cells [7].
The mucosal layer is directly ensheathed by circular and longitudinal smooth
muscle tiers of the muscularis externa within which are embedded the plexus
of myenteric neurons as reported previously [7, 71]. In the mammalian duo-
denum, a typical submucosal layer contain Brunner’s glands, the branched
tubular or branched tubuloalveolar glands that produce alkaline secretions to
neutralize the acidic chime entering the duodenum [98]. However, in the ze-
brafish intestine the submucosa layer and Brunner’s glands are absent (Fig.2.2).
35
Figure 2.2: Cross-section views of zebrafish intestine segments
Hematoxylin/Eosin/alcian blue-stained views of segments S1-S7 in cross sec-
tion. Segments S1-S6 contain three tissue layers: mucosa, muscularis externa
and serosa, while S7 has a simple epithelium directly adjacent to the muscu-
laris externa. Goblet cells (stained blue) are interspersed among the absorptive
cells. Panel H shows a section of a mammalian rat small intestine, for com-
parison purpose. Scale bars: 50µm
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Consistent with our earlier observations of intestinal ridges in segments S1
to S6 and absence of ridges in S7, these ridges in cross-section resemble the spa-
tially separate villi in the mouse or human small intestine (Fig.2.2). The villar
ridges are comparable in height from segments S1 to S5 (Fig.2.2A-E), shorten
and broaden in segment S6 (Fig.2.2F), and absent in segment S7 (Fig.2.2G).
Segments S5 and S7 often contain compact excretions that are ensheathed by
a mucous layer (stained blue by Alcian Blue in (Fig.2.2G). In addition to the
absence of villi, segment S7 is distinguished by its lining of abundant goblet
cells that are interspersed by absorptive epithelial cells (Fig.2.2G). The mus-
cularis externa is apparent, but the mucosa layer, in general, appears very thin
compared with other segments of the intestine. Thus, based on histology and
architecture, the intestinal lining is divided into three morphologically distinct
regions, segments S1-5, S6, and S7.
2.3.2 Distinct molecular signatures along the zebrafish
intestinal tract
Based on gross morphology, segments S1-S5 are similar while segments S6 and
S7 are different. These differences in structure suggest that there should be in-
herent differences in function. To test this idea, we examined and compared the
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molecular signatures of each segment by profiling their transcriptional activity.
Using a standard Bonferroni corrected p-value ≤ 0.1 (adjusted for false discov-
ery) applied to results from a one-way ANOVA analysis, we identified 2,558
genes that were differentially expressed in at least one of the seven segments
and organized the genes by hierarchical clustering analysis [91] (Fig.2.3A) for
similarities in patterns of gene expression. This analysis sorted the seven seg-
ments in their anatomical sequence, S1-S7 with S1-S5 more similar to each
other than to segments, S6 and S7.
To understand the significance of the clusters, we then applied a threshold
of 2.0 fold against pooled RNA extracted from whole adult zebrafish to the set
of 2,558 genes from the ANOVA analysis. This analysis shows the numbers of
genes that are abundantly expressed in each individual segment are: 830 (S1),
801 (S2), 820 (S3), 818 (S4), 825 (S5), 950 (S6) and 1023 (S7). To determine
the extent to which genes are commonly expressed along the intestinal tract,
we determined the overlap in gene sets between pairs of adjacent segments
(Fig.2.3B). Consistent with the clustering results in Fig.2.3A, significant inter-
section was found between segments S1-S5 [more than 700 genes (or ≥89.9%)
for each overlap, Fig.2.3B]. However, segments S6 and S7 express quite dif-
ferent sets of genes than the anterior segments. S5 and S6 overlap in 12.3%
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genes while S6 and S7 share only 45.2% genes in common. Full lists of genes
are shown in the Appendix section (Genes commonly enriched in S1-S5 are
shown in table 1; The rest of genes enriched in S1, S2, S3, S4, S5 are shown in
table 2, table 3, table 4, table 5, table 6, respectively; Genes enriched in S6 are
shown in table 7; Genes enriched in S7 are shown in table 8). Similar results
were also observed from analysis of down-regulated genes (data not shown).
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Figure 2.3: Identification of genes differentially expressed along the anterior-
posterior intestine
(A) Hierarchical clustering of segments S1-7 by differentially expressed genes
selected by ANOVA analysis. Segments S1 to S5 are clustered as one group;
segments S6 and S7 are clustered as another group. (B) Overlap analysis
of up-regulated genes in adjacent segments. The number and percentage of
overlapping genes are indicated within and below the intersection respectively.
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To confirm these patterns of overlap, we identified a number of genes that
were either highly expressed in segments S1-S5 (e.g. gdpd1, chchd7, zgc:11410,
hbl3, etc) or in segments S6 and S7 (e.g. trp, ctsl1, ctsc, gnb3, gsbp1, ppp2r2d,
etc), suggesting a comprehensive functional transition along the zebrafish intes-
tine (Fig.2.4A). The expression patterns of vil1l (Fig.2.4B), fabp2 (Fig.2.4C),
apoa1 (Fig.2.4D), apoa4 (Fig.2.4E), cfl1 (Fig.2.4F), zgc:110410 (Fig.2.4G), typ
(Fig.2.4H) and ctsl1 (Fig.2.4I) were confirmed by real time RT-PCR. Thus,
based on the molecular analyses, the zebrafish intestine can be divided into
three molecularly distinct regions as represented by segments S1-S5, S6, S7,
respectively.
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Figure 2.4: Expression patterns of selected intestinal genes
(A) Expression patterns of selected genes based on microarray data. The
genes were selected based on their known function in the digestive tract and/or
from their expression profiles. (B-I) qRT-PCR validated expression pattern of
selected genes. The histograms show the relative changes of the gene expression
levels compared with their respective levels of the housekeeping gene bactin2.
Gene names are indicated in each panel. 42
2.3.3 Molecular features of the small and large intestine-
like functions
Having shown the intestine can be subdivided into three regions, S1-S5, S6,
and S7, based on similarities in expressed genes, we investigated whether the
identity of the genes gives insight into intestine function and thus we selected
several markers for more detailed analysis.
The functions of the mouse and human small intestine have been character-
ized by well known molecular markers including fabp2 [99], vil1l [100, 101, 102],
apoa1 and apoa4 [103, 104, 105]. All of these genes were detected in S1-S5
in our microarray analyses by their higher levels of expression compared with
total RNAs from whole fish (Fig.2.4A) and confirmed by real time RT-PCR
analyses (Fig.2.4B-E). Intestinal fabp2 gene encodes a fatty acid binding pro-
tein that is specifically involved in the intracellular transport of fatty acids in
the small intestine [99, 106, 107]. This gene is highly conserved in teleosts, am-
phibians, avians and mammals [108]. Previously, a RFP transgenic zebrafish
line under the intestinal fabp2 promoter, Tg(fabp2:RFP), has been generated
and RFP reporter gene is specifically expressed in the intestine [109]. To fur-
ther verify the expression of intestinal fabp2, we isolated an intestine from a
3-month-old Tg(fabp2:RFP) transgenic zebrafish and found that RFP fluores-
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cence was high in segments S1-S4, but quickly diminished around the second
turn of the intestine (Fig.2.5A). This expression pattern was also confirmed by
direct detection of endogenous fabp2 mRNA expression by in situ hybridiza-
tion (Fig.2.5C). Closely resembling the pattern of fabp2 expression, vil1l ex-
pression is also restricted to the mammalian gastrointestinal tracts where it
is highly expressed in the small intestine [101]. Our microarray data show
that zebrafish villin gene (vil1l) is highly expressed in segments S1-S5 and its
expression is reduced in segments S6 and S7. This finding is further validated
by real time RT-PCR (Fig.2.4C), where the expression of vil1l decreases in
segment S5 and to a negligible level in segments S6 and S7. In further sup-
port that segments S1-S4 possess features of a small intestine, another two
conserved markers, apoa1 and apoa4, also showed similar expression pattern
to fabp2 and vil1l genes along the anterior-posterior axis of zebrafish intestine.
These two genes can also be considered to be reliable molecular markers for
small intestine because in 36 human tissues and 45 mouse tissues examined,
expression of mammalian Apoa1 and Apoa4 are highly restricted to the diges-
tive organs including small intestine and liver (GSE2361 and GDS182, GEO
database, NCBI). These patterns of small intestine markers together with the
transcriptome data suggest that the small intestine comprises segments S1-S4
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and transitions into a different function in segment S5.
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Figure 2.5: Identifying the boundary site between the small and the large
intestine
(A) Bright-field image of an intestine isolated from the transgenic line
Tg(fabp2:RFP). (B) Examination of fabp2 gene expression in the same intes-
tine, where expression of RPF reporter was driven by the fabp2 gene promoter.
The circle indicates the site where transgenic fabp2 expression is switched off.
(C) In situ hybridization of fabp2 gene in zebrafish intestine. Endogenous
expression of fabp2 was evident in segments S1, S2, S3, S4, but it quickly
diminished to negligible level in the proximal site of segment S5.
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If segments S1-S4 are small intestine-like, then we investigated whether S5-
S7 expresses gene markers for the large intestine. Two genes, cfl1 (cofilin1) and
aqp3 (aquaporin 3), distinguish segments S5-S7 from S1-S4. Cfl1 belongs to
a family of actin-binding proteins and mediates dynamic stabilization of actin
filaments [110]. Our microarray and real time RT-PCR data (Fig.2.4A and F)
indicate that cfl1 is primarily expressed in segments S5-S7, but down-regulated
in the first four segments. Analysis of rat EST database suggests that Cfl1
is expressed in the large intestine but not in the small intestine (Unigene’s
EST profile viewer, Unigene Rn.11675, NCBI). Similarly, our microarray data
indicated increased expression of Aqp3, an osomoregulatory channel protein
on membrane of epithelial cells [111] and mucus cells of the posterior intestine
of teleost eel [112], in segments S6 and S7 (Fig.2.4A, Dr.76207). Aquaporins
are water channel proteins that facilitate water movement, hence increase wa-
ter permeability, across cell membrane and the increase expression of Aqp3 is
therefore important for absorption of water in the intestine, in particular, for
the fecal dehydration in the large intestine. In line with this, the mammalian
aquaporin 3 is expressed along the gastrointestinal tract, with its highest ex-
pression in the colon [111]. Thus, while segments S1-S5 possess molecular
features of small intestine, segments S6 and S7 have molecular features of
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large intestine with segment S5 as a transitional region.
2.3.4 Analysis of gene ontology along the anterior-posterior
axis
To infer the functions of the intestinal segments, we pooled the data sets of
genes that showed up-regulated expression in each segment into three groups,
S1-S5 (891 genes), S6 (1147 genes), and S7 (1107 genes), and identified on-
tologies that were revealed [92]. The significantly enriched (p-value ≤ 0.01)
categories based on GO analysis are shown in Table 2.1.
As expected from a major metabolic organ, the intestine of zebrafish har-
bors a rich collection of genes involved in metabolism, molecular transport and
localization, catalytic activities among others. However, major differences were
found between the three groups of S1-S5, S6 and S7. There are 56 categories
that were statistically enriched in S1-S5, but only 6 categories in S6 and 8 cate-
gories in S7. Among these enriched categories, up-regulated genes in S1-S5 are
involved in a wide range of metabolic processes, including metabolism of fatty
acid, organic acid, lipid, vitamin, heme, alcohol, glucose, hexose, monosac-
charide, carbohydrate, etc. (Table 2.1). They also play important roles in
energy generation and homeostasis of ion, iron and cations. Notably, a group
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of genes are associated with catalytic activities such as hydrolase activity and
transferase activity, which are important for the absorptive function of the
small intestine. The variety of GO categories in the S1-S5 group supports the
multiple functions of this part of zebrafish intestine with features of the small
intestine (to be discussed below).
The S6 and S7 groups, on the other hand, only show a few statistically
enriched categories. For example, genes from S6 are involved in oxidoreductase
activities while genes from S7 are enriched in biosynthesis of vitamin and
pyridine nucleotide (Table 2.1). They are also involved in intracellular signaling
and pentosyl/phosphoribosyl transferase activity. These results suggest that
segments S6 and S7 represent two regions of zebrafish intestine that perform
tasks apparently different from those of S1-S5.
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Table 2.1: Enriched gene ontologies in zebrafish intestine. O:
observed; E: expected; R: ratio of observed over expected; P:
p-value
segments S1-S5
In biologicial process O E R P
vitamin biosynthesis 3 0.08 37.5 1.55E-05
water-soluble vitamin biosyn-
thesis
3 0.08 37.5 1.55E-05
alcohol metabolism 7 1.28 5.47 2.42E-04
gluconeogenesis 3 0.15 20.0 2.92E-04
alcohol biosynthesis 3 0.18 16.67 5.02E-04
hexose biosynthesis 3 0.18 16.67 5.02E-04
monosaccharide biosynthesis 3 0.18 16.67 5.02E-04
pyruvate metabolism 3 0.18 16.67 5.02E-04
heme biosynthesis 6 1.08 5.56 6.26E-04
heme metabolism 6 1.08 5.56 6.26E-04
monosaccharide metabolism 6 1.08 5.56 6.26E-04
pigment biosynthesis 6 1.08 5.56 6.26E-04
pigment metabolism 6 1.08 5.56 6.26E-04
pyridine nucleotide biosynthe-
sis
2 0.05 40 6.31E-04
vascular endothelial growth
factor receptor signaling path-
way
2 0.05 40 6.31E-04
heterocycle metabolism 7 1.51 4.64 6.70E-04
iron ion transport 7 1.51 4.64 6.70E-04
iron ion homeostasis 7 1.53 4.58 7.41E-04
transition metal ion home-
ostasis
7 1.53 4.58 7.41E-04
water-soluble vitamin
metabolism
3 0.2 15 7.88E-04
secondary metabolism 6 1.13 5.31 8.03E-04
di-, tri-valent inorganic cation
homeostasis
7 1.58 4.43 9.02E-04
metal ion homeostasis 7 1.58 4.43 9.02E-04
porphyrin biosynthesis 6 1.16 5.17 9.04E-04
porphyrin metabolism 6 1.16 5.17 9.04E-04
generation of precursor
metabolites and energy
12 4.37 2.75 1.23E-03
carboxylic acid metabolism 8 2.16 3.7 1.28E-03
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organic acid metabolism 8 2.16 3.7 1.28E-03
cofactor metabolism 9 2.69 3.35 1.31E-03
cation homeostasis 7 1.71 4.09 1.43E-03
cell ion homeostasis 7 1.73 4.05 1.55E-03
cofactor biosynthesis 8 2.24 3.57 1.60E-03
ion homeostasis 7 1.78 3.93 1.84E-03
glucose metabolism 5 0.9 5.56 1.85E-03
cell homeostasis 7 2.01 3.48 3.65E-03
vitamin metabolism 3 0.33 9.09 3.67E-03
hexose metabolism 5 1.08 4.63 4.11E-03
homeostasis 7 2.06 3.4 4.20E-03
main pathways of carbohy-
drate metabolism
5 1.16 4.31 5.51E-03
carbohydrate biosynthesis 3 0.38 7.89 5.63E-03
energy derivation by oxida-
tion of organic compounds
5 1.18 4.24 6.04E-03
In molecular function
fatty acid binding 4 0.15 26.67 4.79E-06
iron ion binding 9 2.19 4.11 2.92E-04
nicotinate phosphoribosyl-
transferase activity
2 0.02 100 3.03E-04
lipid binding 6 1.12 5.36 7.67E-04
catalytic activity 46 32.34 1.42 3.20E-03
acyl-CoA binding 2 0.1 20 3.41E-03
tetrapyrrole binding 5 1.05 4.76 3.59E-03
heme binding 5 1.05 4.76 3.59E-03
ligand-dependent nuclear re-
ceptor activity
4 0.78 5.13 7.06E-03
steroid hormone receptor ac-
tivity
4 0.78 5.13 7.06E-03
cytoskeletal protein binding 4 0.8 5 7.88E-03
hydrolase activity, acting on
carbon-nitrogen (but not pep-
tide) bonds, in linear amides
2 0.15 13.33 8.26E-03
In cellular component
heterotrimeric G-protein 2 0.15 13.33 8.83E-03
complex
plasma membrane part 6 1.81 3.31 8.98E-03
segment S6




5 0.99 5.05 2.48E-03
In molecular function
oxidoreductase activity, act-
ing on the aldehyde or oxo
group of donors, NAD or
NADP as acceptor
3 0.23 13.04 8.81E-04
catalase activity 2 0.05 40 1.11E-03
oxidoreductase activity, act-
ing on the aldehyde or oxo
group of donors
3 0.37 8.11 4.45E-03
In cellular component
contractile fiber 2 0.04 50 9.09E-04
contractile fiber part 2 0.04 50 9.09E-04
segment S7
In biologicial process O E R P
pyridine nucleotide biosynthe-
sis
2 0.08 25 1.78E-03
intracellular signaling cascade 16 7.6 2.11 3.44E-03
vitamin biosynthesis 2 0.13 15.38 5.11E-03
water-soluble vitamin biosyn-
thesis
2 0.13 15.38 5.11E-03
neuropeptide signaling path-
way
3 0.42 7.14 7.01E-03
membrane organization and
biogenesis




3 0.44 6.82 8.38E-03
nicotinate phosphoribosyl-
transferase activity
2 0.04 50 8.54E-04
In cellular component
nil - - - -
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2.3.5 Cross-species Gene Set Enrichment Analysis (GSEA)
indicates the segments S1-S5 to be multi-functional
An independent approach to confirm the identity of the intestine sections as
small and large intestine is by taking the three gene set pools from S1-S5, S6,
and S7 and comparing them by GSEA analysis against the whole transcrip-
tomes of the mouse and human stomach, small intestine and large intestine
(GDS182 and GSE2361, GEO database, NCBI). Results, summarized in Table
2.2, show segments S1-S5 closely resemble the small intestines of mouse and
human with highly significant FDR values (less than 0.001). Segments S1-S5
show little resemblance to stomach (mouse FDR = 0.06; human FDR = 0.68)
and no resemblance to the human cecum. Gene ontology analysis shows that
majority of the genes corresponding to the leading edge of the GSEA curve are
involved in the metabolism of lipid, fatty acid, cholesterol and glycerolipid, or
involved in peptidase, oxidoreductase activity, reminiscent of the activities of
the mammalian small intestine (data not shown). In addition, segments S1-S5
also produced significant FDR values for human colon and rectum, indicating
that these segments are multi-functional.
53
Table 2.2: Comparison of transcriptome similarity of ze-
brafish intestinal segments and human/mouse intestines by
GSEA analyses. FDR: false discovery rate ***highly signifi-
cant; **significant; *marginally significant
Human/mouse intestines S1-S5 S6 S7 GEO accession
Mouse stomach 0.06* 1.00 0.94 GDS182
Human stomach 0.68 0.63 0.55 GSE2361
Mouse small int. ≤0.001*** 0.34 0.40 GDS182
Human small int. ≤0.001*** 0.21* 0.86 GSE2361
Mouse cecum 0.17* 0.28* 0.21* GDS182
Human cecum 1.00 ≤0.001*** 0.016** GSE9254
Human colon ≤0.001*** 1.00 0.90 GSE2361
Human sigmoid colon ≤0.001*** 0.015** 0.038** GSE9254
Human rectum ≤0.001*** ≤0.001*** 0.003*** GSE9254
54
In contrast to segments S1-S5, segment S6 closely resembles the cecum and
rectum of the human large intestine (FDR ≤ 0.001), while segment S7 resem-
bles human rectum only (FDR = 0.003). Gene ontology analysis shows that
S6 resembles human cecum in glycolysis, oxidoreductase activity, metabolism
of amino acid, amine derivative, organic acid, carboxylic acid and alcohol.
While in S7, metabolism of membrane lipid was found to be enriched. Water
retention is a commonly found function in mammalian large intestine and we
found it also enriched in S6/S7 of zebrafish, where several aquaporin genes are
highly expressed including aquaporins 1, 3 and 10. In particular, the aquaporin
3 has been known to be a key component of faecal dehydration in mammalian
colon [111]. Interestingly, significant results are also found between S1-S5 and
the human sigmoid colon and rectum, suggesting that the zebrafish segments
S1-S5 may have broad functions.
In summary, GSEA analysis supports that segments S1-S5 of zebrafish
intestine possess features of a mammalian small intestine, while segments S6
and S7 possess features of a mammalian large intestine (with S7 resembling
rectum in particular).
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2.3.6 Stomach-like functions of the intestine
A striking feature of the zebrafish anatomy is the absence of stomach [72, 113].
To understand whether the gut carries out a cryptic gastric function, we exam-
ined the zebrafish genes encoding enzymes including pepsin and some digestive
proteases with implications of functions of a stomach. Mammalian pepsinogens
are classified into three major groups and two minor groups [114, 115], how-
ever, a pepsinogen gene in zebrafish has never been reported. We searched for
potential pepsinogen sequences in the zebrafish genome. First, we conducted a
BLAST search against the Ensembl genome database (www.ensembl.org) us-
ing sequences of human PGC (PEPSINOGEN C) and PGA (PEPSINOGEN
A) but did not detect any significant hits relevant to the pepsinogen gene.
Then in a more specific TBLASTN search [116] using the pfam00026 domain
that is well conserved across all aspartic proteases in vertebrates, we identified
pepsinogen genes as well as some aspartic protease genes in human, mouse,
Xenopus and Fugu fish, together with a few zebrafish aspartic protease genes
and a putative gene sequence encoding a hypothetical protein NP956325.1.
To determine whether these zebrafish sequences could represent a pepsino-
gen gene, relevant amino acid sequences were aligned, a phylogenetic tree was
constructed using quartet puzzling algorithm implemented in the Tree-Puzzle
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program [117], and the result was visualized by TreeViewX [118]. Our anal-
ysis suggests that the zebrafish has genes coding for rennin, nothepsin and
several members of cathepsins (Fig.2.6). However, none of these zebrafish
genes resemble the mammalian pepsinogen genes. The genome search results
and phylogeny analysis results together suggest that the pepsinogen gene locus
is not present in the zebrafish genome.
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Figure 2.6: Phylogeny analysis of zebrafish genes encoding aspartic proteases
The amino acid sequences of zebrafish digestive proteases were compared with
those from other species, including mammals, amphibians and fishes. The
parasite aspartic protease (Haemonchus contortus), CAA96571, is used as the
outgroup. ? indicates a candidate hypothetical protein product.
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Whereas pepsinogen is not encoded in the zebrafish genome, other stom-
ach markers may be expressed by the intestine. For example, lipf is a gastric
lipase gene encoding an acidophilic lipase known to be secreted by mammalian
gastric chief cells [119, 120]. Its expression in human is restricted to esoph-
agus, stomach and several other tissues, but not in the intestine (Unigene’s
EST profile viewer, UniGene Hs.523130, NCBI database). In contrast, lipf is
expressed in all seven segments of the zebrafish intestine and not restricted to
any particular segment (Fig.2.4A).
2.3.7 Pathway analysis for zebrafish intestine
Genes up-regulated in different segments of zebrafish intestine are selected
in the same way as previously described. Based on similarity of their tran-
scriptomes, they are grouped into three groups, representing segments S1-S5,
S6 and S7, respectively. Pathway analysis was done using the WebGestalt
toolkit [93], with a cut-off p value of 0.01 and requirement that the number of
observed genes is not less than 5.
Pathways that are significantly enriched in segments S1-S5 are shown in
Fig.2.7. In total, there are 26 pathways found to be enriched with p value less
than 0.01 and the number of observed genes not less than 5. One group of
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pathways are involved in cellular signaling, including PPAR signaling, adipocy-
tokine signaling, insulin signaling, VEGF signaling, GnRH signaling and so
on. A second group of pathways are involved in metabolic processes, including
metabolism of fatty acid, citrate, ether lipid, arachidonic acid, pyruvate and so
on. A third group of pathways are involved in cell migration and proliferation,
including tight junction, adherens junction, Wnt signaling, cell cycles and so
on.
Enrichment of Wnt signaling is consistent with our current knowledge that
Wnt signaling is a major pathway mediating the proliferation of intestinal
epithelium [121, 122]. In line with this, cell cycle pathway is also enriched as
the small intestinal epithelium are well known to be renewing at a fast pace [6,
123]. The enrichment of multiple metabolic pathways evidences the metabolic
activities in the small intestine. While the enrichment of tight junction and
adherens junction indicates the barrier function of the epithelial cells.
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Figure 2.7: Enriched pathways in segments S1-S5 of zebrafish intestine.
Pathway analysis was performed using the WebGestalt program. The signif-
icance was tested by a critical p value of 0.01 and requirement of at least 5
gene observed to be present in one pathway. Numbers in brackets indicate the
number of genes that are observed to be present in each pathway. In total,
there are 26 pathways found to be enriched in segments S1-S5 of zebrafish
intestine. See the text for more information about the pathways.
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Using the same settings as mentioned earlier, pathways that are signifi-
cantly enriched in segment S6 are shown in Fig.2.8. In total, there are 22
pathways found to be enriched here. 14 of these pathways are enriched in
S6, but not in S1-S5, including focal adhesion, long-term depression, long-
term potentiation, apoptosis, axon guidance and so on. These differences are
consistent with our previous gene overlapping analysis of their transcriptomes.
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Figure 2.8: Statistically enriched pathways in segment S6 of zebrafish intestine.
Pathway analysis was performed using the WebGestalt program. The signif-
icance was tested by a critical p value of 0.01 and requirement of at least 5
gene observed to be present in one pathway. Numbers in brackets indicate the
number of genes that are observed to be present in each pathway. In total,
there are 22 pathways found to be enriched in segment S6 of zebrafish intestine.
See the text for more information about the pathways.
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Similarly, 14 pathways are found to be enriched in segment S7 of zebrafish
intestine. Results are shown in Fig.2.9. 10 of these pathways have been found
to be also enriched in S6, including focal adhesion, apoptosis, axon guidance,
longterm potentiation, GnRH signaling and so on. The newly emerged path-
ways in S7, compared with S6, include: Wnt signaling, regulation of actin
cytoskeleton, tight junction and PPAR signaling. Thus the distal large intes-
tine shows some functional difference from the proximal large intestine, though
they share some similarity. The enriched pathways in S7 implicate an active
process of cell renewal. On the one hand, MAPK signaling and Wnt signaling
promote cell survival and proliferation; On the other hand, GnRH signaling
counter-mediate cell proliferation and undesired cells may be removed through
apoptosis.
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Figure 2.9: Statistically enriched pathways in segments S7 of zebrafish intes-
tine.
Pathway analysis was performed using the WebGestalt program. The signif-
icance was tested by a critical p value of 0.01 and requirement of at least 5
gene observed to be present in one pathway. Numbers in brackets indicate the
number of genes that are observed to be present in each pathway. In total,
there are 14 pathways found to be enriched in segment S7 of zebrafish intestine.
See the text for more information about the pathways.
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2.3.8 Discussion
The results in this study document that the zebrafish intestine is regionally
segmented into a small intestine and large intestine. This conclusion is sup-
ported by three lines of independent analysis of gene expression profiles from
seven segments of the intestine. Clustering analysis reveals a general similarity
between S1-S5 and differences between S6 and S7 and the degree of similarity
is measured by the degree of overlap in gene sets expressed in neighboring seg-
ments. Second, we showed that well-known markers of the mammalian small
and large intestine such as villin, intestinal fatty acid binding protein, and
cofilin 1 are differentially expressed along the anterior-posterior axis. Finally
by ontologies of genes expressed in the segments are consistent with small and
large intestine function and confirmed by whole transcriptome comparisons
with human and mouse small and large intestine gene sets. Based on these re-
sults, we suggest that the intestinal bulb, mid-intestine, and the anterior third
of the caudal intestine corresponds to the small intestine of the mammalian
gut while the remaining posterior portion of the caudal intestine corresponds
to the large intestine terminating with the rectum.
In comparison with the mammalian intestine, the zebrafish intestine has
a simple architecture with the intestinal lining folded into villar ridges rather
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than distinct finger-shaped villi of the mammalian small intestine. In cross
section, a ridge appears identical to a villus and thus may be an evolutionary
precursor to discrete villi. In support of this idea, an intermediate stage (from
D8-D8.5) in the morphogenesis of the chick intestine includes the initial for-
mation of longitudinally oriented previllous ridges that buckle into a zig-zag
pattern and eventually form villi in adult intestine. Thus, in birds, ridges are
embryological precursors to villi [58].
In addition to the lack of well-defined villi, the zebrafish intestine lacks
well-defined crypts [7, 71], infoldings of the intestinal surface where stem cells
and proliferating cells are located. Intestinal crypts are normally found at the
base of the villus or lining the colon of the large intestine. In the zebrafish
intestine, mitosis is restricted to the base of the villar ridges ( [79] and our
unpublished data), suggesting that the crypts of Lieberkuhn are specializations
of the mammalian intestine. This arrangement also raises questions about the
dynamics of epithelial renewal because cell proliferation in the intestine is
balanced by apoptosis at the villus tips. Location of apoptosis in the adult
zebrafish intestine is rarely reported but we find most cell death occurs in
the distal portion of the villar ridges and apoptosis is much more active when
compared with mammalian intestines (our unpublished data). In contrast,
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apoptosis in the embryonic and larval zebrafish intestine goes undetectable
till morphogenesis completes [7, 71], while apoptosis occurs throughout the
development of the mouse duodenum [124] but is reduced to a few cells per
villus during adulthood [121].
Like many other fish including cyprinids and others [113], the zebrafish has
evolved into a stomachless fish. The absence of a functional pepsinogen gene
from the digestive tract is not unique to zebrafish but also occurs in medaka fish
(Oryzias latipes) and other stomach-less fishes. Interestingly, the expression of
pepsinogen gene in another stomchless fish, the puffer fish (Takifugu rubipes),
is restricted to its skin tissue, adopting different functions [113]. Without
a stomach, digestion and absorption must begin as early as possible in the
limited length of the zebrafish digestive tract. Ingested food is temporarily
stored in the rostral intestinal bulb that bulges like an elastic sac, where food
starts to be broken down in the absence of a stomach [72] and the entire length
of the intestine may serve to degrade food.
Based on analysis in larval zebrafish and other cyprinids, previous reports
raised that the posterior zebrafish intestine may be analogous to the mam-
malian colon [48,49]. This has also been proposed in a recent study based on
histological data and molecular markers [7]. Here our transcriptome data pro-
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vide more solid evidence that this part of intestine in adult zebrafish resembles
mammalian colon and rectum and moreover, segments S6 and S7 distinguish
themselves from each other.
2.3.9 Conclusions
In the present study, the entire intestine of adult zebrafish was systemati-
cally examined at the levels of anatomy, histology and transcriptome. Despite
the lack of crypts and evident structural distinction throughout most of the
length of intestine, our genome-wide gene expression data have shown that
the rostral, mid, and caudal portions of the zebrafish intestine have distinct
functions analogous to the mammalian small and large intestine, respectively.
Organization of ridge structures represents a unique feature of zebrafish in-
testine, though they produce similar cross sections to mammalian intestines.
Evolutionary lack of stomach, crypts, Paneth cells and submucosal glands has
shaped the zebrafish intestine into a simpler but unique organ in vertebrate in-
testinal biology. This scenario may represent an evolutionary primitive feature
of the digestive tract, where functional regionalization precedes morphological
regionalization in a low vertebrate.
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Chapter 3
Regulation of cell fate and




Notch signaling is one of the major regulators of epithelium proliferation in the
intestine [79, 125, 126]. Notch signal is usually restricted to the basal region
of crypts where epithelium proliferation is active. As the cells migrate out
of the basal region, they lose the Notch signal and differentiation is initiated.
The role of Notch, however, goes beyond regulation of proliferation. When
Notch signaling is inhibited in mouse intestine, precursor cells are induced to
differentiate precociously along with a shift in epithelium composition in favor
of the secretory lineage [125, 126]. Here we would like to investigate whether
similar roles of Notch are also played in zebrafish intestine, and further, what
specific mesenchymal cells are responsible for this process in view of the close
interaction between epithelial and mesenchymal cells. By inhibiting Notch sig-
naling through a potent γ-secretase inhibitor, N-[N-(3,5-Difluorophenacetyl-L-
alanyl)]-S-phenylglycine t-butyl ester (DAPT), we found a reduction in epithe-
lium proliferation, accompanied by a cellular compositional shift toward the
secretory lineage in zebrafish intestine. Histological analysis indicated a reduc-
tion in a distinct cohort of glycogen-rich intestinal subepithelial myofibroblasts
(ISEMFs) along the villus axis in response to this compositional shift. In the
mean time, BMP4 signaling, which is usually antagonized near basal region
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of crypts [127], and the activity of GATA6, one of the master regulators of
endodermal gene expression [128], were enhanced.
3.2 Materials and Methods
The Materials and Methods partially overlap with those in Chapter 2, in-
cluding maintenance of zebrafish, tissue sectioning of zebrafish intestine and
quantitative real-time PCR, which have been described in section 2.2 of Chap-
ter 2. Here only the part of the Materials and Methods specific to Chapter 3
are described.
3.2.1 DAPT treatment of zebrafish
Adult male wild-type zebrafish were raised to about six months old according
to established protocols [129], till treatment by DAPT (N-[N-(3,5-Difluorophenacetyl-
l-alanyl]-S-phenylglycine-t-butyl ester; Sigma-Aldrich, USA). DAPT was pre-
pared at 100 µM in 0.1% DMSO. The concentration was optimized from treat-
ment at 50 and 100 µM, respectively, and the 100 µM produced more goblet
cells than 50 µM. Control fish were incubated in 0.1% DMSO. They were
euthanized after treatment for 24 hours for RNA analysis or 72 hours for his-
tological analysis. BrdU was orally administered 20 min before euthanasia if
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proliferation assay was to be carried out. The Tg(nkx2.2a-GFP) transgenic
zebrafish is a kind gift from Dr. Joan K Heath’s laboratory, Ludwig Institute
for Cancer Research, Australia.
3.2.2 Alcian blue and Periodic Acid in Schiff’s reagent
staining
The paraformaldehyde-fixed, paraffin-embedded tissue sections were stained
according to the manufacturer’s protocol coming with the kit (cat# ss020,
BioGenex, San Ramon, USA). Briefly, the slides were dewaxed in HistoClearII
for 5 min twice, rinsed in phosphate-buffered saline and incubated in Alcian
blue solution for 20 min. They were rinsed in tap water before they were
incubated in periodic acid and Schiff’s reagent for 5 min each, then subjected
to the reducing reagent for another 5 min, rinsed between these steps. They
were counterstained by Mayer’s hematoxylin for 1 min and rinsed in running
tap water for 5 min. The slides were then dehydrated in 75%, 95%, 100%
ethanol, respectively, cleared in HistoClearII and finally mounted in DePex
mounting medium with cover slips for microscopy on an Zeiss Axiovert system.
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3.2.3 Whole mount in situ hybridization
Whole-mount in situ hybridization using digoxigenin (DIG)-labeled riboprobes
was carried out as previously described [130]. Briefly, the cDNA clones were
linearized with a selected restriction enzyme, followed by in vitro transcription
for the antisense RNA probe. The samples were fixed with 4% paraformalde-
hyde/ phosphate-buffered saline, hybridized with a DIG labeled RNA probe
in a hybridization buffer (50% formamide, 5XSSC, 50 µg/ml tRNA and 0.1%
Tween 20) at 70oC, followed by incubation with anti-DIG antibody conjugated
with alkaline phosphatase and by staining with the substrates, NBT (nitro blue
tetrazolium) and BCIP (5-bromo, 4-chloro, 3-indolil phosphate), to produce
purple, insoluble precipitates.
3.2.4 Cryosection of zebrafish intestine
The samples after whole mount in situ hybridization were placed on the frozen
surface of a layer of tissue freezing medium (Reichert-Jung, Germany) on the
pre-chilled tissue holder, and coated with a drop of cryostat freezing medium
and then immersed in liquid nitrogen until thoroughly chilled. The frozen block
was placed in the cryostat chamber (Reichert-Jung, Germany) for 30 min to
1 hour to equilibrate with chamber temperature of −30oC. Samples were
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sectioned at 20 µm thickness and collected onto Superfrost plus slides (Fisher,
USA). The slides were completely dried on a 42oC heating block overnight. The
sections were embedded in several drops of glycerol/phosphate-buffered saline
(1:1) for photo-taking on a Zeiss Axiovert imaging system (Zeiss, Germnay).
3.2.5 Immunohistochemistry
BrdU assay was carried out according to the manufacturer’s protocol coming
with the kit (cat# 2760, Chemicon International, USA). Briefly, the paraformaldehyde-
fixed, paraffin-embedded tissue sections were dewaxed in HistoClearII 5 min
for twice, rehydrated in 100%, 90%, 80% and 70% ethanol, respectively. They
were quenched in 3% hydrogen peroxide, incubated in 1X trypsin solution,
then incubated in Denaturing solution. Next they were blocked in Blocking
solution before they were incubated in Detector antibody and Streptavidin-
horse radish peroxidase Conjugate, respectively. Diaminobenzidine substrate
mixed in Substrate Reaction Buffer was added to the slides to produce the dark
brown color before the slides were counterstained by hematoxylin. Finally, the
slides were dehydrated and mounted in DePex mounting medium with cover
slips for microsopcy on a Zeiss Axiovert imaging system (Zeiss, Germany).
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3.3 Results
3.3.1 Inhibition of Notch signaling in larval zebrafish
intestine
Effect of inhibition of Notch signaling by DAPT in larval zebrafish was inves-
tigated by utilizing Tg(nkx2.2a-GFP) zebrafish, where specific expression of
nkx2.2a in enteroendocrine cells was indicated by GFP fluorescence. 14 dpf
Tg(nkx2.2a-GFP) larval fish were incubated in aquarial water containing 100
µM DAPT for 24 hours (the duration of treatment was similar to previous
studies using DAPT for zebrafish larvae [131]). The larvae were immobilized
by 2-phenoxyethanol for imaging on a Zeiss Aviovert system. As shown in
Fig.3.1A and B, the population of nkx2.2a-expressing enteroendocrine cells in
larval fish intestine increased after treatment, consistent with previous reports
of an increase in the pan-secretory cell lineages after inhibition of Notch sig-
naling [125, 126]. Thus the DAPT treatment of zebrafish proves to be effective
in perturbing Notch signaling in larval intestine.
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3.3.2 Verification of inhibition of Notch signaling in adult
zebrafish intestine
Adult zebrafish (6-month-old) were immersed in aquarium water containing
100 µM DAPT for 24 hours and then euthanized for assays. To verify the
effect of inhibition of Notch signaling, RNA was extracted from the zebrafish
intestines and quantitative RT-PCR on several indicator genes was conducted.
Zebrafish atonal homolog gene zath1 (orthologous to Math1 in mouse and
HATH1 in human), the expression of which is normally suppressed by Notch
signaling [126], were found to be up-regulated upon inhibition of Notch sig-
naling (Fig.3.1 C). Another bHLH transcription factor, hes1, which has been
known to be a target gene of Notch signaling [126], was down-regulated as ex-
pected (Fig.3.1 D). These results proved the effectiveness of inhibition of Notch
signaling in adult zebrafish intestine. In addition, we noticed that the down-
stream effector of Wnt signaling, tcf4, was also down-regulated (Fig.3.1E),
consistent with the reduction of the progenitor cells as observed below.
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3.3.3 Reduction in the pool of intestinal progenitor cells
upon inhibition of Notch
BrdU was orally administered 15 min before euthanasia of the fish and the
intestines were isolated for paraffin sectioning. Immunohistochemistry with
antibody against BrdU showed a significant reduction in the population of
intestinal progenitor cells upon inhibition of Notch signaling (Fig.3.2A-C). By
measurement of over 600 villi, we found that the number of BrdU+ progenitor
cells in the intestinal epithelium after Notch inhibition is about one third of
those in the control (Fig.3.2C). The expression of the cell cycle check point
gene p21WAF1/cip1 [132, 133] was also up-regulated upon inactivation of
Notch in zebrafish intestine (Fig.3.2D). This explains the reduction in the
pool of proliferative progenitor cells as more cells are arrested in cell division.
This is also consistent with previous reports that CDK inhibitors p27Kip1 and
p57Kip2 are derepressed upon inactivation of Notch in larval zebrafish [134],
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Figure 3.1: Pharmocological inhibition of Notch signaling by DAPT treatment
(A and B) Fluorescent imaging of the intestines of the 14 dpf Tg(nkx2.2a:GFP)
larval fish. The nkx2.2a-expressing enteroendocrine cells are dispersed along
the intestine in the control fish (A), and their population is increased after
pharmocological inhibition of Notch signaling by DAPT-treatment (B). (C-E)
qRT-PCR results for expression of zath1, hes1 and tcf4, respectively. mRNAs
were extracted from the adult intestines using trizol (Sigma, USA). Suppression
of zath1 expression by Notch is relieved after DAPT-treatment (C); while
expression of hes1 is up-regulated (D). In the mean time, expression of tcf4 is
down-regulated after DAPT-treatment. Scale bar: 100 µm
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Figure 3.2: Changes in BrdU-labelled cells and expression of p21 upon inhibi-
tion of Notch
(A and B) BrdU assay on cross sections of adult fish intestines. BrdU-retaining
cells are stained dark brown. There is an evident decrease in BrdU-retaining
cells upon inhibition of Notch by DAPT treatment (B) when compared with
control (A). (C) Counting of BrdU-labelled cells per villus on cross sections
of adult intestines. A decrease in the cell number is observed after DAPT-
treatment. (D) Changes in the expression of p21 by qRT-PCR with mRNA
extracted from adult intestines. Expression of this gene is up-regulated upon
DAPT-treatment.
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3.3.4 Increase of secretory lineages after inhibition of
Notch signaling
Quantitative RT-PCR and histological examinations were conducted to evalu-
ate the changes in epithelial cell differentiation toward different lineages. Ex-
pression of zath1, a known bHLH transcription factors favoring pan-secretory
lineage differentiation in intestinal epithelium of larval zebrafish [79], was up-
regulated in adult intestine upon inhibition of Notch signaling (Fig.3.1C).
Potential changes in goblet cells were investigated by histology. After in-
hibition of Notch signaling, there was an increase in the population of goblet
cells as well as a more frequent presence of mature goblet cells in the inter-villi
pockets, where precursor cells normally reside (Fig.3.3A and B). The number
of mature goblet cells was further counted on each histological section after
staining of both acidic and neutral mucopolysaccharides richly present in goblet
cells with alcian blue and periodic acid/schiff’s reagent. It was found that the
population of mature goblet cells increased about two folds due to inhibition
of Notch signaling (Fig.3.3C). In the mean time, generation of another secre-
tory lineage, the enteroendocrine cells, was also up-regulated as indicated by
expression of the marker gene, ngn3, which functions downstream of the zath1 -
initiated enteroendocrine lineage differentiation cascade [135] (Fig.3.3D).
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While the increased differentiation along the secretory lineages was evi-
denced by up-regulation of zath1 and ngn3 (Fig.3.1C and Fig.3.3D), differen-
tiation of enterocytes was found to decrease as shown by in situ hybridization
of fabp2 gene (Fig.3.3E and F), which was a marker for differentiated ente-
rocytes. As shown in Fig.3.3E, in the intestines of control fish, fabp2 was
abundantly expressed in enterocytes along the villus axis except the inter-villi
pocket, where most proliferative and undifferentiated progenitor cells resided.
In the intestines of DAPT-treated fish, fabp2 was expressed along the villus
axis at a lower level and had less number of differentiated enterocytes. This
suggests that more progenitors differentiated toward the secretory lineage at
the cost of the absorptive lineage.
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Figure 3.3: Changes in different cell lineages in zebrafish intestinal epithelia
upon inhibition of Notch
(A and B) Alcian blue and Periodic Acid/Schiff’s staining of goblet cells in
a cross-section of the adult zebrafish intestines in control (A) and DAPT-
treated (B) fish. Increase in goblet cell maturation is observed after inhibition
of Notch signaling (B). Precocious differentiation of goblet cells are often seen
in the basal regions of inter-villi pockets where precursor cells normally reside.
(C) Changes in the number of goblet cells upon inhibition of Notch signaling.
(D) Changes in expression of ngn3 by qRT-PCR upon inhibition of Notch
signaling. (E and F) fabp2 expression in zebrafish intestine as detected by
in situ hybridization on cross sections of intestine in control (E) and DAPT-
treated zebrafish (F).
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3.3.5 Enhanced expression of gata6 upon inhibition of
Notch in the intestine
gata6 is one of the major GATA transcription factors, along with gata-4 and
gata-5, in the maintenance of the endodermal gene expression from the early
developmental stages to adulthood [108] and gata6 has been suggested as a
suppressor gene of brain tumor [136, 137, 138]. In situ hybridization showed a
moderate increase in the expression of gata6 along the villus after the DAPT
treatment (Fig.3.4A and B). In accordance, quantitative RT-PCR also de-
tected an increased expression of gata6 in the intestines of adult zebrafish upon
treatment with DAPT (Fig.3.4C). The expression of gata6 was seen in the dif-
ferentiated epithelial cells lining the middle-to-upper part of villi (Fig.3.4A).
Toward the inter-villi pocket, where most proliferating cells were residing, its
expression appeared to be absent in the control fish (Fig.3.4A), but present in
the DAPT-treated fish (Fig.3.4B, arrow heads). The complementary localiza-
tion of gata6 + differentiated epithelium and proliferating progenitors shows
existence of the compartment of cell differentiation (Fig.3.4A, region 1) and
the compartments of cell proliferation (Fig.3.4A, region 2), similar to that in
mammalian intestines where cells proliferate in crypts and differentiate along
the villi [42].
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3.3.6 Enhanced activity of BMP signaling due to inhi-
bition of Notch signaling
The BMP signal has been known to be crucial for mediating epithelium-
mesenchyme interaction in the intestine [42, 139] and BMP4 is transcrip-
tionally activated by GATA6 [140]. In order to examine whether BMP sig-
naling is enhanced upon inhibition of Notch, quantitative RT-PCR and in situ
hybridization were conducted for zebrafish intestine. There was an induced up-
regulation in the expression of smad1 and smad4, the down-stream effectors
of BMP signaling, as determined by quantitative RT-PCR (Fig.3.5A and B).
These results supported an enhanced activity of BMP signaling together with
gata6. To identify the link between BMP signaling and gata6 activity in the
intestine, we examined the promoter sequences of some relevant genes in search
of the conserved GATA-binding motifs, (A/T)GATA(A/G) [141]. For exam-
ple, bmp4 and bmp7 are known ligands that may initiate the BMP signaling
cascade [142, 143]. As we have found, there are several conserved GATA bind-
ing sites in the promoter regions of bmp4 and bmp7 (Fig.3.5). In addition, the
same binding motifs have also been found in the promoter regions of another
two ligands, tgfb2 and tgfb3, which are members of the transforming growth
factor beta subfamily that mediate the signaling cascade through smad2/3/4
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(Fig.3.5). Thus GATA transcription factors appear to positively regulate the
activities of BMP signaling through their ligand expression in the intestine and
we expect to see enhanced BMP signaling after DAPT-treatment.
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Figure 3.4: Up-regulation of gata6 expression upon inhibition of Notch
(A and B) In situ hybridization for gata6 gene on cross sections of adult in-
testines. Transcripts of gata6 are present along the villus of both control intes-
tine (A) and DAPT-treated intestine (B). This gene is abundantly expressed in
the differentiated epithelia along the villi, though its expression level is higher
in the upper part of villi. In the inter-villi pockets, the transcripts are largely
absent in the control intestine (A) but detected at a higher level in DAPT-
treated intestine (B),as indicated by arrows. (C) qRT-PCR results for gata6
expression. mRNAs were extracted in the intestines of control fish or DAPT-
treated fish. Expression level of gata6 is moderately higher upon inhibition of
Notch by DAPT.
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Figure 3.5: BMP signaling and GATA regulation
(A) qRT-PCR for smad1. mRNAs were extracted from adult intestines of
control and DAPT-treated fish, respectively. The expression of smad1 is up-
regulated upon inhibition of Notch by DAPT treatment. (B) qRT-PCR for
smad4. mRNAs were extracted from adult intestines of control and DAPT-
treated fish, respectively. The expression of smad4 is also up-regulated upon
inhibition of Notch by DAPT treatment. (C) Identification of GATA binding
motifs. The GATA binding motifs were analysed in the promoter regions of
several genes (about 3kb upstream of trasncription start sites) and the number
of their occurrences are shown.
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3.3.7 Suppression of glycogen-rich intestinal subepithe-
lial myofibroblasts (ISEMFs) along the villus axis
due to inhibition of Notch signaling
Periodic acid/Schiffs reagent staining of paraffin-embedded, paraformaldehyde
fixed sections showed that the glycogen-rich intestinal subepithelial myofibrob-
lasts (ISEMFs) were present along the whole villus axis in the intestines of
control fish (Fig.3.6A). These cells were located closely beneath the epithelial
cells and they were featured by presence of abundant glycogen in the cyto-
plasm. Inhibition of Notch signaling caused a decrease in the number of these
cells and their localization were restricted only to the basal region of the villus
axis (Fig.3.6B). The goblet cells were stained blue (acidic mucopolysaccha-
rides by alcian blue) or magenta (neutral mucopolysaccharides by periodic
acid/schiff’s). Glycogen-rich ISEMFs were also stained magenta, but these
cells were distinguished by their localization beneath the single-celled epithe-
lial layer and their glycogen-rich granules (Fig.3.6A and B, arrows in insets),
which were smaller in size than the huge secretory vesicles in goblet cells -
those vesicles were typically residing near the apical membranes of cells and
identifiable by openings toward the intestinal lumen. In the mean time, it was
observed that the glycogen-rich ISEMFs were mainly restricted to the lower
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half of the villus axis after inhibition of Notch signaling (Fig.3.6C). The induced
reduction in the population of glycogen-rich ISEMFs may imply the involve-
ment of this population in mediating differentiation of progenitor cells toward
the secretory lineage, in view of the multitude of secreted signaling molecules
by the ISEMFs such as hepatocyte growth factor [144], cytokines (especially
interleukins), stem cell factor, vascular endothelial growth factor [145] and so
on.
The role of glycogen+ ISEMFs in the whole picture of intestinal epithelium
homeostasis is sketched in Fig.3.7. Yet so far it is not clear what secreted
molecules are important for the secretory lineage development and whether
they act upstream or downstream of, or even in parallel to zath1.
90
Figure 3.6: Reduction in glycogen-rich ISEMFs with increased goblet popula-
tion
(A and B) Alcian blue and Periodic Acid/Schiff’s staining on cross sections
of adult intestine. Acidic mucin-secreting goblet cells are stained blue and
neutral mucin-secreting goblet cells are stained purple. Granules of glycogen
are stained purple. The glycogen+ ISEMFs are distributed along the whole
villous axis in control intestine (A), but they are restricted to the lower half
of villi in DAPT-treated intestine (B). (C) Counting of glycogen+ ISEMFs
in over 100 villi on cross sections of adult intestines. Compared with control,
there is a decrease in the number of glycogen+ ISEMFs, and majority of the
cells are restricted in the lower half of villi after inhibition of Notch signaling.
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Figure 3.7: Potential role of the glycogen-rich ISEMFs in mediating the gen-
eration of goblet cells
In view of the negative correlation between glycogen-rich ISEMFs and goblet
cell population, these cells potentially interact with the development of goblet
cells through secreted molecules in a paracrine manner and it could be either
zath1-dependent or zath1-independent. The potential signaling molecules se-
creted by the ISEMFs, however, remain unknown.
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3.4 Discussion
3.4.1 Notch signaling and binary lineage allocation
The requirement of Notch signal in epithelial cell proliferation of mouse intes-
tine [125] and its role in goblet cell differentiation [126] have been reported.
Here, the effects of Notch signal on proliferation and secretory lineage differ-
entiation are further confirmed in adult zebrafish intestine. Notch signaling
has been shown to regulate a broad range of cellular events from early devel-
opmental stages till adulthood [146]. In the intestines, Notch has been shown
to play a role in bipotential cell fate decisions between absorptive lineage and
secretory lineage [79, 125]. Inhibition of Notch by DAPT could influence the
cell fate decisions in favor of the secretory lineage by producing more gob-
let and enteroendocrine cells in the intestines. In consistence with previous
studies [125, 126], our work showed increased goblet cell differentiation caused
by inhibition of Notch signal in zebrafish intestine. Pan-secretory lineage dif-
ferentiation was increased by inhibition of Notch as evident from increased
expression of zath1 (Fig.3.1); Enteroendocrine lineage differentiation was also
enhanced as indicated by the increased ngn3 expression (Fig.3.3). The in-
creased population of goblet cells was confirmed with alcian blue staining of
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histological sections (Fig.3.3).
As the intestinal epithelium is constantly renewed, changes in lineage allo-
cation process will be manifested by changes in the cellular composition of the
differentiated epithelial tissue. Appropriate lineage allocation is thus pivotal
to the maintenance of tissue homeostasis. By inhibiting Notch signaling, one of
the most important signals involved in this process, we were able to show that
the reduction in the pool of the multipotent progenitor cells incurred a shift
in the lineage allocation process, where the secretory lineage took a higher
priority over the absorptive cells (Fig.3.2, Fig.3.3). In another study where
beta-catenin was knocked out in mouse intestine, the proliferative crypt pro-
genitor cells were almost depleted, but the population of goblet cells remained
almost intact despite the impaired generation of absorptive cells and shrink-
ing in villus size [121]. These results suggest a potentially important concept:
a higher priority for generation of secretory cells may be used as a counter-
measure when the pool of multipotent progenitors was reduced. In contrast,
studies that allowed an increase in the pool of progenitors by knockout of the
BMP signaling receptor, Bmpr1a, revealed a significant increase in the ab-
sorptive population (as manifested by the villus size), whereas the secretory
population remained largely unchanged [147]. Together, these results reveal
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the prioritizing nature of the lineage allocation process where the secretory
lineage often takes higher priority.
Based on the evidence above, together with our own results, we would like
to hypothesize the existence of a prioritized lineage allocation mechanism in the
intestinal epithelium. Upon perturbations that may disrupt the homeostatic
cell type composition, the secretory lineage would tend to take higher priority
over that of the absorptive lineage, in terms of cell production.
3.4.2 Involvement of a distinct cohort of glycogen-rich
ISEMFs in cell lineage allocation
As our BrdU assay showed, the size of the proliferative compartment was
significantly reduced upon inhibition of Notch signaling (Fig.3.2). This may
force the immature progenitors to leave this compartment earlier than usual.
The prioritizing lineage allocation mechanism thus probably extends beyond
the proliferative compartment and allows other signals to gain a chance to
influence this allocation procedure. As discussed below, a distinct cohort of
glycogen-rich ISEMFs appear to be specifically involved in this process.
The epithelium-mesenchyme interaction has been known to be essential for
maintaining homeostasis of epithelial tissues in the intestine [6]. The BMP4
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pathway represents one of the major communicating channels between the
two tiers of cells with the ligands expressed in epithelia while the receptors
expressed in the underlying mesenchyme [42, 6]. Here we showed that the ac-
tivity of BMP signaling was enhanced after inhibition of Notch signal and this
was accompanied by a reduction in cell number and retractive redistribution of
glycogen-rich ISEMFs (Fig.3.6). ISEMFs are important for the organogenesis
of the intestine, and a collection of growth factors and cytokines secreted by
these cells promote epithelial restitution and proliferation [148]. BMP signal-
ing, however, presents a reversed gradient against Notch and Wnt signaling
along the villus axis (Fig.3.1 panel E) and suppression of it also inhibited
the epithelial cell differentiation [127, 139, 149]. The induced changes in the
number and distribution of the glycogen-rich ISEMFs by inhibition of Notch
(Fig.3.6) indicate that they may mediate the equilibrium between proliferation
and differentiation of the epithelia by bridging the cross-talk signals between
the epithelia and the mesenchyme. The retraction in the distribution of the
glycogen-rich ISEMFs along the villus axis may cause a redistribution of sig-
nals for the prioritizing lineage allocation procedure and shift in favor of the
secretory cells.
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3.4.3 Preferable targeting of secretory cells in cancer
The prioritizing nature of the lineage allocation mechanism thus appears to
maintain the secretory cells with higher priority. During hyper-proliferation,
the secretory population was best maintained whereas the absorptive popu-
lation was over generated [147]; During hypo-proliferation when the pool of
progenitor cells were reduced, the secretory population would be generated
at the cost of absorptive cells, as documented in this study and other stud-
ies [125, 126].
Is there a situation where homeostasis of the secretory population is dis-
rupted with higher priority even in the presence of a sufficiently large pool
of progenitor cells? The positive answer comes from cancer studies. It has
been well documented that there is a significant reduction in mucin-secreting
goblet cells during development of colorectal cancer as only very few goblet
cells are present in colorectal carcinoma specimens [150, 151, 152, 153, 154]. As
discussed earlier, the Notch and Wnt/beta-catenin signaling pathways are pos-
itively cooperating with each other under normal physiology. During develop-
ment of colorectal cancer where Wnt/beta-catenin signaling is frequently over-
activated [155, 156], one might anticipate that the secretory population would
increase. This is, however, not true. The lineage allocation process, in the case
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of cancer, is distorted in such a way that the absorptive cells are overwhelm-
ingly generated, whereas the secretory cells are greatly reduced [157, 151],
probably through down-regulation of HATH1 (or Math1 in mouse).
3.4.4 Cooperative BMP and gata6 activities in epithe-
lial differentiation
It has been previously shown that inhibition of Notch is potent to induce
differentiation of proliferating cells both in normal intestinal tissue and ade-
nomas [125, 126], but the downstream events are not well understood. Here
we have shown that the glycogen-rich ISEMFs may be involved in this process
(Fig.3.6). As noticed, the increased differentiation toward secretory lineage
was accompanied by a reduction in epithelium proliferation and an increased
expression of gata6, the master GATA factor mediating endodermal gene ex-
pressions. This suggests a suppressive role of gata6 against epithelium pro-
liferation in the intestine, in agreement with its role as a tumor suppressor
in astrocytoma, where gata6 expression was turned off during development
of astrocytoma [136]. In the intestine, however, gata6 suppresses epithelium
proliferation by turning on cell differentiation allowing expression of a group
of endodermal genes.
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One of the suggested gata6 target genes, fabp2, is highly expressed in en-
terocytes [108]. The zebrafish fabp2 gene is located on chromosome 1 con-
sisting of 4 exons. Our analysis shows that the conserved GATA binding
sites (A/T)GATA(A/G)(ref. [141]) are present in the promoter region of fabp2
gene in zebrafish (Ensembl genome database Zv7 data not shown). Notably,
the GATA binding sites are also present in the promoter region of fabp2 gene
in other species, including mouse (3 GATA binding sites, data not shown) and
Xenopus (3 GATA binding sites, Ref. [108]) among others, implying that this
regulatory mechanism is well conserved across species.
The link between GATA transcription and BMP signaling is known. For
example, transcriptional activation of BMP4 by GATA6 has been reported
during mammalian organogenesis [140] and cardiomyocyte maturation [158].
In the adult intestine, BMP signals appear to cooperate with gata6 medi-
ating proliferation and differentiation of the epithelium, as suggested by our
results (Fig.3.5, Fig.3.4). BMP signals are known to be an important chan-
nel for epithelium-mesenchyme crosstalk [159] and their activities are usually
suppressed toward the basal crypts [127]. But BMP signaling is active in
differentiated epithelium, where removal of BMP signaling would impair the
differentiation of the intestinal secretory lineage [147]. This agrees with our
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finding that BMP signaling becomes more active when secretory lineage dif-
ferentiation is enhanced. In addition, our analysis identified GATA binding
sites in the promoter regions of BMP4, BMP7, TGFb2 and TGFb3 (based on
Ensembl genome database Zv7, Fig.3.4). This may explain the enhanced BMP
signaling accompanying the increased gata6 expression level in the intestine.
3.5 Conclusion
This study has shown that inhibition of Notch signal reduces epithelium pro-
liferation and in the mean time, shifts the lineage allocation in favor of the
secretory lineage. The Notch-mediated secretory lineage allocation procedure
correlates the decrease of glycogen-rich ISEMFs. The secretory lineage is main-









The small intestine has been a nice model for the study of epithelium renewal,
stem cell function and tissue regeneration. The mammalian intestinal epithe-
lium is organized into hierarchical cell lineages derived from a small number of
stem cells, which are located near the bottom of the crypts (about four or five
cell position from the very bottom) [160]. Stem cells produce progenitor cells
that undergo rapid clonal expansion, migrate out of the crypt and differentiate
into absorptive cells, goblet cells, Paneth cells and enteroendocrine cells [18, 6].
The only exception is the Paneth cell population, which remain in the crypt
during its whole life span.
Due to the persistent presence of stem cells, potential gene mutations or
chromosomal aberrations to the stem cell genome may yield a long term effect
on the epithelium renewal process, while a second or third mutation will sig-
nificantly increase the frequency of carcinogenesis in the intestinal tract [161].
This explains one of the common scenarios where colorectal cancer occurs,
with transformed cells proliferating in a uncontrolled manner, disrupting the
normal epithelium renewal mechanism that is maintained during normal phys-
iology. In addition, it is worth mentioning that the intestinal stem cells are
very sensitive to radiation [80], which raises concerns over radiotherapy appli-
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cations.
Current clinical management of colorectal cancers includes three major
components: surgery, radiotherapy and chemotherapy. The effectiveness of
these three components has been recognized during the past three to four
decades, though wide variations in clinical outcomes still exist around the
world [162, 163]. Part of the variations come from our limited understanding
about the effects of radiation on tissue renewal and regeneration, such as the
responsive nature of the regeneration process.
To understand the stem cell function, epithelium regeneration and ra-
diation response, mammalian models have been used during the past few
decades [9, 6, 26, 80]. But in recent years, zebrafish has been rising as a
convenient model for the same purposes. In terms of intestine, this cryptless
vertebrate shares several levels of similarity with the traditional mammalian
models. At tissue level, zebrafish intestine features ridge-like in-foldings, which
produce villus structures on two dimensional sections that appear similar to
those of mammalian intestines. At cell level, absorptive cells, goblet cells and
enteroendocrine cells are all present. At molecular level, the well known in-
testinal marker genes like intestine specific fatty acid binding proteins, villin
and apolipoproteins are all conserved in zebrafish. Metabolic pathways of fatty
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acids, lipids and vitamins that are active in mammalian intestines are similarly
active in zebrafish intestine (refer to Chapter 2).
In comparison with mammalian models, which have a more limited thresh-
old to whole body radiation [164, 165], zebrafish represents a vertebrate model
that shows better tolerance to whole body radiation (to be shown below).
This feature of zebrafish will allow us to study the effects of radiation on the
whole intestinal tract from low dose to high dose radiation. By investigating
the regeneration process over a widened range of radiation doses, knowledge
may be gained to understand how the zebrafish intestine manages to survive
the high dose radiation where mammalian intestines can not. To illustrate
such potential applications, we have characterized the regeneration process in
predefined regions of zebrafish intestine following high dose whole body radia-




4.2.1 Experiment setup for radiation
Adult zebrafish were subject to 16 gray whole body radiation (WBR) in a
Gamma Chamber 2000 system at a rate of 2.2 gray per minute, with energy
setting at 13.3 MeV using Co60 source. Detailed experiment setup is shown
in Fig.4.1. Some concerns regarding this setup are to be addressed in the
Discussion section.
4.2.2 Sampling schedule
These fish were then cultured in the aquarium under standard conditions and
sacrificed at 3 hours, 1, 3, 5, 7, 9, 11 and 13 days after radiation (dpR),
respectively, for RNA analysis and histological analysis. The time of sacrifice
was scheduled in a manner that the fish were sampled on the same time of the
day, that is, always at 3 pm of the day, except the first time point (6 pm or
3 hpR: hours post radiation). The sampling schedule is summarized in Table
4.1.
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4.2.3 RNA extraction and real-time PCR
RNA was extracted using Trizol as described in Section 2.2 of Chapter 2.
Real-time polymerase chain reaction was performed as described in previous
chapters. The results were normalized against actin beta 2 level within each
sample to minimize the internal error, as before.
4.2.4 Paraffin embedding and AB-PAS staining
Samples were fixed in 4% paraformaldehyde, embedded in paraffin and sec-
tioned at 7 µm thickness. Details are described in previous chapters. Alcian
blue and periodic acid in Schiffs reagent (AB-PAS) staining was performed
according to the manufacturer’s protocol. Details are described in previous
chapters.
4.2.5 Alkaline phosphatase staining
PFA-fixed paraffin sections were dewaxed, rehydrated as described above. In-
testinal expression of alkaline phosphatase was visualized by incubation in
NBT/ BCIP substrates (4.5 µl NBT and 3.5 µl BCIP dissolved in freshly pre-
pared buffer 9.5) for 30 min. The sections were then washed by PBST for 5
min twice, dehydrated as described above, cleared in histoclear, mounted in
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DePex mounting medium (Gurr, England) and sealed by cover slips for image
acquisition on an Zeiss Axiovert system (ZEISS, Germany).
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Figure 4.1: Experiment setup for radiation using a Gamma Chamber 2000
system.
Adult zebrafish were subject to a homogenous field of radiation at a rate of
2.2 gray per minute with total exposure of 16 gray. A measuring cylinder with
a nominal volume of 1 litre was used (PolyLab, USA), covered with aluminum
foil (Richmond, USA).
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Table 4.1: Sampling schedule of radiated zebrafish
Time point for RNA for histology time
ctrl 5 3 3 pm
3 hrs 5 3 6 pm
1 day 5 3 3 pm
3 day 5 3 3 pm
5 day 5 3 3 pm
7 day 5 3 3 pm
9 day 5 3 3 pm
11 day 5 3 3 pm
13 day 5 3 3 pm
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4.3 Results
4.3.1 Survival of zebrafish after whole body gamma ra-
diation
The zebrafish appeared much stressed immediately after radiation, swam around
at a lower-than-normal speed and showed a slow response to disturbances.
There was occasional, light bleeding in the dorsal region of a couple of fishes.
They still had a reasonable appetite for artemia, though responding in a less
active manner. They were able to expel feces that looked normal. Their gen-
eral behaviors became apparently normal again within three days. They were
monitored for at least two weeks and all of them successfully survived the
radiation till the time of sacrifice [164].
4.3.2 Two rounds of elimination of intestinal villi
Histological analysis was performed to examine the architectural changes for
the paraformaldehyde-fixed, paraffin-embedded intestinal sections.
Alcian blue-periodic acid in Schiff’s reagent (AB-PAS) staining was per-
formed for the intestines of zebrafish after whole body radiation. Three regions
of zebrafish intestine, segments I, IV and V were analyzed. Degeneration of
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villi was found since 3 hpR, but complete elimination of villous structures was
first found by 24 hpR in segment I, resulting in vast regions along the intestinal
circumferential wall covered by a flat sheet of epithelium (Fig.4.2). Following
the first wave of proliferation, nascent villi were regenerated (from 3 days to
7 days). But the newly restituted tissue did not last long and the second
round of villi elimination occurred by 9 dpR, again resulting in vast regions of
flat epithelium lining. The two rounds of villi elimination did not annihilate
the regenerative potential of zebrafish intestine, and the regeneration robustly
ensued after the second round of villi elimination (Fig.4.2).
Though degeneration of villous structures took place along the intestine,
these events in segment IV and segment V were not as evident as in segment
I (Fig.4.2). Comparing the three regions of zebrafish intestine, whole body
radiation was best manifested in segment I through complete elimination and
regeneration of nascent villi before the tissue homeostasis was reestablished.
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Figure 4.2: AB-PAS staining of paraffin sections of zebrafish intestine after
total body radiation.
The fish were sacrificed at different time points following whole body radiation,
as indicated by the numbers. Complete elimination of villi is first found by 24
hpR, and the second wave come by 216 hpR. hpR: hours post radiation. Scale
bar: 100 µm
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4.3.3 Two waves of Wnt/beta-catenin signaling: a driver
of proliferation
To investigate the effect of radiation on zebrafish intestine, the total RNA of
intestine was extracted and subjected to quantitative RT-PCR on a Roche
LC480 system (Roche Applied Sciences, Swiss). As Wnt/beta-catenin is a
major signaling pathway driving epithelial proliferation in the intestine [39,
42, 121, 78], expression level of ctnnb1 (encoding beta-catenin in zebrafish)
was measured at different time points following the exposure to radiation. As
shown in Fig.4.3 panel A, the expression of ctnnb1 was increased immediately
after radiation (3 hpR), and this higher level of expression was maintained till
24 hpR. After that, there was a temporary drop in its expression to around
the basal level. A second peak of ctnnb1 expression was observed around 7
dpR, probably because of a second wave of cell proliferation. It did not return
to basal level until around 11 dpR.
Interestingly, the ezh2 gene (enhancer of zeste homolog 2), encoding a
member of the Polycomb group (PcG) family that is involved in cell prolifera-
tion through regulating the activity of the Prc2/Eed-Ezh2 complex for histone
modification [166, 167, 168, 169], also showed two waves of enhanced activities
following the radiation (Fig.4.3 panel B), similar to ctnnb1. The two peaks
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occurred at 24 hpR and 9 dpR, respectively. The two genes seemed to share
similar cycling profiles, but the expression of ezh2 temporally lagged a little
behind that of ctnnb1. Expression of the house-keeping gene bact2 is shown
in Fig.4.3 panel C for reference purpose.
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Figure 4.3: Two waves of proliferation in the intestine after whole body radi-
ation.
(A) Expression of beta catenin (ctnnb1 ) in zebrafish intestine by quantitative
RT-PCR. (B) Expression of enhancer of zeste homolog2 (ezh2 ) in zebrafish
intestine by quantitative RT-PCR. (C) Expression of actin beta 2 (actb2 ) in
zebrafish intestine by quantitative RT-PCR.
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4.3.4 Cell proliferation as measured by pcna staining
As Wnt/beta-catenin signaling mediates the expression of a wide range of
potential target genes [122], its effects may not be exclusively limited to pro-
liferation. To further investigate the effects of radiation on cell proliferation,
immunohistochemistry of pcna staining was carried out and results are shown
in Fig.4.4. The number of cells expressing pcna was evidently increased by 3
hpR. But this increase did not last very long and by 24 hpR, pcna staining only
identified a few cells in the inter-villi region. This was the time point when villi
structures were undergoing degeneration and they shrunk significantly in size.
The level of proliferation remained low till 5 dpR, and then suddenly increased
by 7 dpR, driving fast repopulation of the epithelial tissue and growth of the
villi. The level of proliferation, however, went down again at 9 dpR, when the
villi structures underwent second round of degeneration. It did not return to
normal level until 11 ∼ 13 dpR.
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Figure 4.4: Cell proliferation as measured by pcna staining.
There is an increase in the population of PCNA positive cells by 3 hpR. The
second increase is seen by 7 dpR. By 13 dpR, the number of cells expressing
pcna becomes close to normal level. Scale bar: 100 µm
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4.3.5 Radiation induced cell apoptosis
Radiation-induced cell death occurred virtually along the whole intestine fol-
lowing the whole body radiation. Some examples are shown in Fig.4.5 panel
A. Typically, radiation induced some specific cell death in the inter-villi re-
gion, where stem and progenitor cells were known to reside, while in normal
intestine, cell death in this region is a rare event. This agrees with previous
studies that intestinal stem cells are sensitive to radiation [170, 171].
To understand whether radiation-induced cell death involves DNA frag-
mentation, quantitative RT-PCR was performed and result is shown in Fig.4.5
panel B. During the 24 hours post radiation, dnase1 (deoxyribonuclease I) was
expressed at a high level. But its expression seemed to have decreased after
24 hours.
On the other hand, apoptosis routinely occurs at the tips of villi in zebrafish
intestine. Compared with radiation effects on stem cells, the effects of radiation
on cell apoptosis at the tips of villi is less studied. Here a TUNEL assay was
carried out to investigate the changes in apoptosis induced by radiation at the
tips of villi. 16 gray whole body radiation immediately increased the level of
apoptosis both at the tips and at the inter-villi regions (Fig.4.6) . This higher
level of apoptosis was observed during the first 24 hours post radiation, till
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the first round of villi elimination took place. A second high level of apoptosis
was seen on 7 dpR (both at tips of villi and in the inter-villi region), preceding
the second round of villi elimination. But in between, there was a temporary
decrease in apoptosis around 5 dpR.
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Figure 4.5: Gamma-radiation induced cell death through DNA fragmentation
in the intestine.
(A) The chromosomes are often condensed and fragmented, with cellular or-
ganelles degenerated by neighbouring cells, leaving certain cavity behind after
cell death. The inter-villi bottom region, where stem/progenitor cells reside, is
the most frequent site for epithelial cell death. Scale bar: 100 µm (B) Elevated
expression of DNaseI indicates a DNA fragmentation-dependent cell death.
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Figure 4.6: TUNEL assay for gamma-radiation induced cell apoptosis in ze-
brafish intestine.
A larger number of cells are going through apoptosis in zebrafish intestine
immediately after the exposure, including specific cells in the inter-villi region.
Note the high level of apoptosis at 3 dpR and 7 dpR. Scale bar: 100 µm
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4.3.6 Changes in the intestinal epithelium renewal
Intestinal epithelium renewal is primarily determined by cell proliferation and
cell apoptosis. Combining the results of proliferation assay and TUNEL assay
shown earlier, it is obvious to see the changes in epithelium renewal. This is
summarized and illustrated in Fig.4.7. Changes in proliferation and apoptosis
are tabulated in the upper panel and sketched in the lower panel. There
was an immediate increase in both proliferation and apoptosis, resulting in
fast epithelium renewal at 3 hpR. Later on, a second orchestrated increase in
both proliferation and apoptosis resulted in another fast renewal of epithelium
around 7 dpR, before tissue homeostasis was reestablished by 13 dpR.
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Figure 4.7: Changes in epithelium renewal as estimated from proliferation and
apoptosis.
Changes in proliferation and apotosis are tabulated in the uper panel. c for
control; + for increase; - for decrease; ∼ for little change. The resulting changes
in epithelium renewal is sketched in the lower panel. There is a decrease both
in epithelium renewal and villi size till the first round of villi elimination takes
place. Later, a wave of fast epithelium renewal is seen preceding the second
round of villi elimination, featuring high levels of proliferation and apoptosis.
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4.3.7 Regeneration of the secretory epithelial cells
The secretory cells include the goblet cells and the enteroendocrine cells in
the zebrafish intestine (where the Paneth cells are absent). As the goblet cells
play an important role in maintaining the intestinal mucosal integrity and the
enteroendocrine cells serve as a major regulator of intestinal peristalsis, it is
necessary to examine their changes in order to understand how the zebrafish
survived the strong radiation.
Quantitative RT-PCR analysis was performed for two key factors, the zinc-
finger Kruppel-like transcription factor klf4 and the bHLH transcription factor
neurogenin 3, responsible for generation of the goblet cells and the enteroen-
docrine cells, respectively [172, 173, 174, 175, 16, 176]. Expression of klf4
was elevated immediately following radiation (Fig.4.8 panel A). Its expression
peaked at 24 hpR when the first round of villi elimination occurred and the
higher level of expression was maintained throughout the whole recovery pro-
cess of the intestine, indicating an active and prolonged process of regenerating
goblet cells during tissue restitution. The expression of neurogenin 3, however,
did not show an immediate response to radiation. The elevated expression of
neurogenin 3 was seen by 3 dpR and it peaked by 7 dpR (Fig.4.8 panel B),
preceding the occurrence of the second round of villi elimination.
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Figure 4.8: Quantitative RT-PCR results for response of klf4 and ngn3 genes
to radiation.
(A) Expression of klf4 was increased since 3 hpR and the higher level of ex-
pression was seen during the whole recovery process. (B) Expression of ngn3
did not show an immediate response to radiation. But an increase was seen
by 72 hpR and reached to a peak when the second round of villi elimination
occurred.
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4.3.8 Maintenance of basic intestinal functions follow-
ing radiation
As 16 gray whole body radiation may cause extensive damages, it is interesting
that all the fish survived the radiation. To understand how the fish managed to
survive the radiation, we were interested to know whether the basic functions
of the intestine were maintained. Thus expression of some basic genes like
intestine specific fatty acid-binding protein 2 (fabp2 ) and alkaline phosphatase
was examined by in situ hybridization. In the mean time, expression of smooth
muscle-specific gene, actin a2, was also examined.
Expression of fabp2 was robustly maintained during the 72 hours following
radiation (Fig.4.9), though the strong radiation later caused a decrease in its
expression. By 13 dpR, expression of fabp2 was largely restored around its
normal level in segment IV, but its expression in segment I was still lower than
control level, indicating an incomplete recovery in this region of intestine. As
sustained expression of fabp2 gene ensured basic intestinal metabolic processes
to go on before complete tissue recovery, this partially explains the survival
of fish after radiation. In the mean time, intestinal smooth muscle was also
affected by the radiation and expression of actin a2 gene was generally lower
after the radiation (Fig.4.9).
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Endogenous alkaline phosphatase was highly expressed at the apical mem-
branes of mature intestinal epithelial cells during normal physiology. To fur-
ther confirm the results of sustained intetsinal functions following radiation,
expression of alkaline phosphatase was examined. Consistent to the expression
of fbap2, expression of alkaline phosphatase was constantly maintained along
the intestine, despite exposure to strong radiation (Fig.4.10). This further il-
lustrated the presence of functional enterocytes that were maintained during
the tissue recovery process, allowing the fish to survive the strong radiation.
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Figure 4.9: In situ hybridization for intestinal specific fatty acid binding pro-
tein 2 (fabp2 ) and smooth muscle specific actin a2 genes in zebrafish intestine,
following exposure to whole body gamma radiation.
Expression of fabp2 was maintained at a high level during the first 72 hours
following radiation. It was decreased from 3 days but largely recovered by 13
days. Expression of actb2 was present during most of the time. Note that fabp2
is exclusively expressed in the epithelium and actb2 is exclusively expressed in
the intestinal smooth muscle. Scale bar: 100 µm
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Figure 4.10: In situ hybridization for alkaline phosphatase in zebrafish intes-
tine, following exposure to whole body gamma radiation.
Endogenous alkaline phosphatase was highly expressed in the apical mem-
branes of epithelial cells in control. Its expression was continually maintained
during the recovery process. Scale bar: 100 µm 129
4.3.9 Active involvement of intestinal stem cells during
tissue restitution
Intestinal stem cells have been known to be capable of maintaining tissue home-
ostasis during normal physiology by producing all the epithelial cell types in
the intestine [31, 33, 39, 45]. Recently, several marker genes have been pro-
posed to identify the intestinal stem cells, including Lgr5, Bmi1, Dcamkl1,
Msh-1 and several others [28, 48, 41, 43, 44, 177]. To investigate the role of
intestinal stem cells during tissue recovery after exposure to radiation, expres-
sion of the candidate stem cell marker gene, bmi1 and dcamkl1, was examined
by quantitative RT-PCR.
Consistent to our results of Wnt/beta-catenin mediated epithelial prolifera-
tion, expression of bmi1 was also elevated immediately after radiation (Fig.4.11
panel A). Expression of both bmi1 and ctnnb1 reached their highest levels
around 1 dpR and 7 dpR. The elevation in their expression was seen through-
out the whole regenerating procedure.
The other putative intestinal stem cell marker, dcamkl1, showed some dif-
ference in its expression. A moderate elevation in expression was also seen
immediately following radiation (Fig.4.11 panel B). Then its expression level
steadily scaled up after 3 dpR and reached its highest level by 9 dpR, when the
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second round of villi elimination occurred. From 11 dpR to 13 dpR, however,
its expression returned to the normal level.
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Figure 4.11: (A)Quantitative RT-PCR results for expression of bmi1 in ze-
brafish intestine after whole body radiation. (B)Quantitative RT-PCR results
for expression of dcamkl1 in zebrafish intestine after whole body radiation.
There was an elevation in expression of both genes after radiation.
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4.3.10 Elevated mesenchymal activities
Epithelium-mesenchyme cross-talk has been important for maintainenance of
tissue homeostasis during normal physiology. In case of radiation, the sig-
naling of the fibroblast growth factor (FGF) family members has been sug-
gested to have the potential to protect the intestine against the side effects
of radiation therapy [178, 179]. Quantitative RT-PCR was performed to in-
vestigate the response of one of the major receptors of FGF signaling, fgfr1,
in zebrafish intestine. The fgfr1 receptor showed an immediate response to
radiation (Fig.4.12). Its expression was elevated at 3 hpR and maintained at a
high level throughout the whole recovery period of the intestine. Such a quick
and prolonged response supported its significant role during intestinal tissue
repair following whole body radiation.
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Figure 4.12: Quantitative RT-PCR results for expression of fgfr1 in zebrafish
intestine after whole body radiation.




4.4.1 Concerns regarding the radiation setup
Some concerns have been raised regarding the radiation setup as indicated in
Fig.4.1, especially the effects of the covering foil and water. To address the po-
tential absorptive effects on radiation, we need to examine the traveling path
of radiation in the chamber: air → aluminum foil → water → fish. Linear
attenuation coefficients of the materials are listed in Table 4.2. These coeffi-
cients, however, may vary depending on the energy settings. So we need to
estimate the numbers according to the energy level used in our experiment,
which is 1.33 meV. Both polynomial and exponential curve fitting had been
tried, and it was found that the exponential curve fitting worked much better.
The fitted attenuation functions appear in the following form:
y = c0e
−ax (4.1)
where c0 and a are parameters to be fitted based on known values shown in
Table 4.2. Fitting results are shown here.
For air:
y = 0.0002162e−0.0013x (4.2)
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For aluminum:
y = 0.4767e−0.0015x (4.3)
For water:
y = 0.1843e−0.0013x (4.4)
The attenuation coefficients at 1.33 meV as determined by these formulae
are indicated in Table 4.2. Based on these coefficients and the distance traveled
in each material, the effects of absorption can be easily calculated. Results are
shown in Table 4.3.
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Table 4.2: Attenuation coefficients of radiation (unit: cm−1)
material 100 keV 200 keV 500 kev ... 1.33 meV
known aluminum 0.435 0.324 0.227 ?
predicted aluminum 0.410 0.353 0.225 0.0648
known water 0.167 0.136 0.097 ?
predicted water 0.162 0.142 0.096 0.0327
known air 0.195e-3 0.159e-3 0.112e-3 ?
predicted air 0.190e-3 0.167e-3 0.113e-3 0.384e-4
Table 4.3: Absorption effects by different materials travelled
by gamma radiation
material distance absorption (portion) absorption (gray) remaining (gray)
air ∼10 cm 0.00040 0.0064 15.994
foil 0.0018 cm 0.00002 0.0003 15.993
water at 3cm 0.00012 0.0019 15.991
water at 6 cm 0.00023 0.0040 15.987
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4.4.2 Impressive regenerative capacity of zebrafish in-
testine
People normally think that the regenerative capacity of most vertebrate an-
imals including zebrafish is very limited [180, 181]. In terms of radiation,
whole body radiation has been a challenge for mammalian models like mice
or rats, where medium-to-high range doses tend to kill the animals. For in-
stance, whole body radiation at 10.4 gray will kill all mice by 14 days, while
whole body radiation at 16 gray will kill all mice by 9 days [165]. In contrast,
all zebrafish we tested (more than 50 fish in total) successfully survived the
16 gray whole body radiation within 14 days and a few spared fish survived
pretty well even after one month. Though there is some difference in the prac-
tical experimental settings (for instance, mice are exposed to radiation in air,
whereas zebrafish are in water), the absorption effects by foil and water, as we
have shown above, are minimal. So we believe the difference in biology plays
a significant role here.
Such an advantage of the zebrafish model had allowed us to monitor the
intestinal responses to radiation over 14 days interval and for the first time, we
reported the featured two waves of intestinal proliferation and correspondingly,
two rounds of villi elimination during tissue restitution, though details of the
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molecular mechanism behind largely remain unclear today.
4.4.3 Differential sensitivity of intestine to radiation and
cancer rate
Upon exposure to radiation, the small intestine of zebrafish responds differ-
entially to the large intestine (Previously, we have characterized the features
of small and large intestine in zebrafish through analysis of genome-wide gene
expressions). Radiation-induced apoptosis in the inter-villi region is more fre-
quently observed in the small intestine than in the large intestine. In terms
of villi elimination, it is most evident in segment I and segment IV (the small
intestine), but less evident in segment V (the proximal large intestine). As
altruistic cell apoptosis and elimination of villi serve as part of the mechanism
to remove damaged cells and protect the intestine from potential development
of cancer, the higher sensitivity to radiation and thorough elimination of dam-
aged villi in the small intestine suggests an inherently better protection against
environmental insults to its genome integrity, supporting the hypothesis that
presence of such a mechanism explains, at least in part, the difference of cancer
incidence in the small intestine and the large intestine [182].
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4.4.4 Implications for colorectal cancer therapy
Over the past three decades, radiation therapy and chemotherapy have been
introduced and improved in the treatment of patients with localized gastroin-
testinal malignancies. For patients with advanced stages of gastrointestinal
cancer, radiation therapy and chemotherapy are often applied and sometimes
integrated as adjuvant therapy, in a pre-operative or post-operative manner,
to enhance local control resulting in improved survival and outcome of the
patients [162, 183, 184, 185].
The protocol for delivery of radiation, however, is still actively evolving
today. For instance, in many European cancer centers, the radiation schedule
of 25 gray in 5 gray fractions for rectal cancer is being adopted. But in many
rectal cancer centers in the USA, radiation therapy treatment approaches usu-
ally deliver 45 gray to the tumor and pelvic lymphatics, followed by additional
radiation to gross tumor to a total dose of 50.4 to 54 gray in 28 to 30 frac-
tions over 5.5 to 6 weeks [162]. Other protocols also exist in other parts of the
world. While acute or late toxicity has been a concern, researchers are still
taking effort to investigate the responses and outcomes in patients. Here, our
study in zebrafish intestine has shed new light on these clinical applications
by illustrating the presence of at least two waves of cell proliferation together
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with two rounds of villi elimination. The temporal features of proliferation or
villi elimination, once tested in patients, may be taken advantage to target the
optimal time window for the best killing effects on radiation-sensitive cancer
cells, thorough elimination of the transformed tissue and finally, regeneration
of normal tissue. Therefore, characterization of the responsive features of the
intestine to radiation will be of value for medicinal professionals to optimize the
radiation delivery protocols to achieve minimal toxicity and better prognostic
outcomes in patients.
4.4.5 Future directions
Our results on multiple rounds of cell proliferation and villi elimination appear
interesting as this has not been reported in the current literature. Future work
in this field may continue to explore whether there are third or more rounds of
proliferation and villi elimination in zebrafish intestine following radiation. In
the mean time, potential drugs or compounds that may have a protective effect
from radiation should be tested. Some work has already been done along this
direction [165, 186]. But the rational research will require further knowledge
about the major pathways involved in mediating the radiation-induced cell
removal, many aspects of which still remain elusive today.
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The cycling nature of the regenerating process, however, may represent a
universal feature of the intestinal biology, in view of the cross-species analogy at
tissue, anatomy and molecular levels. Thus it is also interesting to carry out
similar studies in other species and characterize their responsive properties.
Though the potential cycling frequency and duration may be different, the
universal cycling property of the regenerating process, if present, may be taken
advantage in order to thoroughly remove the damaged/ transformed cells or
tissues, maximizing the therapeutic effects for human patients.
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Chapter 5
STORM: A General Model to
Investigate Stem Cell Number
and Their Adaptive Changes
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5.1 Background
The intestinal epithelium represents the most rapidly renewing tissue in mam-
mals [187, 6]. The intestinal stem cells play a pivotal role in epithelium renewal
[188] and their deregulation will often lead to development of cancer, where
colorectal cancer is one of the leading cancers in modern societies [13, 189].
Estimation of the number of stem cells and their adaptive changes in cell num-
ber or dividing frequency during physiopathological conditions would thus be
helpful in diagnostics. To date, however, there is no tool available for this
purpose. In this work, we aim to develop such a tool to facilitate the analysis
of stem cells in the intestinal tracts of different species.
Current literature includes various reports studying the epithelium renewal
process [190, 191, 192, 193, 194, 195, 196] by using either a grid model [197],
lattice-free model [191] or multi-compartmental model [193]. For example, a
hypothetical growth factor has been introduced to study the dynamics of ep-
ithelium proliferation and differentiation [190]; An age-structured model and
a continuous model have been employed to study epithelium homeostasis and
initiation of colon cancer [195]. None of the models in current literature, how-
ever, has been designed to directly address the number of intestinal stem cells
and their adaptive changes. The progenies of intestinal stem cells are known
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to migrate along the villous axis in a linear fashion, rendering linear strips of
genetically marked cells along the villi [28, 8, 198, 199]. The intestinal epithe-
lium renewal process, therefore, simplifies into a two-dimensional process that
may be described by a two-dimensional mathematical model. In this work, a
two-dimensional model has been developed to examine the number of intestinal
stem cells present in each histological section of crypt in mammalian intestines,
or equivalently, inter-villus pocket in zebrafish. It is named as STORM model
(STemcellmediatedOptimalRenewalofepitheliumModel). As an illustration,
the model was applied to zebrafish, murine and human intestines, though it
may also be applied to gastrointestinal tracts of other species. As the results
suggest, the stem cell number is largely conserved across species during normal
physiology. In the mean time, the results supports zebrafish as a valid model
for study of intestinal stem cells [86, 7, 71, 79].
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5.2 Materials and Methods
5.2.1 Development of the STORM model
Assumptions of the model
The model is developed based on two major assumptions: (1) Epithelial tissue
is renewed in a stem cell - transit amplification - differentiation - apoptosis
paradigm (Fig.5.1A); (2) The renewal rate of epithelial tissue has been evo-
lutionarily optimized for efficient renewal of epithelium with requirement of
minimal number of active stem cells.
Take zebrafish as an example. Incorporation of bromodeoxyuridine assay
showed that the labeled cells were restricted in the lower part of the villi
(Fig.5.1B). The cells were differentiated while they migrated upward. Once
they reached the tips of villi, they underwent apoptosis (Fig.5.1C) and then
were exfoliated. Thus four compartments can be defined along the villus axis:
stem cell compartment, proliferation compartment, differentiation compart-
ment and apoptosis compartment (Fig.5.1D). In mouse and human, the in-
testinal epithelium is organized and renewed in essentially the same manner
[200]. Thus, the model we develop here will be applicable to both teleost and
mammalian intestinal tracts. Coordination between epithelium renewal rate
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and maintenance of genome integrity is pivotal to the rapidly renewing intesti-
nal epithelium. Daily abrasion may wear out the differentiated epithelium and
new cells need to be generated, but maintenance of genome integrity remains a
high priority. This is especially important for an organism with a long lifespan
like human as gastrointestinal cancers are becoming popular in modern soci-
eties [13, 189]. These two opposing requirements serve as the major driving
forces for achieving an optimal epithelium renewal rate with minimal risk of
carcinogenic transformations. Based on this, we have developed the model as
follows.
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Figure 5.1: Paradigm of intestinal epithelium renewal and construction of the
STORM model
(A) Paradigm of epithelium renewal. The intestinal epithelium is compart-
mentalized into four components while constructing the model, based on the
analogous paradigm of epithelium renewal across teleost, murine and human
species. x1: population of stem cells; x2: population of transit amplifying
cells; x3: population of differentiated epithelial cells. Note that all popula-
tions will be normalized against their homeostatic populations to produce a
dimensionless model. (B) Cell proliferation assay with incorporation of BrdU,
where S-phase cells are stained in dark brown color by the anti-BrdU antibody
(see Materials and Methods for detail). (C) TUNEL assay for cell apoptosis.
The apoptotic cells are stained in green color (see Materials and Methods for
detail). (D) Compartmentalization of epithelium into stem cells, transit ampli-
fying cells, differentiated cells and apoptotic cells along a villus. (E) Flowchart
of the STORM model.
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General workflow of the model
The overall workflow of the model is illustrated in Fig.5.1E. Based on the as-
sumptions above and using measured populations of transit amplifying cells
and differentiated cells, the optimization formulation will determine the num-
ber of active stem cell as well as their adaptive changes. Species-specific out-
come of the model will require species-specific input information about the
populations of cells.
A starting model for epithelium homeostasis
The process of epithelium turnover in the intestine is sketched in Fig.5.1A.
This model consists of three major components: the stem cells, the transit
amplifying cells and the differentiated epithelial cells. The population of stem
cells is maintained through self-renewal and production of progenies. The
population of transit amplifying cells is maintained through supply from stem
cells and expense to cell commitment. The population of post-mitotic, differ-
entiated epithelial cells is maintained through supply from transit amplifying
progenitors and expense to apoptosis. All the populations are normalized
against their homeostatic populations, respectively. It has been known that
epithelium lining of one villus is constantly renewed by cells generated from
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multiple crypts [8]. It has also been known that newly generated epithelial
cells migrate along the villous axis in a linear fashion, rendering linear strips of
genetically marked cells along the villi [8, 28, 198]. The intestinal epithelium
renewal process, therefore, simplifies into a two-dimensional process that may
be described by a two-dimensional mathematical model. Based on Fig.5.1A,
a simple two-dimensional mathematical model can be derived assuming that
fluxes of cells move only in a one-way manner. Transit amplifying progenitors
do not reversely dedifferentiate to stem cells, which has been suggested to be
a possibility under some special circumstances [200], as we are studying the




= c1x1 − c0x1 (5.1)
dx2
dt
= c0x1 − k1x2 (5.2)
dx3
dt
= k1x2 − k2x3 (5.3)
where c0, c1, k1 and k2 denotes the rates of cell flux for the population of
stem cells, transit amplifying cells, differentiated cells and apoptosis, respec-
tively. A non-trivial steady state may occur only if c1 = c0. If c1 > c0, the
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model exhibits exponential growth(unbounded growth of stem cells); whereas
if c1 < c0 , the model exhibits exponential decay(extinction of stem cells and
finally, of all cell populations). Thus the stability of this system depends on
whether the relation c1 = c0 holds and thus the system is structurally un-
stable. Biological disturbances either caused by genome duplication-induced
mutations or epigenetic deregulations may lead to unbounded growth of cells.
In order for the system to maintain tissue homeostasis in a robust manner, as
observed in reality, it is necessary to incorporate a feedback mechanism into
the model.
The feedback mechanism in epithelium homeostasis
Equation (5.1) may be modified based on the assumption that stem cell differ-
entiation is related to the second order of stem cell population (equivalent to
a linear function of stem cell population for the differentiation coefficient c0).
Thus equation (5.1) becomes:
dx1
dt
= c1x1 − c0x21 (5.4)
Now the stem cell population can be maintained in a more robust way, but
this model still yields limited information about dynamics of the epithelium
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turnover process. Then a term k5−x3
k4+x3
is incorporated into equation (5.2) and
(5.3) introducing a saturable feedback regulation of stem cell self-renewal and
transit amplifying cell division [201, 202, 203, 204, 205, 148, 206, 207, 208,
209]. In the mean time, a factor α, denoting the ratio of transit amplifying
population over stem cell population, and a factor β, denoting the ratio of
differentiated population over transit amplifying population, were incorporated
into the model, respectively. To reflect the amplifying nature of the transit
population, a factor is incorporated. Accordingly, the two modified equations


















x3 − k2x3 (5.6)
The modified model consists of equations (5.4), (5.5) and (5.6). As all cell
populations are normalized against their homeostatic values, they are to be
1.0 when the system achieves tissue homeostasis. Thus we have:
c0 = c1 = αk1 = αβk2/γ (5.7)
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k5 = 1.0 (5.8)
for the homeostatic state. This information will be utilized in the following
sections.
Dynamics of the intestinal epithelium turnover process
The steady state of the system is (1.0, 1.0, 1.0), normalized against respective
cell populations. It represents the homeostatic state of the tissue. Equations
(5.5) and (5.6) are of special interest as they contain the information on dy-
namics of epithelium turnover. By setting their gradients to zero, only one
non-trivial steady state was found, which is {xˆ2 = 1.0, xˆ3 = 1.0}, just as we
expected. The Jacobian matrix of for equation (5.5) and (5.6) is given as
follows:
J(x2,x3) =











At steady state of {xˆ2 = 1.0, xˆ3 = 1.0}, the Jacobian matrix simplifies as:
J(xˆ2=1.0,xˆ3=1.0,) =









Its eigenvalues are given in two parts, respectively. The first part is given
by:





The second part is given by:
P2eig(J∗) = ± 1
2β(1 + k4)
√
(s(1 + k4)(β + γ) + β)




where s = c0/α. So the two eigenvalues are P1+P2. When the determinant
under the squared root sign is non-negative, the two eigenvalues are purely
real and negative; when this determinant is negative, the two eigenvalues will
assume the complex form yielding an oscillatory component of the system.
Thus this steady state will be stable for all non-negative values of β, γ, s and
k4. Such information on dynamics of epithelium turnover will allow us to
estimate the number of stem cells contained in each section of crypt.
The two-dimensional STORM formulation to estimate the number
of epithelial stem cells on a histological section
The number of intestinal stem cells contained in a section of the mammalian
crypt (or inter-villi pocket for zebrafish) will be determined by solving the
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following formulation:




(s(1 + k4)(β + γ) + β)
2 − 4sβγ(1 + k4)(1 + βγ + s+ sk4)
s.t.(s(1 + k4)(β + γ) + β)




This is a multivariate optimization problem with non-linear objective func-
tion and non-linear constraints. γ is directly related to the in vivo division
frequency of the transit amplifying cells. Given the species-specific value of α,
β and γ, we are able to find out the stem cell number by solving the above
formulation. This is a generalized model that may be applied to the intesti-
nal tracts of teleost, murine and human where the same epithelium renewal
paradigm holds (illustrated in Fig.5.1A). For adaptive changes to stem cells
upon perturbation, we like to introduce the term of the capacity of stemness,
which refers to the capacity of stem cells producing non-stem cell descendants,
either through adaptation in stem cell number or through adaptation in divid-
ing frequency.
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5.2.2 Maintenance of zebrafish
Zebrafish (Danio rerio) were obtained from local aquarium and maintained in
a controlled environment according to standard condition with a 14/10 hour
light-dark cycle at 28oC [129].
5.2.3 Tissue sectioning
Intestines were isolated from euthanized adult zebrafish, washed in ice-cold
phosphate-buffered saline (PBS), fixed overnight in a 4% paraformaldehyde
solution in PBS at room temperature. Fixed tissue was dehydrated in ethanol
with increasing gradients (75%, 90%, 95%, 100% twice), cleared in histoClearII
twice and embedded overnight in paraffin that was melted at 58oC. Samples
were then sectioned at 7 µm using a Reichert-Jung 2030 machine.
5.2.4 Immunohistochemistry
25mM Bromodeoxyuridine (Sigma-aldrich, St Louis, United States) was orally
administered 50µL per fish 20 minutes before they were euthanized. Immuno-
histochemistry was performed according to the manufacturer’s protocol (cat
#2760, Chemicon International, United States). Briefly, the paraformaldehyde-
fixed, paraffin-embedded slides were dewaxed in histoClear II, rehydrated and
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quenched in 3% hydrogen peroxide, incubated in 0.2% trypsin solution for 10
minutes, denatured for 30 minutes. Slides were blocked for 10 minutes before
incubation with detector (anti-BrdU) antibody for 60 minutes at room temper-
ature. Then streptavidin-horse radish peroxidase conjugate was applied for 10
minutes and slides were subjected to a mixture of diaminobenzidine and sub-
strate reaction buffer until color developed. The slides were covered by cover
slips and sealed by DePex mounting medium and later, images were taken
using a Zeiss Axiovert imaging system. Immunofluorescent TUNEL assay was
carried out according to the manufacturer’s protocol (cat #S7111, Chemicon
International, United States). Briefly, slides were dewaxed in histoClear II,
rehydrated and incubated in proteinase K (20µg/ml) for 15 minutes at room
temperature. Equilibration buffer was applied before incubation in terminal
deoxyribonucleic transferase enzyme in a humidified chamber at 37oC for 60
minutes. Then stop buffer was applied before slides were incubated in anti-
digoxigenin conjugate solution in a humidified chamber for 30 minutes at room
temperature in dark. The slides were incubated in 0.5µg/ml propidium iodide
for 10 minutes as a fluorescent counterstaining of nuclei. Finally the slides
were covered by cover slips, sealed by DePex mounting medium and images
were taken using a Zeiss Axiovert imaging system.
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5.3 Results
Formulation of the two-dimensional STORM model as we have developed is
indicated by equation (5.13) in the Materials and Methods section.
5.3.1 General characteristics of the crypt-villus system
There are some general characteristics of the crypt-villus system independent
of model details. First, as an adaptation to the villus size (varying value of
β), the ratio of stem cells over transit amplifying cells may vary in response
to different values of β (Fig.5.2A). Second, the renewal cycle of epithelium is
correlated to the value of β. The epithelium will be renewed slowly for big
values of β, but quickly for small values of β (Fig.5.2B). To tailor the model
to be species-specific, information about the populations of transit amplifying
cells, differentiated cells and in vivo dividing frequency of stem cells will be
needed. The in vivo division frequency of intestinal stem cells is not well
characterized in current literature, but it has been speculated to be once or
twice every day [123, 39, 210]. For the transit amplifying cells, each round of
cell division will double the cell number, so the amplifying factor γ has been
introduced, which takes the value of 2.0.
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5.3.2 Determination of the number of epithelial stem
cells in a 2D section of the inter-villi pocket of
zebrafish (Danio rerio) intestine
Cell counting over 200 villi in zebrafish based on our own specimens shows the
population of proliferating cells (including transit amplifying cells and stem
cells) to be 12.5 ± 3.2 cells (mean±std) and the population of differentiated
cells with 100± 24 cells (mean±std). Representative histological sections are
shown in Fig.5.1B. Based on these data, a prior β assumes the value of 8.0 for
zebrafish. The STORM formulation may be solved with these inputs. After
obtaining the stem cell number, the population of transit amplifying cells needs
to be corrected in order to produce a posterior β with correction. This process
is repeated several times until the solution converges. The final solution is as
follows:




As the population of transit amplifying cells is known from the BrdU label-
ing assays, the number of stem cells may be calculated given the ratio between






The actual number of active stem cells is dependent on their in vivo division
frequency. If they divide once per day, then 4.1 stem cells need to be present
in each section of the inter-villi pocket; If they divide twice per day, then only
2.0 stem cells need to be present. The results are shown in Table 5.1 with
those of other species.
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Figure 5.2: Results from the STORM model
(A) General relationship between ratio β and ratio s. (B) General relation-
ship between ratio β and renewal cycle τ . (C) Adaptive changes of stem cell
number versus epithelium renewal cycle in zebrafish intestine. (D) Adaptive
changes of stem cell number versus epithelium renewal cycle in mouse intestine.
(E) Adaptive changes of stem cell number versus epithelium renewal cycle in
human intestine.
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Table 5.1: The number of intestinal stem cells per section of
mammalian crypt (or teleost inter-villi pocket) of the small
intestine as suggested by the STORM model
in vivo division frequency once per day twice per day species
stem cell number 4.1 2.0 zebrafish
stem cell number 4.1 2.0 mouse
stem cell number 3.5 1.8 human
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To examine the adaptive changes in the capacity of stemness, the epithe-
lium homeostasis was reduced by 50%, simulating damage caused to the ep-
ithelium. The system responds by initiating tissue restitution process. In the
beginning stage, the value of β starts at 4.0 and by referring to the results
in Fig.5.2B, the epithelium renewal cycle is 36% faster than the normal cycle
and this will trigger an increase in the capacity of stemness (either the number
of active stem cells or their dividing frequency) by 1.95-fold (Fig.5.2A). The
increase in the capacity of stemness supports a transient expansion of transit
amplifying population up to 14.5% (equivalent to one to two cells; Fig.5.3C).
As new epithelium are being generated, the ratio of β gradually grows back to
normal value; The transit amplifying and stem cell population will also return
to their respective homeostatic states upon completion of epithelium restitu-
tion. The general correlation between the capacity of stemness and epithelium
turnover cycle in zebrafish is plotted in Fig.5.2C.
5.3.3 Determination of the stem cell number in each
crypt of mouse small intestine
In the small intestine of mouse, the population of differentiated epithelial cells
is 96 ± 18; the crypt population is 38 ± 8; the population of labeled cells is
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11.5 ± 2.5 (the numbers estimated based on references [39, 201, 147, 121,
211, 212, 126]). So the prior β assumes the value of 10.7 for mouse small
intestine. The STORM formulation may be solved with these inputs. After
posterior-correction as mentioned earlier, the model yields the final solution as
follows:









If the stem cells divide once per day, then 4.1 active stem cells need to be
present per section of crypt; If they divide twice per day, then only 2.0 stem
cells need to be present per section of crypt. Results are displayed in Table
1 with those of other species. The result here generally agrees with previous
estimations about the number of intestinal stem cells in the literature [200,
27, 31] as well as recent results with newly identified stem cell markers, which
showed about 2-4 stem cells on each histological section of a crypt [198, 213].
Similar perturbation to the system has been conducted to examine the adaptive
changes in the capacity of stemness. Briefly, 50% loss of the epithelium renders
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β to be 5.3 and by referring to Fig.5.2B, the epithelium renewal cycle is 35%
faster than the normal. The capacity of stemness grows by 1.9-fold (Fig.5.2D),
supporting a transient expansion of transit amplifying population up to 14.7%
(equivalent to one to two cells; Fig.5.3C). The system later may return to its
homeostatic state. The general correlation between the capacity of stemness
(in terms of stem cell number with fixed dividing frequency) and epithelium
turnover cycle in mouse is shown in Fig.5.2D.
5.3.4 Determination of the stem cell number in each
crypt of human duodenum
In human duodenum, the population of differentiated epithelial cells in the
villus is 120 ± 33; the population of total cells in a crypt is 92 ± 12; the
population of labeled cells is 8.8±2.1 (compiled from refs. [214, 215, 216, 217]).
So the prior β assumes the value of 23.1 for human duodenum. The STORM
formulation may be solved with these values. After posterior-correction, the
final solution is as follows:










If stem cells divide once per day, then 3.5 stem cells need to be present per
section of crypt; If they divide twice per day, then only 1.8 stem cells need to be
present per section of crypt. The results are displayed in Table 1 together with
those of other species. Similar perturbation has been conducted to examine
the adaptive changes in the capacity of stemness in human. Briefly, 50% loss
of epithelium renders the value of β to be 12.0 and by referring to Fig.5.2B,
the epithelium renewal rate is 40% faster than the normal. The capacity of
stemness grows by 2.5-fold (Fig.5.2E), supporting a transient expansion of
transit amplifying population up to 11% (equivalent to one cell; Fig.5.3C).
The system later may return to its homeostatic state. The general correlation
between stem cell number and epithelium turnover cycle in human is shown in
Fig.5.2E.
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Figure 5.3: Comparing the transient response of the intestines of three different
species
(A) The ratios of TA over stem cells. (B) The ratio of differentiated over TA
cells (ratio of β) (C) Transient expansion of TA population in response to villus
damge. (D) Recovery time in arbitrary unit after villus damage.
167
5.3.5 Comparison of the intestines of different species
To compare the epithelium renewal among three different species, the ratios
between stem cells, transit amplifying cells and differentiated epithelial cells
are shown in Fig.5.3A and B. There is a higher transit amplifying-to-stem cells
ratio in teleost. This ratio is the lowest in human and it is accompanied by
a higher differentiated-to-transit amplifying cells ratio in human. This prob-
ably reflects two different strategies in the epithelium renewal mechanism:
Rapid repair and quick restitution of epithelium take higher priority in the
teleost system, whereas slower tissue repair and restitution is allowed in hu-
man, with achievement of high fidelity in genomic duplication and reduction in
susceptibility of carcinogenic transformations. The process of tissue restitution
takes relatively longer time in human, but the transit amplifying population
is better restrained from expansion compared with murine and teleost mod-
els (Fig.5.3C and D). This is important as unrestrained expansion of transit
amplifying population is often seen before initiation of cancer. As the model
reveals, unrestrained expansion of transit amplifying population tend to occur
in extreme situations for the teleost and murine models, but it is not easily
seen in human (Fig.5.4A). This may be partially explained by the feedback
mechanism of the crypt-villus system. When the feedback signal is weakened
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(with bigger k4 value), the system tends to become unstable (Fig.5.4A). This
is in consistence with the experimental finding that deficiency of Muc2 gene,
the most abundantly secreted gastrointestinal mucin in mammals, would lead
to formation of intestinal tumors in mouse [154].
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Figure 5.4: Analysis of the stability of the villus system in three species
(A) Transient expansion of TA population. Uncontrolled expansion of TA
population in response to extremely severe villus damage is possible in zebrafish
and mouse, but less likely in human. The result shows the inbuilt robustness
of the human crypt-villus system. Inverted triangle: zebrafish; circle: mouse;
square: human. (B) Analysis of the stability of the system. When the strength
of the feedback mechanism is forced to be weakened (k4 goes toward bigger
values), the villus system is prone to higher risk of uncontrolled stem cell
expansion (expansion of the unstable region). In other words, the stem:TA
ratio has to be kept small in order for the system to remain stable. A slight
increase in the stem:TA ratio will likely initiate tissue hyperplasia, frequently
seen before tumor develops, in the case of impaired feedback control.
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5.3.6 Uncontrolled expansion of the capacity of stem-
ness upon impaired feedback mechanism
As an important finding, the capacity of stemness will quickly explode when
the feedback mechanism is impaired (i.e. force k4 to grow), accompanied by
faster epithelium renewal. Thus the STORM model highlights the pivotal
role of the feedback mechanism, which relays signals from the differentiated
population to the immature population. A major source of the feedback signals
likely lies with the secretory cells, including goblet cells and enteroendocrine
cells. This finding is further signified by the frequent observation of abnormal
biogenesis of secretory cells in case of colorectal cancer [157, 153]. Accordingly,
genetic deletion of Muc2 gene in mouse intestine produced colorectal cancers
with impaired biogenesis of goblet cells and faster epithelium renewal [154],
just as the STORM model suggests. Based on these results, we like to propose
the hypothesis that the homeostasis of intestinal secretory cells takes higher
priority than that of absorptive cells, and the feedback mechanism that they
represent serves a key brake on development of colorectal cancers.
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5.3.7 Application of the model to help evaluate hyper-
plasia in human duodenitis and ulcer
Previously, Bransom et al reported of mucosal cell proliferation in the duo-
denum with duodenitis or ulcer in endoscopic biopsies of a group of patients
[215]. They intended to examine the epithelial hyperplasia. That may be
achieved by quantitative analysis using the model we developed here. Based
on the histological results, the villi were shortened by 30-50% in duodenal ulcer
and duodenitis. Epithelium proliferation, as indicated by the labeling index, is
15.6± 1.7 in duodenal ulcer and 17.8± 1.5 in duodenitis. Utilizing these data,
the model yields that: (1) For duodenal ulcer, s = 0.419, τ/τ0 = 0.54, average
capacity of stemness = 8.0 (in normal human duodenum, the stem cell number
is 1.8-3.5, averaged 2.65 as shown earlier). As the model suggests, there is an
increase in the capacity of stemness and an accelerated epithelium renewal rate
(about two-fold faster than normal), supporting duodenal hyperplasia. (2) For
duodenitis, s = 0.444, τ/τ0 = 0.60, stem cell = 7.5 on average. The model
suggests a significant increase in the capacity of stemness and an accelerated
epithelium renewal rate (about 1.7-fold faster), supporting duodenal hyperpla-
sia. The actual presence of hyperplasia is evidenced by the histological results




5.4.1 Epithelium apoptosis is actively initiated in ze-
brafish intestine before mature cells get exfoliated
at the tips of villi
In contrast with the mammalian intestines, the number of apoptotic cells is
notably larger in zebrafish, typically around 15-20 cells per villus (Fig.5.1C).
In mouse, only a few cells are going through apoptosis along each villus. For
instance, about 7 apoptotic cells were observed per 100 villi in mouse intestine
[121]. The vast difference in cell apoptosis indicates a different strategy em-
ployed in teleosts, where apoptosis is initiated before cells are exfoliated into
the intestinal lumen. This contrasts with that of mammals, where cells are
exfoliated often before apoptosis is initiated.
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5.4.2 Achieving the optimal epithelium renewal rate might
be a fundamental principle of the crypt-villus sys-
tem design by nature
The renewal rate of the intestinal epithelium tissue is a concern when it comes
to maintenance of tissue integrity, sustainable organ function and potential risk
of carcinogenic transformation. A high turnover rate would allow quick resti-
tution of the lost tissue upon damage, but on the other hand, high turnover
rate would require the presence of more active stem cells and more cell divi-
sions, increasing the susceptibility to genome duplication-induced mutations
and carcinogenic transformation of the epithelium tissue. These two opposing
requirements ultimately lead to existence of an optimal turnover rate, allowing
best possible maintenance of genome integrity with minimal requirement on
the number of stem cells or stem cell divisions. The optimization model based
on this rationale successfully yields an estimation of the stem cell number
on a histological section of crypt that generally agrees previous speculations
[39, 27, 31] as well as recent advances [198, 213]. As no stem cell marker has
been established in zebrafish intestine, verification of the model results still
awaits future progress in this field.
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5.4.3 The number of stem cells is largely conserved in
the small intestines of teleost, murine and human
Despite the vast differences in villus size from teleost to mammals, the stem
cell number appears more or less conserved across species. Maintenance of a
large number of stem cells on a daily basis seems not preferable due to their
sensitivity to DNA damage and carcinogenic potential [218, 80, 219]. In pres-
ence of an amplifying mechanism, tissue homeostasis and restitution may be
achieved through a prompt and capable response offered by the transit ampli-
fying population. Of all the species examined, the human duodenum seems to
be designed in a very robust manner in terms of maintaining genome integrity
and reducing carcinogenic risk. This feature of the crypt-villus system appears
understandable when one considers the long life-span of humans compared with
teleosts and murines.
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5.4.4 A general model for analysis of stem cell number
with equal applicability to teleost, murine and hu-
man intestinal tracts
For the first time, a general model is developed to analyze the number of
stem cells in the intestinal tracts of teleost, murine and human with experi-
mental input of cell proliferation and differentiation information (illustration
in Fig.5.1E). In absence of a universal stem cell marker for all species, this
model provides a useful tool for us to examine the adaptive changes in stem
cell number and epithelium renewal dynamics during physiological and patho-
logical states of the organ.
5.4.5 Homeostasis of intestinal secretory cells takes high
priority to ensure the integrity of the feedback
mechanism
Genetic perturbations to the homeostasis of intestinal tissue would help us
understand this feature built in the natural design of the crypt-villus system.
Knockout of Bmpr1a gene (BMP receptor 1a, almost ubiquitously expressed
in the intestinal epithelium) in mouse intestine showed increased population of
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BrdU labeled cells and increased villus size (dominantly absorptive cells), but
there was no significant change in goblet cells and Paneth cells [147]. On the
other hand, knockout of beta-catenin in mouse intestine led to quick decrease
in proliferating cells and degeneration of villi within a couple of days, but
the number of goblet cells remained the same during that time period [121].
These two examples clearly suggest the homeostasis of the secretory cells to
be more robust than that of the absorptive cells in the intestine, underlying
the significance of the feedback mechanism we mentioned, which probably
serves as a brake against the development of colorectal cancer. Go one step
further and it is conceivable that the feedback mechanism will be preferably
targeted during the initiation of colorectal cancer. In line with this, frequent
observation of abnormal biogenesis of secretory cells in colorectal cancers has
been documented [157, 153, 220, 221].
5.4.6 Growing evidence for validity of the model
After the development of the STORM model in mid 2007, new evidence sup-
porting the validity of this model keeps coming out. First, the intestinal stem
cell marker of Lgr5 was published in late 2007 [198, 213], which identified the
number of stem cells to be about 2 to 5 per section of crypt in mouse. In early
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2009, the same group reported a more specific marker of Ascl2 [36], which
showed the typical number of stem cells to be no more than 4 per section of
crypt. Another suggested stem cell marker, Olfm4, shows similar results both
in the small intestines of mouse and human (human ortholog, OLFM4). For
the large intestine, our STORM model has suggested presence of one or two
stem cells per section of crypt, less than the number of stem cells in the small
intestine. Interestingly, the reported Lgr5 marker showed one or two stem cells
per section of crypt in mouse colon [198]. In April 2009, report of a new marker
for human colon, aldehyde dehydrogenase 1, also shows presence of only one
or two stem cells per section of crypt [222]. These results all agree well with
the prediction of our STORM model.
5.5 Conclusion
In conclusion, the STORM model we developed may serve as a useful tool
to analyze the number of stem cells in the intestinal tracts across species.
Taking input information that is easily measurable, our model is able to provide
quick and informative knowledge about stem cell number, epithelium turnover







Prior to this thesis, not much work has been performed regarding adult ze-
brafish intestine. There has been a growing need among the zebrafish com-
munity to understand the analogy between zebrafish intestine and mammalian
intestines in order to establish the zebrafish model for human gastrointestinal
diseases. The current work, for the first time, has investigated the morpho-
logical, histological and molecular characteristics of adult zebrafish intestine
using a systems biology approach. Findings of this work should lay down some
foundations that will facilitate future research work where adult zebrafish in-
testine is utilized as a model organ of research. Major findings of the current
work include:
(1) Zebrafish intestine regionalizes into at least two functionally different parts
that are molecularly analogous to the small intestine and the large intestine
of human, respectively. The small intestine connects to the large intestine
through a region of transitional small intestine. The large intestine may be
further divided into proximal and distal parts.
(2) Zebrafish intestinal villi extend to form long ridge-like structures with bi-
furcations to increase the inner surface of the intestinal tract. These ridge-like
structures shrink in length and density toward the posterior intestine and com-
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pletely disappear in the distal large intestine (segment S7).
(3) Zebrafish esophagus directly connects to its intestine without a stomach.
There is no cecum found either. The pepsin gene locus that is generally con-
served across most vertebrates is absent in zebrafish genome, accompanying
the absence of stomach.
(4) There are no crypts of Lieberkuhn in zebrafish intestine. Proliferation of
intestinal epithelium is restricted in the inter-villi pockets, without presence
of Paneth cells. Apoptosis occurs at the tips of intestinal villi.
(5) Zebrafish intestine has demonstrated an impressive capability of regenera-
tion following high range whole body radiation, reshaping our current under-
standing on the regenerative capability of vertebrate organs. It shows multiple
waves of epithelial proliferation and correspondingly, multiple rounds of villi
elimination before homeostasis is re-established. Similar observations have not
been reported in other species so far. Moreover, zebrafish small intestine is
more sensitive to radiation than its large intestine, supporting the hypothesis
that the radiation-sensitive epithelium elimination mechanism would reduce
the cancer incidence in the small intestine.
(6) Compared to highly specialized segments of mammalian digestive tracts,
zebrafish intestine is functionally more versatile and less specialized along the
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anterior-posterior axis. This indicates that the fish intestine may represent a
primitive feature in evolution.
(7) Notch signaling mediates the fate determination of the bipotent precursors
toward either an absorptive or a secretory lineage in the zebrafish intestine
with involvement of a group of glycogen-rich intestinal subepithelial myofi-
broblasts.
(8) Intestinal stem cells are presumably located in the bottom of the inter-villi
pockets and our computational analysis suggests the number to be 2 to 4 cells
per section of one crypt-villus.
(9) STORM is a computational model that addresses the number of intestinal
stem cells as well as their adaptive changes. Apart from fish, this model also
applies to mammalian intestines and helps us to evaluate the biological status
of the intestine organ.
6.2 Future research directions
To date, some questions in this field still remain open and are worthy of further
studies. Here are some suggested future research directions:
(1)Homeostasis of villous ridges. Zebrafish intestine has no crypts but instead,
it has villous ridges. During the day-to-day renewal of the intestinal epithe-
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lium, the ridges may also go through a remodeling process where their shape,
size and surface area will adapt to the physiological state of the fish. Studies
on villi structures normally focus on cell renewal along the base-to-tip villous
axis (viewed from the cross section), but homeostasis of the ridge structures
in a different dimension (roughly along the circular axis of the whole intestine,
see Fig.2.1) are largely ignored. We have noticed that they may grow or shrink
in length, may duplicate themselves through bifurcation and may grow from
anew. But the genes and molecules regulating the rate of their growth and
duplication is not known yet. Further studies may be done by micro-dissecting
the cells sitting on the edge of ridges or cells located at the bifurcating point.
Analysis of their gene expression may discover genes important for controlling
the diameter of the intestinal tube or the inner surface area of the intestine,
which will affect the efficiency of nutrient absorption.
(2)The mechanism of tissue restitution. Stem cells are known to be impor-
tant for maintaining tissue integrity during normal physiology. Since they are
very sensitive to radiation, high dose radiation may remove all of them. Then
the question rises regarding the regeneration of intestine thereafter: Is there
another source of stem cell supply, for instance, from bone marrow, coming
for rescue? Lineage tracing studies where bone marrow cells are genetically
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labeled may address this question and verify this concept. While annihilation
of stem cells may be verified by using animals whose intestinal stem cells are
labeled, for example, by Bmi1 or Ascl2.
(3)Cycling nature of intestinal regeneration. Though a lot of work has been
done using low dose radiation to perturb the stem cells, the regenerating pro-
cess of the whole intestine following exposure to high dose radiation has not
been well characterized. Our results have indicated multiple waves of villi
elimination, which is most evident in the small intestine. But whether this
is a general phenomenon in other species, such as mouse and human, still re-
mains to be studied. In the mean time, assays may be developed to measure
the level of genomic DNA damage (both double strand break and point mu-
tations), from where it is possible to tell the efficiency of DNA repair during
regeneration: Is multiple waves of villi elimination a better way of removing
radiation-damaged tissues (if it is not present in other species)?
(4)Protection of intestine from radiation damage. This is of interest when ra-
diotherapy is applied to colorectal cancer patients. Several drugs have been
tested to have some protective effect, for example, R-spondin1 [165]. Since
zebrafish seems to have a much better tolerance to radiation, the molecular
mechanism may be revealed by profiling the responsive genes in zebrafish in-
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testine following radiation. Using high throughput approaches like microarray
or massive RNA sequencing, a group of genes may be identified this way and
they will provide a list of candidates for a rational research in this field.
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Table 1: Genes that are commonly enriched in S1 through S5
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.85699 ZGC:158130 Zgc:158130 Dr.42999 ZGC:110246 Zgc:110246




Dr.123192 Transcribed locus Dr.75117 CKMA Creatine kinase, muscle a
Dr.104972 Transcribed locus,




Dr.83251 Transcribed locus Dr.75902 ZGC:158387 Zgc:158387
Dr.122767 Transcribed locus Dr.115973 ARNT2 Similar to Aryl hydro-
carbon receptor nuclear
translocator 2 (ARNT pro-
tein 2) (zfARNT2)
Dr.20961 CPLA2 Cytosolic phospholipase a2 Dr.84284 LOC572016 Hypothetical LOC572016
Dr.80069 Transcribed locus Dr.82091 Transcribed locus
Dr.105241 SCD Hypothetical protein
LOC792020
Dr.122884 Transcribed locus
Dr.79463 SI:CH211-146M5.2 Si:ch211-146m5.2 Dr.124929 ZGC:113362 Zgc:113362




Dr.12383 BCMO1 Beta-carotene 15,15’-
monooxygenase 1
Dr.78859 KPNA3 Karyopherin (importin)
alpha 3
Dr.105556 Transcribed locus, weakly





Dr.80070 Transcribed locus Dr.80756 ZGC:77748 Zgc:77748
Dr.36543 AQP8 Aquaporin 8 Dr.76919 TIMM17A Translocase of inner mi-
tochondrial membrane 17
homolog A (yeast)
Dr.76148 ATP2B1A ATPase, Ca++ transport-
ing, plasma membrane 1a




Dr.123334 Transcribed locus Dr.75197 ZGC:172243 Zgc:172243
Dr.133403 Transcribed locus Dr.53929 SNF1LK2B SNF1-like kinase 2b
Dr.107097 WU:FK81D02 Wu:fk81d02 Dr.3552 ZGC:136371 Zgc:136371
Dr.84413 Transcribed locus Dr.113895 LOC793400 Hypothetical protein
LOC793400
Dr.76999 Transcribed locus Dr.14238 Transcribed locus
Dr.139852 Transcribed locus Dr.89530 ZGC:77727 Zgc:77727
Dr.77210 ZGC:112368 Hypothetical protein
LOC792169
Dr.77310 ANXA11A Annexin A11a
Dr.143616 TPI1B Triosephosphate isomerase
1b
Dr.4883 HSD17B4 Hydroxysteroid (17-beta)
dehydrogenase 4
Dr.79004 ZGC:114137 Zgc:114137 Dr.76638 ZGC:77282 Zgc:77282
Dr.80443 ZGC:55398 Zgc:55398 Dr.76874 TEP1 Telomerase-associated
protein 1
Dr.105907 LOC796793 Similar to LOC566928 pro-
tein
Dr.80057 ZGC:153984 Zgc:153984
Dr.5571 Transcribed locus Dr.82013 ZGC:153411 Zgc:153411
Dr.78276 SI:DKEY-146N1.1 Si:dkey-146n1.1 Dr.78328 ZGC:91874 Zgc:91874
Dr.138552 Transcribed locus Dr.81368 ENPP6 Sb:cb727
Dr.132866 ZGC:136551 Zgc:136551 Dr.77198 SERPINB1 Serpin peptidase inhibitor,
clade B (ovalbumin),
member 1
Dr.19519 ZGC:92440 Zgc:92440 Dr.82469 SCP2 Sterol carrier protein 2
Dr.76067 CNOT6L CCR4-NOT transcription
complex, subunit 6-like
Dr.80041 LOC407663 Hypothetical protein
LOC407663
Dr.80025 LOC569162 Hypothetical LOC569162 Dr.41821 WU:FJ47D05 Wu:fj47d05
Dr.105704 CASZ1 Castor zinc finger 1 Dr.120048 LOC100003731 Hypothetical protein
LOC100003731
Dr.82567 SI:CH211-284E13.2 Si:ch211-284e13.2 Dr.123008 Transcribed locus
Dr.105901 FAM60AL Family with sequence sim-
ilarity 60, member A, like
Dr.80071 Transcribed locus
Dr.78419 MGC162288 Hypothetical LOC562365 Dr.77771 SI:DKEY-252H13.6 Si:dkey-252h13.6
Dr.567 BMP4 Bone morphogenetic pro-
tein 4
Dr.81791 Transcribed locus
Dr.75837 STOM Stomatin Dr.52663 ZGC:153764 Hypothetical protein
LOC791835
Dr.79464 Transcribed locus Dr.32415 Transcribed locus
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Dr.80430 TMEM184A Transmembrane protein
184a
Dr.76985 CLDN10L Claudin 10 like
Dr.75182 SDHB Succinate dehydrogenase
complex, subunit B, iron
sulfur (Ip)
Dr.38006 CYP2V1 Hypothetical protein
LOC792107











protein isoform 1 [Danio
rerio]





Dr.10050 ADIPOR2 Adiponectin receptor 2 Dr.79911 Transcribed locus
Dr.134285 DAO.2 D-amino-acid oxidase 2 Dr.10898 ZBTB8OS Zinc finger and BTB do-
main containing 8 opposite
strand
Dr.84719 LOC795901 Hypothetical protein
LOC795901
Dr.105092 ZGC:136353 Zgc:136353
Dr.75974 PDZK1L PDZ domain containing 1
like
Dr.75449 Transcribed locus
Dr.106173 MYO1BL2 Myosin 1b-like 2 Dr.78830 SI:DKEY-267I17.5 Si:dkey-267i17.5





Dr.132203 HOXC6A Homeo box C6a Dr.78217 ZGC:112992 Zgc:112992
Dr.75963 DAP1A Death associated protein
1a
Dr.74624 WU:FJ21G01 Wu:fj21g01
Dr.84829 THRAP6 Thyroid hormone receptor
associated protein 6
Dr.83284 Transcribed locus
Dr.132277 Transcribed locus Dr.121549 LOC798137 Similar to Secretory car-
rier membrane protein 2




Dr.75440 Transcribed locus Dr.76374 CASPA Caspase a
Dr.107078 REVERBB1 Rev erb beta 1 Dr.123527 Transcribed locus
Dr.51340 ZGC:77739 Zgc:77739 Dr.4960 MDH1A Malate dehydrogenase 1a,
NAD (soluble)
Dr.77204 ZGC:136771 Zgc:136771 Dr.76507 FAAH2A Fatty acid amide hydrolase
2a
Dr.12642 Transcribed locus Dr.115707 PRKRI Hypothetical protein
LOC791666
Dr.78424 CD2APL CD2-associated protein
like
Dr.105991 Transcribed locus
Dr.31637 ZGC:92275 Zgc:92275 Dr.91756 Transcribed locus
Dr.8705 LOC794415 Hypothetical protein
LOC794415
Dr.79907 NUCB2B Nucleobindin 2b
Dr.79949 TM4SF5 Transmembrane 4 L six
family member 5
Dr.77336 ZGC:113196 Zgc:113196
Dr.78050 ZGC:73324 Zgc:73324 Dr.78358 LOC100000526 Hypothetical protein
LOC100000526
Dr.105434 ZGC:77177 Hypothetical protein
LOC791497
Dr.75994 WU:FA56D06 Wu:fa56d06
Dr.76989 ABAT 4-aminobutyrate amino-
transferase
Dr.21082 LOC791814 Hypothetical protein
LOC791814
Dr.121917 Transcribed locus Dr.79404 Transcribed locus
Dr.78126 PARP3 Poly (ADP-ribose) poly-
merase family, member 3
Dr.80699 SLC9A6A Solute carrier family 9
(sodium/hydrogen ex-
changer), member 6a
Dr.75549 ZGC:55420 Hypothetical protein
LOC792156
Dr.78188 ZGC:110540 Zgc:110540
Dr.42958 OSR2 Hypothetical protein
LOC792005
Dr.105248 Transcribed locus, mod-




Dr.119936 ZGC:92392 Zgc:92392 Dr.26261 Transcribed locus
Dr.37831 ZGC:103611 Zgc:103611 Dr.121965 Transcribed locus
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Dr.124243 Transcribed locus, weakly





Dr.132329 LOC100004607 Similar to Apoa4 protein
Dr.123269 Transcribed locus Dr.110644 SI:DKEY-21K10.1 Si:dkey-21k10.1
Dr.83470 ZGC:123113 Zgc:123113 Dr.26496 GPSN2 Hypothetical protein
LOC791459
Dr.107259 SEPP1A Selenoprotein P, plasma,
1a
Dr.26560 ELOVL5 ELOVL family member 5,
elongation of long chain
fatty acids (yeast)
Dr.83076 CDNA clone IM-
AGE:7250984
Dr.78540 IM:7156396 Im:7156396
Dr.133115 Transcribed locus Dr.80855 Transcribed locus, mod-
erately similar to NP
001012948.1 B-cell
CLL/lymphoma 6 (zinc
finger protein 51) [Gallus
gallus]
Dr.77083 ZGC:86714 Zgc:86714 Dr.132567 ZGC:136791 Zgc:136791
Dr.76671 HMGB3A High-mobility group box
3a
Dr.5461 LOC402880 Hypothetical protein
LOC402880
Dr.78673 LOC571547 Hypothetical LOC571547 Dr.116914 LOC100005579 Hypothetical protein
LOC100005579
Dr.76905 ZGC:92744 Zgc:92744 Dr.683 FAM73A Family with sequence sim-
ilarity 73, member A
Dr.77157 ZGC:110064 Zgc:110064 Dr.75558 SLC4A2 Solute carrier family 4, an-
ion exchanger, member 2
Dr.76014 CALM2B Calmodulin 2b, (phospho-
rylase kinase, delta)
Dr.1301 PRKAG1 Hypothetical protein
LOC791615
Dr.105771 LOC100007704 Similar to Slc7a8-prov pro-
tein
Dr.84404 Transcribed locus




Dr.36830 ZGC:101682 Zgc:101682 Dr.81478 SULT1ST3 Sulfotransferase family 1,
cytosolic sulfotransferase 3
Dr.76994 CTH Cystathionase (cystathio-
nine gamma-lyase)





Solute carrier family 15
(oligopeptide transporter),
member 1 [Danio rerio]
Dr.6064 LOC100000433 Hypothetical protein
LOC100000433
Dr.11921 NR5A5 Nuclear receptor subfam-
ily 5, group A, member 5
Dr.107820 HNF4A Hepatocyte nuclear factor
4, alpha
Dr.80184 ZGC:101071 Zgc:101071 Dr.85714 Transcribed locus
Dr.14492 Transcribed locus Dr.77914 Transcribed locus
Dr.36558 EHD3L EH-domain containing 3,
like
Dr.86109 ZGC:100913 Hypothetical LOC554386
Dr.75475 MAFBA V-maf musculoaponeu-
rotic fibrosarcoma onco-





Dr.84935 FAM125BB Family with sequence sim-
ilarity 125, member B
Dr.16130 ADH8B Alcohol dehydrogenase 8b Dr.75118 ZGC:112098 Zgc:112098
Dr.79263 SLC3A2 Solute carrier family 3,
member 2
Dr.13867 Transcribed locus
Dr.19659 EZRL Ezrin like Dr.80298 ZGC:111859 Zgc:111859
Dr.76395 ZGC:110340 Zgc:110340 Dr.839 LOC571955 Similar to hCG1987869
Dr.81221 C14ORF159 Chromosome 14 open
reading frame 159
Dr.35566 ZGC:123283 Zgc:123283
Dr.77311 RBP2A Retinol binding protein 2a,
cellular
Dr.77810 UGT1AA UDP glucuronosyltrans-
ferase 1 family a, a
Dr.81788 TBXAS1 Thromboxane A synthase
1 (platelet, cytochrome
P450, family 5, subfamily
A)
Dr.86203 Transcribed locus,




Dr.144128 ZGC:109868 Zgc:109868 Dr.81620 ZGC:113305 Hypothetical LOC554551
Dr.76268 CBR1L Hypothetical protein
LOC792137
Dr.72387 LOC557691 Hypothetical LOC557691
Dr.85726 Transcribed locus Dr.76645 Transcribed locus
211
Dr.140543 Transcribed locus, mod-
erately similar to NP
775564.1 solute carrier
family 43, member 2 [Mus
musculus]
Dr.37144 Transcribed locus
Dr.27215 ZGC:92770 Zgc:92770 Dr.4573 LGALS9L1 Hypothetical protein
LOC791953







Dr.135374 ZGC:113336 Zgc:113336 Dr.21056 ZGC:77734 Zgc:77734
Dr.87549 ZGC:112418 Zgc:112418 Dr.77660 ZGC:100963 Zgc:100963
Dr.109065 Transcribed locus, weakly
similar to NP 038841.1
erythrocyte protein band
4.1-like 3 [Mus musculus]
Dr.79916 NR1H4 Nuclear receptor subfam-
ily 1, group H, member 4
Dr.84231 KITLGA Kit ligand a Dr.90271 ZGC:114175 Zgc:114175
Dr.76570 SI:CH211-219I10.1 Si:ch211-219i10.1 Dr.26719 ZDHHC16 Zinc finger, DHHC domain
containing 16
Dr.77072 Transcribed locus Dr.27189 LOC567259 Similar to ATP-binding
cassette transporter 1
Dr.42009 Transcribed locus Dr.84913 LOC100000643 Hypothetical protein
LOC100000643
Dr.80802 ITPK1 Inositol 1,3,4-triphosphate
5/6 kinase
Dr.79390 ZGC:77868 Zgc:77868
Dr.75352 XPNPEP1 X-prolyl aminopeptidase
(aminopeptidase P) 1,
soluble
Dr.120392 ADA Hypothetical protein
LOC792200




Dr.77103 WU:FB63A08 Wu:fb63a08 Dr.84486 LOC558790 Similar to novel sulfotrans-
ferase family protein




Dr.1574 Transcribed locus Dr.76436 Transcribed locus
Dr.114529 LOC100003771 Similar to OT-
THUMP00000028706
Dr.81614 Transcribed locus
Dr.79906 WU:FD59G01 Wu:fd59g01 Dr.48159 Transcribed locus, weakly
similar to XP 001331394.1
PREDICTED: hypotheti-
cal protein [Danio rerio]
Dr.107944 ABP1 Amiloride binding protein
1 (amine oxidase (copper-
containing))
Dr.121805 Transcribed locus
Dr.84019 ZGC:63614 Zgc:63614 Dr.104708 HIPK2 Homeodomain interacting
protein kinase 2
Dr.84574 PCDH2AB2 Hypothetical protein
LOC791897
Dr.131199 Transcribed locus
Dr.77107 SCCPDHA Zgc:174379 Dr.76864 ZGC:65827 Wu:fb52e12
Dr.10429 ZGC:77067 Hypothetical LOC573178 Dr.23502 APOEB Apolipoprotein Eb
Dr.76924 ZGC:110339 Zgc:110339 Dr.78758 GPD1 Hypothetical protein
LOC792059





Dr.82025 ZGC:112208 Zgc:112208 Dr.118399 LOC564350 Similar to cytochrome
P450
Dr.77381 ZGC:92479 Zgc:92479 Dr.81832 LOC553407 Hypothetical protein
LOC100006308
Dr.69146 LOC799188 Hypothetical protein
LOC799188
Dr.114385 ZGC:163023 Zgc:163023
Dr.106780 ZGC:63486 Zgc:63486 Dr.86220 ETFA Electron-transfer-
flavoprotein, alpha
polypeptide
Dr.76489 ZGC:92763 Zgc:92763 Dr.84970 ZGC:63602 Zgc:63602
Dr.52856 ABCG2A ATP-binding cassette,
sub-family G (WHITE),
member 2a
Dr.75844 IDH1 Isocitrate dehydrogenase 1
(NADP+), soluble
Dr.77089 APOA4 Apolipoprotein A-IV Dr.78000 LOC553341 Hypothetical protein
LOC553341




Dr.115882 LOC796920 Hypothetical protein
LOC796920
Dr.80224 PSMB9B Proteasome (prosome,
macropain) subunit, beta
type, 9b
Dr.23638 Transcribed locus Dr.76547 ZGC:158323 Zgc:158323
Dr.3325 Transcribed locus Dr.16380 ALDH8A1 Aldehyde dehydrogenase 8
family, member A1




Dr.80438 VIL1L Villin 1 like Dr.91373 DGAT2 Diacylglycerol O-
acyltransferase 2
Dr.143630 Transcribed locus Dr.24063 ABCC2 ATP-binding cas-
sette, sub-family C
(CFTR/MRP), member 2
Dr.105351 Transcribed locus Dr.80312 GABPB2 Hypothetical LOC554849
Dr.82986 Transcribed locus Dr.77668 HBL3 Hexose-binding lectin 3
Dr.32732 INVS Inversin Dr.11569 OSBPL2 Oxysterol binding protein-
like 2
Dr.9564 ZGC:162874 Zgc:162874 Dr.75578 ZGC:92628 Zgc:92628
Dr.76174 Transcribed locus Dr.13823 Transcribed locus






Dr.83673 MET Similar to c-Met receptor
tyrosine kinase
Dr.77043 ZGC:85789 Zgc:85789
Dr.25239 SULT2ST1 Hypothetical protein
LOC792298
Dr.122174 Transcribed locus
Dr.140575 CD164 CD164 molecule, sialo-
mucin
Dr.2648 ARPP19 CAMP-regulated phospho-
protein 19
Dr.81250 CBLN1 Cerebellin 1 precursor Dr.79904 SLC5A8L Solute carrier family 5 (io-
dide transporter), member
8-like
Dr.78356 GATA6 GATA-binding protein 6 Dr.76346 Transcribed locus
Dr.78058 MYH11 Myosin, heavy polypeptide
11, smooth muscle
Dr.91916 HLXB9LA Homeo box HB9 like a
Dr.82536 LOC556236 Hypothetical LOC556236 Dr.79778 OSTF1 Osteoclast stimulating fac-
tor 1
Dr.121957 Transcribed locus Dr.74509 LAD1 Ladinin
Dr.80026 Transcribed locus Dr.34109 SI:DKEY-91F15.6 Si:dkey-91f15.6
Dr.122838 Transcribed locus Dr.37073 ZGC:101553 Zgc:101553
Dr.80003 Transcribed locus Dr.40063 ACO1 Aconitase 1, soluble
Dr.129054 Transcribed locus Dr.117581 ZGC:154087 Zgc:154087
Dr.1967 Transcribed locus Dr.81328 SI:CH211-218C17.2 Si:ch211-218c17.2
Dr.76827 Transcribed locus Dr.80063 RETSAT Retinol saturase (all-
trans-retinol 13,14-
reductase)
Dr.82256 ZGC:153186 Zgc:153186 Dr.78118 Transcribed locus
Dr.113556 UGDH UDP-glucose dehydroge-
nase
Dr.117819 LOC791911 Hypothetical protein
LOC791911
Dr.79378 LOC561658 Hypothetical LOC561658 Dr.123223 Transcribed locus
Dr.133125 Transcribed locus Dr.134550 ZGC:77906 Zgc:77906
Dr.77166 ZGC:85790 Zgc:85790 Dr.81599 SI:DKEY-98P3.7 Si:dkey-98p3.7
Dr.79900 CX28.9 Connexin 28.9 Dr.78731 Transcribed locus
Dr.2976 SI:CH211-200O3.4 Si:ch211-200o3.4 Dr.76097 ZGC:103594 Zgc:103594
Dr.75775 APOA1 Apolipoprotein A-I Dr.81163 ZGC:85947 Hypothetical protein
LOC791634
Dr.86683 LOC100002984 Hypothetical protein
LOC100002984





Dr.82554 LOC568302 Hypothetical LOC568302 Dr.77139 RH50 Rh50-like protein
Dr.78711 ACSL4 Acyl-CoA synthetase long-
chain family member 4
Dr.83942 Transcribed locus
Dr.111542 Transcribed locus Dr.14424 ZGC:112518 Zgc:112518
Dr.1479 BLMH Bleomycin hydrolase Dr.76783 PLA2G12B Phospholipase A2, group
XIIB
Dr.14156 Transcribed locus Dr.82199 Transcribed locus
Dr.4955 Transcribed locus Dr.21703 ZGC:110680 Zgc:110680
Dr.80059 ZGC:92732 Zgc:92732 Dr.107659 ABI1 Abl-interactor 1
Dr.26580 VAPA VAMP (vesicle-associated
membrane protein)-
associated protein A
Dr.21094 Transcribed locus, weakly
similar to XP 001333287.1
PREDICTED: similar to
ENSANGP00000022061
isoform 1 [Danio rerio]
Dr.76256 DSC2L Desmocollin 2 like Dr.122419 Transcribed locus
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Dr.139822 Transcribed locus Dr.143586 Transcribed locus,
strongly similar to NP
001002205.1 dehydro-
genase/reductase (SDR
family) member 1 [Danio
rerio]
Dr.46547 ZGC:114067 Zgc:114067 Dr.122713 Transcribed locus
Dr.38064 ANXA2B Hypothetical protein
LOC791669
Dr.91379 ZGC:103433 Hypothetical protein
LOC791921
Dr.83415 Transcribed locus Dr.104435 SI:CH211-93F2.1 Si:ch211-93f2.1
Dr.85634 S100A10A S100 calcium binding pro-
tein A10a
Dr.86025 Transcribed locus
Dr.123250 Transcribed locus Dr.91549 ZGC:111958 Zgc:111958
Dr.105078 CYP1A Cytochrome P450, family
1, subfamily A
Dr.75691 GORASP2 Golgi reassembly stacking
protein 2
Dr.106940 RGL1 Ral guanine nucleotide dis-
sociation stimulator-like 1
Dr.47557 WU:FA18F11 Wu:fa18f11
Dr.90487 ZGC:172295 Zgc:172295 Dr.19947 LMBR1L Limb region 1 like
Dr.10826 Transcribed locus, weakly




Dr.72371 WU:FB60G05 Wu:fb60g05 Dr.121770 Transcribed locus
Dr.140606 Transcribed locus Dr.2478 TXNDC4 Thioredoxin domain con-
taining 4 (endoplasmic
reticulum)
Dr.111731 AQP10 Aquaporin 10 Dr.23314 WAS Wiskott-Aldrich syn-
drome (eczema-
thrombocytopenia)
Dr.81907 TMEM19 Transmembrane protein 19 Dr.78902 Transcribed locus
Dr.35698 LOC100003669 Hypothetical protein
LOC100003669
Dr.117056 ZGC:101030 Hypothetical protein
LOC791832
Dr.10893 SARA2 Hypothetical protein
LOC792159
Dr.74237 ZGC:101555 Zgc:101555
Dr.78736 WU:FC28F08 Wu:fc28f08 Dr.17457 ZGC:63667 Hypothetical protein
LOC100005281
Dr.12800 PTPLB Protein tyrosine
phosphatase-like (pro-
line instead of catalytic
arginine), member b
Dr.116678 ZGC:110200 Zgc:110200
Dr.106395 Transcribed locus Dr.76544 Transcribed locus,




Dr.2625 Transcribed locus Dr.110647 EPHX1 Epoxide hydrolase 1, mi-
crosomal (xenobiotic)
Dr.75392 AK3L1 Adenylate kinase 3-like 1 Dr.14176 CTSH Cathepsin H
Dr.104230 LOC569770 Hypothetical LOC569770 Dr.61277 AK2 Adenylate kinase 2
Dr.23008 Transcribed locus Dr.20705 ZGC:103537 Zgc:103537
Dr.88645 ZGC:86611 Zgc:86611 Dr.102843 Transcribed locus
Dr.14219 ZGC:64043 Hypothetical protein
LOC791889
Dr.75825 NOTCH1B Notch homolog 1b
Dr.77508 MAO Monoamine oxidase Dr.9528 PDK2 Pyruvate dehydrogenase
kinase, isoenzyme 2
Dr.11244 GPIA Glucose phosphate iso-
merase a
Dr.82585 LOC562304 Similar to cytochrome
P450, family 2, subfamily
J, polypeptide 2




Dr.122079 Transcribed locus Dr.114476 ZGC:92161 Hypothetical protein
LOC791539
Dr.122712 CLIC5 Chloride intracellular
channel 5
Dr.88609 TH Tyrosine hydroxylase
Dr.117328 LOC559563 Hypothetical LOC559563 Dr.75931 CKMT1 Creatine kinase, mitochon-
drial 1
Dr.105120 Transcribed locus Dr.76083 DNAJC11 DnaJ (Hsp40) homolog,
subfamily C, member 11
Dr.76046 ATP1B1A ATPase, Na+/K+ trans-
porting, beta 1a polypep-
tide
Dr.134327 ZGC:85816 Zgc:85816
Dr.75374 Transcribed locus Dr.80219 Transcribed locus
Dr.82564 ESR2B Estrogen receptor 2b Dr.122977 Transcribed locus
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Dr.133221 Transcribed locus, mod-









Dr.105084 RDHE2 Epidermal retinal dehy-
drogenase 2
Dr.133710 ZGC:63812 Zgc:174035
Dr.117302 ZGC:92083 Zgc:92083 Dr.76124 ZGC:153978 Zgc:153978
Dr.132305 ZGC:77439 Zgc:77439 Dr.82376 ZGC:63863 Hypothetical protein
LOC797468
Dr.83273 ZGC:63960 Zgc:63960 Dr.133174 Transcribed locus,
strongly similar to NP
991283.1 testis derived
transcript [Danio rerio]
Dr.143409 RORAB RAR-related orphan re-
ceptor A, paralog b
Dr.43950 Transcribed locus
Dr.80724 SULT1ST6 Sulfotransferase family,
cytosolic sulfotransferase
6
Dr.120175 HSD11B3 Hydroxysteroid (11-beta)
dehydrogenase 3
Dr.77306 UPB1 Ureidopropionase, beta Dr.77502 ZGC:113301 Hypothetical LOC554606
Dr.122409 Transcribed locus Dr.3583 ZGC:111843 Zgc:111843
Dr.28948 TWF1B Twinfilin, actin-binding
protein, homolog 1b
Dr.8749 WBP2 WW domain binding pro-
tein 2
Dr.77202 RDH1L Retinol dehydrogenase 1,
like
Dr.122701 Transcribed locus
Dr.77343 Transcribed locus Dr.87576 ZGC:92205 Zgc:92205
Dr.121609 Transcribed locus Dr.106816 ZGC:154090 Zgc:154090
Dr.21543 Transcribed locus Dr.88598 Isolate G5197 T-cell recep-
tor alpha variable region
Dr.37032 CYP2J30 Cytochrome P450, family
2, subfamily J, polypep-
tide 30
Dr.14609 Transcribed locus
Dr.75843 CHPT1 Choline phosphotrans-
ferase 1
Dr.108840 RDH12L Retinol dehydrogenase 12,
like
Dr.39606 ZGC:136891 Zgc:136891 Dr.75429 CPT2 Carnitine palmitoyltrans-
ferase II
Dr.40298 WU:FB58E08 Wu:fb58e08 Dr.72352 SI:CH211-286M4.4 Si:ch211-286m4.4
Dr.77610 ZGC:101667 Zgc:101667 Dr.79800 LOC569894 Hypothetical LOC569894
Dr.77295 PGD Phosphogluconate hydro-
genase
Dr.121806 Transcribed locus
Dr.132490 ZGC:77867 Zgc:77867 Dr.24921 GPX4B Glutathione peroxidase 4b
Dr.87714 PKNOX1.2 Pbx/knotted 1 homeobox
1.2
Dr.113808 PLS1 Plastin 1 (I isoform)
Dr.132547 Transcribed locus Dr.121757 Transcribed locus
Dr.86150 Transcribed locus Dr.43919 ZGC:112954 Zgc:112954
Dr.87070 ZGC:85680 Zgc:85680 Dr.79889 ZGC:92254 Zgc:92254
Dr.80128 ZGC:158435 Similar to solute carrier
family 26 meber 1
Dr.76793 GPX4A Glutathione peroxidase 4a
Dr.12608 LASS2 LAG1 homolog, ceramide
synthase 2 (S. cerevisiae)
Dr.18920 ZGC:136871 Zgc:136871
Dr.32573 RPL11 Ribosomal protein L11 Dr.8695 LOC793786 Hypothetical protein
LOC793786
Dr.91521 ZGC:101575 Zgc:101575 Dr.77160 CYP3A65 Cytochrome P450, family
3, subfamily A, polypep-
tide 65
Dr.88778 GLI1 GLI-Kruppel family mem-
ber 1
Dr.79664 Transcribed locus
Dr.82435 CH211-106H4.4 Similar to MAM domain
containing 4
Dr.82727 Transcribed locus
Dr.122690 Transcribed locus Dr.76802 Transcribed locus
Dr.115711 LOC567858 Hypothetical LOC567858 Dr.132259 PSMB10 Proteasome (prosome,
macropain) subunit, beta
type, 10
Dr.29092 Transcribed locus Dr.82519 FECH Ferrochelatase
Dr.75229 Transcribed locus Dr.36376 TFB2M Transcription factor B2,
mitochondrial





Dr.75372 STARD3NL STARD3 N-terminal like Dr.30709 ZGC:92630 Zgc:92630
Dr.131930 Transcribed locus Dr.5040 CYB5A Cytochrome b5 type A
(microsomal)
Dr.81511 ZGC:113156 Zgc:113156 Dr.76235 ZGC:92631 Zgc:92631
Dr.77009 CA2 Similar to Carbonic anhy-
drase II
Dr.25277 AGR2 Anterior gradient homolog
2 (Xenopus laevis)
Dr.40624 LOC569148 Hypothetical LOC569148 Dr.81269 PAX2B Paired box gene 2b
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Dr.106515 LOC795458 Similar to EN-
SANGP00000022061
Dr.77140 RAB1A RAB1A, member RAS
oncogene family
Dr.133084 ZGC:110131 Zgc:110131 Dr.108245 ZGC:113169 Zgc:113169
Dr.143804 TBX18 T-box 18 Dr.82968 GCHFR GTP cyclohydrolase I
feedback regulator
Dr.80987 ZGC:153628 Zgc:153628 Dr.78105 ZGC:56518 Zgc:56518
Dr.76753 Transcribed locus Dr.76749 CD63 Cd63 antigen
Dr.23444 SERPINB1L3 Serpin peptidase inhibitor,
clade B (ovalbumin),
member 1, like 3
Dr.85668 RGN Regucalcin






Adenylate kinase 3-like 1
[Danio rerio]
Dr.79965 CYP4V2 Cytochrome P450, family
4, subfamily V, polypep-
tide 2
Dr.80946 Transcribed locus
Dr.140737 Transcribed locus, mod-
erately similar to NP
957035.1 cysteine dioxy-






Dr.114483 LOC799845 Hypothetical protein
LOC799845
Dr.26481 EPS8L3 EPS8-like 3 Dr.78519 SPAG1 Sperm associated antigen
1
Dr.19030 ZGC:92360 Zgc:92360 Dr.76983 ZGC:110286 Hypothetical protein
LOC791833
Dr.294 Transcribed locus Dr.39467 ZGC:110312 Zgc:110312
Dr.13438 IM:7145298 Im:7145298 Dr.81276 NOG3 Noggin 3
Dr.118182 ZGC:103681 Zgc:103681 Dr.33603 GPT2 Glutamic pyruvate
transaminase (alanine
aminotransferase) 2
Dr.77462 Transcribed locus Dr.43244 Transcribed locus,




Dr.132693 LOC798331 Hypothetical protein
LOC798331
Dr.105736 Transcribed locus
Dr.492 Transcribed locus Dr.75810 PDX1 Pancreatic and duodenal
homeobox 1
Dr.90055 ZGC:112172 Zgc:112172 Dr.24982 ZGC:56585 Hypothetical protein
LOC792146
Dr.47275 HNRPKL Hypothetical protein
LOC791602
Dr.75470 LOC563514 Hypothetical LOC563514
Dr.132653 ZGC:162095 Zgc:162095 Dr.133296 YAF2 YY1 associated factor 2
Dr.30247 ZGC:77118 Zgc:113969 Dr.132399 MTX2 Metaxin 2




Dr.125451 Transcribed locus Dr.77809 Transcribed locus
Dr.79183 ZGC:101040 Zgc:101040 Dr.80201 Transcribed locus
Dr.104488 MAPK12 Mitogen-activated protein
kinase 12
Dr.47567 SI:DKEY-30H14.2 Si:dkey-30h14.2
Dr.87644 ZGC:113259 Zgc:113259 Dr.132384 SULT1ST1 Sulfotransferase family,
cytosolic sulfotransferase
1
Dr.27131 CD9 CD9 antigen (p24) Dr.81384 SLC35A5 Solute carrier family 35,
member A5
Dr.72337 Transcribed locus, mod-




initiation factor 4, gamma
1 isoform a [Rattus
norvegicus]
Dr.107707 Transcribed locus
Dr.9584 LOC567688 Similar to hCG28765 Dr.6336 ZGC:77387 Hypothetical protein
LOC792296
Dr.20850 FABP7A Fatty acid binding protein
7, brain, a
Dr.39952 VPS33A Vacuolar protein sorting
33A
Dr.32636 LOC558298 Similar to stress-activated
protein kinase-3
Dr.132343 ZGC:86722 Wu:fb65d05
Dr.1304 ARHGDIA Rho GDP dissociation in-
hibitor (GDI) alpha
Dr.79923 GPX1B Glutathione peroxidase 1b
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Dr.77407 SI:DKEY-190L1.1 Si:dkey-190l1.1 Dr.41512 GNG2 Guanine nucleotide bind-
ing protein (G protein),
gamma 2
Dr.78484 ZGC:85843 Hypothetical protein
LOC791495
Dr.123024 Transcribed locus
Dr.82649 ZGC:73259 Zgc:73259 Dr.10121 TFG TRK-fused gene
Dr.79901 Transcribed locus Dr.78805 ZGC:56517 Hypothetical protein
LOC792074
Dr.144 Transcribed locus Dr.116160 LOC792335 Hypothetical protein
LOC792335
Dr.88724 ZGC:109902 Zgc:109902 Dr.83294 ZGC:92178 Zgc:92178
Dr.36001 LOC571420 Si:dkey-236e20.5 Dr.29419 PPP1CB Protein phosphatase 1,
catalytic subunit, beta
isoform
Dr.89328 Transcribed locus Dr.72357 ZGC:153136 Zgc:153136
Dr.132672 WU:FD46E10 Wu:fd46e10 Dr.86201 Transcribed locus
Dr.132916 Transcribed locus Dr.118221 ZGC:92349 Zgc:92349
Dr.37828 ZGC:162025 Zgc:162025 Dr.26640 CYP46A1 Cytochrome P450, family
46, subfamily A, polypep-
tide 1
Dr.100029 ZGC:77732 Zgc:77732 Dr.122414 Transcribed locus
Dr.79847 ZGC:112279 Zgc:112279 Dr.118526 LOC556210 S100 calcium binding pro-
tein V1
Dr.23036 ZGC:112282 Zgc:112282 Dr.78399 ZGC:73292 Zgc:73292
Dr.69856 LOC562640 Similar to LOC495046 pro-
tein
Dr.76748 CALM3B Calmodulin 3b (phospho-
rylase kinase, delta)
Dr.107002 Transcribed locus Dr.36440 ABHD3 Abhydrolase domain con-
taining 3
Dr.106921 ZGC:110586 Zgc:110586 Dr.80055 Transcribed locus
Dr.37659 BIN2 Bridging integrator 2 Dr.78702 ZGC:92326 Zgc:92326
Dr.83039 GCGA Glucagon a Dr.75522 GOT1 Glutamic-oxaloacetic
transaminase 1, soluble
Dr.86937 Transcribed locus Dr.79272 TTC4 Tetratricopeptide repeat
domain 4
Dr.2710 TOM1 Similar to target of myb1
(chicken)
Dr.121673 Transcribed locus
Dr.33635 ZGC:110087 Zgc:110087 Dr.76110 COX5AB Cytochrome c oxidase sub-
unit Vab
Dr.132340 Transcribed locus Dr.81902 LOC100004225 Hypothetical protein
LOC100004225
Dr.80850 PTPN6 Protein tyrosine phos-
phatase, non-receptor
type 6
Dr.12429 NITR4A Novel immune-type recep-
tor 4a
Dr.77358 ZGC:110411 Zgc:110411 Dr.77116 ZGC:101540 Zgc:101540
Dr.77172 ZGC:153968 Zgc:153968 Dr.86126 Transcribed locus
Dr.78256 IVNS1ABPA Influenza virus NS1A
binding protein a
Dr.77176 LOC571991 Hypothetical LOC571991
Dr.118073 ZGC:110641 Zgc:110641 Dr.76586 ZGC:65964 Zgc:65964
Dr.78765 ZGC:64130 Zgc:64130 Dr.45962 LOC792966 Similar to cathepsin A
Dr.88608 ZGC:92332 Zgc:92332 Dr.75473 LMNB2 Lamin B2
Dr.133388 Transcribed locus Dr.48703 ZGC:92869 Zgc:113898
Dr.4243 CX32.3 Connexin 32.3 Dr.22246 LOC100008492 Hypothetical protein
LOC100008492
Dr.36960 ZGC:91861 Zgc:91861 Dr.21044 Transcribed locus
Dr.75090 IHHB Hypothetical protein
LOC791618
Dr.83192 SI:DKEY-3N22.7 Si:dkey-3n22.7
Dr.52445 LOC553339 Hypothetical protein
LOC553339
Dr.76945 S100U S100 calcium binding pro-
tein U
Dr.104980 APOC2 Apolipoprotein C-II Dr.76319 SRI Hypothetical protein
LOC791966
Dr.122443 Transcribed locus Dr.78941 WU:FC47E12 Wu:fc47e12
Dr.94336 LOC100004795 Similar to lambda-
recombinase-like protein
Dr.81537 ZGC:101021 Zgc:101021
Dr.79516 ZGC:92027 Zgc:92027 Dr.77631 Transcribed locus
Dr.75679 Transcribed locus Dr.132239 ZGC:153440 Zgc:153440
Dr.97099 RDH1 Retinol dehydrogenase 1 Dr.47346 Transcribed locus
Dr.132874 CYP2J22 Cytochrome P450, family
2, subfamily J, polypep-
tide 23
Dr.86370 ZGC:77076 Zgc:173915
Dr.91454 ZGC:110410 Zgc:110410 Dr.36480 ZGC:103645 Zgc:103645
Dr.140625 Transcribed locus, mod-




Dr.77507 MALT1 Mucosa associated lym-
phoid tissue lymphoma
translocation gene 1
Dr.90519 OLFM1A Olfactomedin 1a Dr.122020 Transcribed locus
Dr.123452 Transcribed locus Dr.31094 RBKS Hypothetical protein
LOC792027
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Dr.77432 LYRICL Lyric-like Dr.79892 KMO Kynurenine 3-
monooxygenase
Dr.79979 Transcribed locus Dr.76266 PSME2 Proteasome activator sub-
unit 2
Dr.122207 Transcribed locus Dr.119008 LOC569427 Hypothetical LOC569427
Dr.132155 GATA5 GATA-binding protein 5 Dr.107323 ZGC:56005 Zgc:56005








Dr.80189 LOC559610 Hypothetical LOC559610
Dr.76653 NET1 Neuroepithelial cell trans-
forming gene 1
Dr.80066 Transcribed locus
Dr.121695 Transcribed locus, mod-




Dr.22212 CYP3C1L2 Cytochrome P450, family
3, subfamily c, polypep-
tide 1 like, 2
Dr.82172 PSMA6B Proteasome (prosome,
macropain) subunit, alpha
type, 6b




DICTED: similar to Major
vault protein isoform 1
[Danio rerio]
Dr.42866 MGST1 Microsomal glutathione S-
transferase 1
Dr.89100 ALLC Allantoicase Dr.132777 ZGC:63493 Zgc:63493
Dr.13779 Transcribed locus Dr.114908 ZGC:100952 Hypothetical protein
LOC791585
Dr.78303 Transcribed locus Dr.76855 ZGC:66117 Zgc:66117
Dr.82782 Transcribed locus Dr.79051 ZGC:153507 Zgc:153507
Dr.20277 ACTA2 Actin, alpha 2, smooth
muscle, aorta
Dr.105356 ZGC:92026 Zgc:92026
Dr.39930 UGT1AB Zgc:123097 Dr.79547 IM:6895749 Im:6895749
Dr.85924 PURA Purine-rich element bind-
ing protein A
Dr.81544 Transcribed locus
Dr.83720 Transcribed locus Dr.27946 Transcribed locus
Dr.84183 LOC100005118 Hypothetical protein
LOC100005118
Dr.80870 Transcribed locus
Dr.20376 CLIC4 Chloride intracellular
channel 4
Dr.83166 ZGC:101630 Hypothetical LOC573613
Dr.86287 ZGC:63651 Zgc:63651
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Table 2: Genes that are enriched in S1 (in addition to those genes commonly enriched in
S1-S5)
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.13660 ZGC:101744 Hypothetical protein
LOC791489
Dr.122797 Transcribed locus
Dr.79969 LOC566714 Hypothetical LOC566714 Dr.86133 MPP2B Membrane protein, palmi-
toylated 2b (MAGUK p55
subfamily member 2b)
Dr.108168 CSAD Cysteine sulfinic acid de-
carboxylase
Dr.121301 NITR3A Novel immune-type recep-
tor 3a
Dr.74715 LOC571260 Zgc:162816 Dr.77866 SI:RP71-39B20.7 Si:rp71-39b20.7
Dr.79354 Transcribed locus Dr.122503 Transcribed locus
Dr.89216 Transcribed locus Dr.27305 ZGC:92111 Zgc:92111
Dr.83156 Transcribed locus Dr.945 PGAM1 Phosphoglycerate mutase
1
Dr.75672 LOC796109 Similar to Eukaryotic
translation initiation
factor 3, subunit 8
Dr.3585 AGT Angiotensinogen
Dr.78704 ZGC:66317 Zgc:66317 Dr.80701 Transcribed locus
Dr.80471 ZGC:110537 Hypothetical protein
LOC791913
Dr.76457 Transcribed locus,




Dr.79021 ZGC:92903 Zgc:92903 Dr.80635 Transcribed locus
Dr.87802 ZGC:112146 Zgc:112146 Dr.78934 PCF11 Zgc:175013
Dr.82671 SI:CH211-51L3.4 Si:ch211-51l3.4 Dr.22286 Transcribed locus
Dr.75811 INS Preproinsulin Dr.29744 SP8L Sp8 transcription factor-
like
Dr.87101 ZGC:110143 Zgc:110143 Dr.85455 ZGC:112432 Zgc:112432
Dr.28449 SLC2A12 Solute carrier family 2
(facilitated glucose trans-
porter), member 12
Dr.75226 KHDRBS1 KH domain containing,
RNA binding, signal
transduction associated 1
Dr.78375 3-Sep Septin 3 Dr.78088 ZGC:101000 Zgc:101000
Dr.31849 ZGC:136380 Zgc:158165 Dr.3332 ANGPTL3 Angiopoietin-like 3
Dr.89368 ZGC:103506 Hypothetical protein
LOC792269
Dr.82598 STAR Steroidogenic acute regu-
latory protein
Dr.10723 TBR1 T-box 1, brain Dr.17802 LOC796123 Hypothetical protein
LOC796123
Dr.76732 GLDC Glycine dehydrogenase
(decarboxylating)




Dr.75441 VTNA Vitronectin a
Dr.77547 ZGC:100868 Zgc:100868 Dr.76353 TIAL1 TIA1 cytotoxic granule-
associated RNA binding
protein-like 1




Dr.122425 Transcribed locus Dr.86306 LOC100002825 Hypothetical protein
LOC100002825
Dr.84337 Transcribed locus Dr.88913 TH2 Tyrosine hydroxylase 2
Dr.11111 Transcribed locus Dr.78018 PDSS1 Prenyl (decaprenyl)
diphosphate synthase,
subunit 1
Dr.84618 ZGC:92762 Zgc:92762 Dr.48573 DISP1 Zgc:111866
Dr.12007 WU:FJ98A08 Wu:fj98a08 Dr.117029 ZGC:112265 Zgc:112265
Dr.84727 CHMP7 CHMP family, member 7 Dr.134435 ZGC:91876 Zgc:91876
Dr.83978 ZGC:110755 Zgc:110755 Dr.83965 ZGC:103754 Zgc:103754





Dr.22087 Transcribed locus Dr.120697 FADS2 Fatty acid desaturase 2
Dr.122080 Transcribed locus Dr.33222 ZGC:56053 Zgc:56053
Dr.78320 ZGC:110281 Zgc:110281 Dr.79590 BARHL2 BarH-like 2
Dr.81191 LOC793458 Similar to Peptide Y Dr.81898 ZGC:110741 Zgc:110741
Dr.89227 PPM1E Protein phosphatase 1E
(PP2C domain containing)
Dr.77181 CYP2J28 Ccytochrome P450, family
2, subfamily J, polypep-
tide 28
Dr.80398 ZGC:153079 Zgc:153079 Dr.77992 MEIS4.1A Myeloid ecotropic viral in-
tegration site 4.1a
Dr.23725 Transcribed locus Dr.114006 LRRC6L Leucine-rich repeat-
containing 6 like
Dr.54293 Transcribed locus Dr.133139 Transcribed locus
Dr.76656 CAPN8 Calpain 8 Dr.22416 Transcribed locus
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Dr.5169 WU:FC20C02 Wu:fc20c02 Dr.30454 NR5A1B Nuclear receptor subfam-
ily 5, group A, member 1b
Dr.78089 COX5AA Cytochrome c oxidase sub-
unit Vaa
Dr.30880 VKORC1L1 Vitamin K epoxide reduc-
tase complex, subunit 1-
like 1
Dr.80282 ZGC:110141 Zgc:110141 Dr.41381 FAM20B Family with sequence sim-
ilarity 20, member B (H.
sapiens)
Dr.123399 Transcribed locus, weakly
similar to XP 682884.1
PREDICTED: hypothet-
ical protein isoform 1
[Danio rerio]
Dr.115139 PMPCA Peptidase (mitochondrial
processing) alpha
Dr.84633 ABHD2B Zgc:153750 Dr.83836 ZGC:109965 Zgc:109965
Dr.78779 Transcribed locus Dr.91088 ZGC:113307 Zgc:113307
Dr.87130 ZGC:85888 Zgc:85888 Dr.74470 JAK1 Janus kinase 1
Dr.75609 BTF3 Basic transcription factor
3
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Table 3: Genes that are enriched in S2 (in addition to those genes commonly enriched in
S1-S5)
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.13660 ZGC:101744 Hypothetical protein
LOC791489
Dr.122797 Transcribed locus
Dr.79969 LOC566714 Hypothetical LOC566714 Dr.86133 MPP2B Membrane protein, palmi-
toylated 2b (MAGUK p55
subfamily member 2b)
Dr.108168 CSAD Cysteine sulfinic acid de-
carboxylase
Dr.121301 NITR3A Novel immune-type recep-
tor 3a
Dr.74715 LOC571260 Zgc:162816 Dr.77866 SI:RP71-39B20.7 Si:rp71-39b20.7
Dr.79354 Transcribed locus Dr.122503 Transcribed locus
Dr.89216 Transcribed locus Dr.27305 ZGC:92111 Zgc:92111
Dr.83156 Transcribed locus Dr.945 PGAM1 Phosphoglycerate mutase
1
Dr.75672 LOC796109 Similar to Eukaryotic
translation initiation
factor 3, subunit 8
Dr.3585 AGT Angiotensinogen
Dr.78704 ZGC:66317 Zgc:66317 Dr.80701 Transcribed locus
Dr.80471 ZGC:110537 Hypothetical protein
LOC791913
Dr.76457 Transcribed locus,




Dr.79021 ZGC:92903 Zgc:92903 Dr.80635 Transcribed locus
Dr.87802 ZGC:112146 Zgc:112146 Dr.78934 PCF11 Zgc:175013
Dr.82671 SI:CH211-51L3.4 Si:ch211-51l3.4 Dr.22286 Transcribed locus
Dr.75811 INS Preproinsulin Dr.29744 SP8L Sp8 transcription factor-
like
Dr.87101 ZGC:110143 Zgc:110143 Dr.85455 ZGC:112432 Zgc:112432
Dr.28449 SLC2A12 Solute carrier family 2
(facilitated glucose trans-
porter), member 12
Dr.75226 KHDRBS1 KH domain containing,
RNA binding, signal
transduction associated 1
Dr.78375 3-Sep Septin 3 Dr.78088 ZGC:101000 Zgc:101000
Dr.31849 ZGC:136380 Zgc:158165 Dr.3332 ANGPTL3 Angiopoietin-like 3
Dr.89368 ZGC:103506 Hypothetical protein
LOC792269
Dr.82598 STAR Steroidogenic acute regu-
latory protein
Dr.10723 TBR1 T-box 1, brain Dr.17802 LOC796123 Hypothetical protein
LOC796123
Dr.76732 GLDC Glycine dehydrogenase
(decarboxylating)




Dr.75441 VTNA Vitronectin a
Dr.77547 ZGC:100868 Zgc:100868 Dr.76353 TIAL1 TIA1 cytotoxic granule-
associated RNA binding
protein-like 1




Dr.122425 Transcribed locus Dr.86306 LOC100002825 Hypothetical protein
LOC100002825
Dr.84337 Transcribed locus Dr.88913 TH2 Tyrosine hydroxylase 2
Dr.11111 Transcribed locus Dr.78018 PDSS1 Prenyl (decaprenyl)
diphosphate synthase,
subunit 1
Dr.84618 ZGC:92762 Zgc:92762 Dr.48573 DISP1 Zgc:111866
Dr.12007 WU:FJ98A08 Wu:fj98a08 Dr.117029 ZGC:112265 Zgc:112265
Dr.84727 CHMP7 CHMP family, member 7 Dr.134435 ZGC:91876 Zgc:91876
Dr.83978 ZGC:110755 Zgc:110755 Dr.83965 ZGC:103754 Zgc:103754





Dr.22087 Transcribed locus Dr.120697 FADS2 Fatty acid desaturase 2
Dr.122080 Transcribed locus Dr.33222 ZGC:56053 Zgc:56053
Dr.78320 ZGC:110281 Zgc:110281 Dr.79590 BARHL2 BarH-like 2
Dr.81191 LOC793458 Similar to Peptide Y Dr.81898 ZGC:110741 Zgc:110741
Dr.89227 PPM1E Protein phosphatase 1E
(PP2C domain containing)
Dr.77181 CYP2J28 Ccytochrome P450, family
2, subfamily J, polypep-
tide 28
Dr.80398 ZGC:153079 Zgc:153079 Dr.77992 MEIS4.1A Myeloid ecotropic viral in-
tegration site 4.1a
Dr.23725 Transcribed locus Dr.114006 LRRC6L Leucine-rich repeat-
containing 6 like
Dr.54293 Transcribed locus Dr.133139 Transcribed locus
Dr.76656 CAPN8 Calpain 8 Dr.22416 Transcribed locus
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Dr.5169 WU:FC20C02 Wu:fc20c02 Dr.30454 NR5A1B Nuclear receptor subfam-
ily 5, group A, member 1b
Dr.78089 COX5AA Cytochrome c oxidase sub-
unit Vaa
Dr.30880 VKORC1L1 Vitamin K epoxide reduc-
tase complex, subunit 1-
like 1
Dr.80282 ZGC:110141 Zgc:110141 Dr.41381 FAM20B Family with sequence sim-
ilarity 20, member B (H.
sapiens)
Dr.123399 Transcribed locus, weakly
similar to XP 682884.1
PREDICTED: hypothet-
ical protein isoform 1
[Danio rerio]
Dr.115139 PMPCA Peptidase (mitochondrial
processing) alpha
Dr.84633 ABHD2B Zgc:153750 Dr.83836 ZGC:109965 Zgc:109965
Dr.78779 Transcribed locus Dr.91088 ZGC:113307 Zgc:113307
Dr.87130 ZGC:85888 Zgc:85888 Dr.74470 JAK1 Janus kinase 1
Dr.75609 BTF3 Basic transcription factor
3
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Table 4: Genes that are enriched in S3 (in addition to those genes commonly enriched in
S1-S5)
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.79635 ZGC:158316 Zgc:158316 Dr.23725 Transcribed locus




Dr.77138 CPA2 Hypothetical protein
LOC792272
Dr.78089 COX5AA Cytochrome c oxidase sub-
unit Vaa
Dr.108168 CSAD Cysteine sulfinic acid de-
carboxylase
Dr.80282 ZGC:110141 Zgc:110141
Dr.106275 Transcribed locus Dr.84633 ABHD2B Zgc:153750
Dr.79354 Transcribed locus Dr.87130 ZGC:85888 Zgc:85888
Dr.77514 ELA3L Elastase 3 like Dr.84169 ZGC:175098 Zgc:175098
Dr.82353 ELA2 Similar to Ela2 protein Dr.122797 Transcribed locus
Dr.77126 CTRB1 Chymotrypsinogen B1 Dr.86133 MPP2B Membrane protein, palmi-
toylated 2b (MAGUK p55
subfamily member 2b)
Dr.77127 ZGC:66382 Zgc:66382 Dr.121301 NITR3A Novel immune-type recep-
tor 3a
Dr.80832 Transcribed locus Dr.77866 SI:RP71-39B20.7 Si:rp71-39b20.7
Dr.83156 Transcribed locus Dr.122503 Transcribed locus
Dr.47389 CEL.2 Hypothetical protein
LOC792128
Dr.945 PGAM1 Phosphoglycerate mutase
1
Dr.75672 LOC796109 Similar to Eukaryotic
translation initiation
factor 3, subunit 8
Dr.80701 Transcribed locus
Dr.79021 ZGC:92903 Zgc:92903 Dr.80635 Transcribed locus
Dr.75811 INS Preproinsulin Dr.78934 PCF11 Zgc:175013
Dr.87101 ZGC:110143 Zgc:110143 Dr.22286 Transcribed locus
Dr.28449 SLC2A12 Solute carrier family 2
(facilitated glucose trans-
porter), member 12
Dr.29744 SP8L Sp8 transcription factor-
like
Dr.78375 3-Sep Septin 3 Dr.75226 KHDRBS1 KH domain containing,
RNA binding, signal
transduction associated 1
Dr.31849 ZGC:136380 Zgc:158165 Dr.104993 ZGC:158450 Similar to eukaryotic
translation initiation
factor 4 gamma, 1
Dr.89368 ZGC:103506 Hypothetical protein
LOC792269
Dr.78088 ZGC:101000 Zgc:101000
Dr.10723 TBR1 T-box 1, brain Dr.82598 STAR Steroidogenic acute regu-
latory protein
Dr.76732 GLDC Glycine dehydrogenase
(decarboxylating)
Dr.76099 CDKN1C Cyclin-dependent kinase
inhibitor 1C (p57, Kip2)
Dr.47548 HOXD11A Homeo box D11a Dr.17802 LOC796123 Hypothetical protein
LOC796123
Dr.77547 ZGC:100868 Zgc:100868 Dr.81274 SEMA3H Semaphorin 3h
Dr.113486 SLC34A2A Solute carrier family 34
(sodium phosphate), mem-
ber 2a
Dr.86306 LOC100002825 Hypothetical protein
LOC100002825
Dr.122425 Transcribed locus Dr.88913 TH2 Tyrosine hydroxylase 2
Dr.77689 ZGC:153769 Zgc:153769 Dr.78018 PDSS1 Prenyl (decaprenyl)
diphosphate synthase,
subunit 1
Dr.75547 TRY Trypsin Dr.48573 DISP1 Zgc:111866
Dr.84337 Transcribed locus Dr.134435 ZGC:91876 Zgc:91876
Dr.116102 ELA2L Elastase 2 like Dr.83965 ZGC:103754 Zgc:103754
Dr.11111 Transcribed locus Dr.120697 FADS2 Fatty acid desaturase 2
Dr.84618 ZGC:92762 Zgc:92762 Dr.33222 ZGC:56053 Zgc:56053
Dr.12007 WU:FJ98A08 Wu:fj98a08 Dr.79590 BARHL2 BarH-like 2
Dr.84727 CHMP7 CHMP family, member 7 Dr.77181 CYP2J28 Ccytochrome P450, family
2, subfamily J, polypep-
tide 28
Dr.75138 NOLC1L Nucleolar and coiled-body
phosphoprotein 1-like
Dr.77992 MEIS4.1A Myeloid ecotropic viral in-
tegration site 4.1a
Dr.83978 ZGC:110755 Zgc:110755 Dr.114006 LRRC6L Leucine-rich repeat-
containing 6 like





Dr.22087 Transcribed locus Dr.22416 Transcribed locus
Dr.76170 ZGC:55429 Zgc:55429 Dr.30454 NR5A1B Nuclear receptor subfam-
ily 5, group A, member 1b
Dr.89525 P2RX1 Purinergic receptor P2X,
ligand-gated ion channel, 1
Dr.30880 VKORC1L1 Vitamin K epoxide reduc-
tase complex, subunit 1-
like 1
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Dr.81191 LOC793458 Similar to Peptide Y Dr.115139 PMPCA Peptidase (mitochondrial
processing) alpha
Dr.89227 PPM1E Protein phosphatase 1E
(PP2C domain containing)
Dr.83836 ZGC:109965 Zgc:109965
Dr.80398 ZGC:153079 Zgc:153079 Dr.34348 LOC566646 Hypothetical LOC566646
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Table 5: Genes that are enriched in S4 (in addition to those genes commonly enriched in
S1-S5)
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.79635 ZGC:158316 Zgc:158316 Dr.81191 LOC793458 Similar to Peptide Y
Dr.79887 SLC6A19 Solute carrier family 6
(neurotransmitter trans-
porter), member 19
Dr.89227 PPM1E Protein phosphatase 1E
(PP2C domain containing)
Dr.77138 CPA2 Hypothetical protein
LOC792272
Dr.80398 ZGC:153079 Zgc:153079
Dr.108168 CSAD Cysteine sulfinic acid de-
carboxylase
Dr.23725 Transcribed locus
Dr.106275 Transcribed locus Dr.5169 WU:FC20C02 Wu:fc20c02
Dr.75792 HOXD9A Homeo box D9a Dr.80282 ZGC:110141 Zgc:110141
Dr.123166 Transcribed locus Dr.84633 ABHD2B Zgc:153750
Dr.77514 ELA3L Elastase 3 like Dr.78779 Transcribed locus
Dr.82353 ELA2 Similar to Ela2 protein Dr.87130 ZGC:85888 Zgc:85888
Dr.77126 CTRB1 Chymotrypsinogen B1 Dr.84169 ZGC:175098 Zgc:175098
Dr.77127 ZGC:66382 Zgc:66382 Dr.122797 Transcribed locus
Dr.80832 Transcribed locus Dr.86133 MPP2B Membrane protein, palmi-
toylated 2b (MAGUK p55
subfamily member 2b)
Dr.10201 SEPW1 Selenoprotein W, 1 Dr.78888 ZGC:77415 Zgc:77415
Dr.6725 Transcribed locus Dr.77866 SI:RP71-39B20.7 Si:rp71-39b20.7
Dr.47389 CEL.2 Hypothetical protein
LOC792128
Dr.122503 Transcribed locus
Dr.32109 ZGC:91959 Zgc:91959 Dr.945 PGAM1 Phosphoglycerate mutase
1
Dr.77027 KNTC2L Kinetochore associated 2-
like
Dr.80635 Transcribed locus
Dr.75672 LOC796109 Similar to Eukaryotic
translation initiation
factor 3, subunit 8
Dr.22286 Transcribed locus
Dr.79047 ZGC:113480 Zgc:113480 Dr.29744 SP8L Sp8 transcription factor-
like
Dr.89368 ZGC:103506 Hypothetical protein
LOC792269
Dr.78088 ZGC:101000 Zgc:101000
Dr.10723 TBR1 T-box 1, brain Dr.3332 ANGPTL3 Angiopoietin-like 3
Dr.76732 GLDC Glycine dehydrogenase
(decarboxylating)





Dr.17802 LOC796123 Hypothetical protein
LOC796123
Dr.47548 HOXD11A Homeo box D11a Dr.81274 SEMA3H Semaphorin 3h
Dr.77547 ZGC:100868 Zgc:100868 Dr.77272 E2F4 E2F transcription factor 4
Dr.113486 SLC34A2A Solute carrier family 34
(sodium phosphate), mem-
ber 2a
Dr.76353 TIAL1 TIA1 cytotoxic granule-
associated RNA binding
protein-like 1
Dr.122425 Transcribed locus Dr.86306 LOC100002825 Hypothetical protein
LOC100002825
Dr.121990 Transcribed locus Dr.78018 PDSS1 Prenyl (decaprenyl)
diphosphate synthase,
subunit 1
Dr.77689 ZGC:153769 Zgc:153769 Dr.48573 DISP1 Zgc:111866
Dr.75547 TRY Trypsin Dr.134435 ZGC:91876 Zgc:91876
Dr.84337 Transcribed locus Dr.83965 ZGC:103754 Zgc:103754
Dr.116102 ELA2L Elastase 2 like Dr.96078 ZGC:100836 Zgc:100836
Dr.11111 Transcribed locus Dr.120697 FADS2 Fatty acid desaturase 2
Dr.83578 LOC556669 Hypothetical LOC556669 Dr.33222 ZGC:56053 Zgc:56053
Dr.84618 ZGC:92762 Zgc:92762 Dr.79590 BARHL2 BarH-like 2
Dr.12007 WU:FJ98A08 Wu:fj98a08 Dr.77181 CYP2J28 Ccytochrome P450, family
2, subfamily J, polypep-
tide 28
Dr.84727 CHMP7 CHMP family, member 7 Dr.77992 MEIS4.1A Myeloid ecotropic viral in-
tegration site 4.1a
Dr.83978 ZGC:110755 Zgc:110755 Dr.114006 LRRC6L Leucine-rich repeat-
containing 6 like





Dr.121574 Transcribed locus Dr.86192 LOC559127 Similar to AWKS9372
Dr.22087 Transcribed locus Dr.30880 VKORC1L1 Vitamin K epoxide reduc-
tase complex, subunit 1-
like 1
Dr.76170 ZGC:55429 Zgc:55429 Dr.115139 PMPCA Peptidase (mitochondrial
processing) alpha
Dr.89525 P2RX1 Purinergic receptor P2X,
ligand-gated ion channel, 1
Dr.85728 LOC557582 Hypothetical LOC557582
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Table 6: Genes that are enriched in S5 (in addition to those genes commonly enriched in
S1-S5)
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.79635 ZGC:158316 Zgc:158316 Dr.76170 ZGC:55429 Zgc:55429
Dr.79887 SLC6A19 Solute carrier family 6
(neurotransmitter trans-
porter), member 19
Dr.21244 UCP2 Uncoupling protein 2




Dr.108168 CSAD Cysteine sulfinic acid de-
carboxylase
Dr.32320 LGMN Legumain
Dr.106275 Transcribed locus Dr.76172 FUCA1 Fucosidase, alpha-L- 1, tis-
sue
Dr.75792 HOXD9A Homeo box D9a Dr.5169 WU:FC20C02 Wu:fc20c02
Dr.77514 ELA3L Elastase 3 like Dr.80289 Transcribed locus
Dr.82353 ELA2 Similar to Ela2 protein Dr.80282 ZGC:110141 Zgc:110141
Dr.77126 CTRB1 Chymotrypsinogen B1 Dr.84633 ABHD2B Zgc:153750
Dr.77127 ZGC:66382 Zgc:66382 Dr.88326 SLC10A2 Solute carrier family 10
(sodium/bile acid cotrans-
porter family), member 2
Dr.89216 Transcribed locus Dr.78779 Transcribed locus
Dr.32560 ZGC:113564 Zgc:113564 Dr.132230 ZGC:101116 Zgc:101116
Dr.80832 Transcribed locus Dr.111513 LOC100001879 Similar to Widely-
interspaced zinc finger
motifs
Dr.83156 Transcribed locus Dr.87130 ZGC:85888 Zgc:85888
Dr.30882 ZGC:103420 Zgc:103420 Dr.84169 ZGC:175098 Zgc:175098
Dr.78850 Transcribed locus Dr.86913 FABP6 Fatty acid binding protein
6, ileal (gastrotropin)
Dr.82756 LOC402976 Hypothetical protein
LOC402976
Dr.122503 Transcribed locus
Dr.47389 CEL.2 Hypothetical protein
LOC792128
Dr.27305 ZGC:92111 Zgc:92111
Dr.32109 ZGC:91959 Zgc:91959 Dr.122381 Transcribed locus
Dr.75672 LOC796109 Similar to Eukaryotic
translation initiation
factor 3, subunit 8




Dr.79021 ZGC:92903 Zgc:92903 Dr.80635 Transcribed locus
Dr.80589 SCPEP1 Serine carboxypeptidase 1 Dr.18814 WU:FI40C08 Wu:fi40c08
Dr.75811 INS Preproinsulin Dr.2918 SAFB Scaffold attachment factor
B
Dr.87101 ZGC:110143 Zgc:110143 Dr.132909 SNX14 Sorting nexin 14
Dr.81287 KRML2 Kreisler (mouse) maf-
related leucine zipper
homolog 2
Dr.75226 KHDRBS1 KH domain containing,
RNA binding, signal
transduction associated 1
Dr.31849 ZGC:136380 Zgc:158165 Dr.78088 ZGC:101000 Zgc:101000
Dr.10723 TBR1 T-box 1, brain Dr.3332 ANGPTL3 Angiopoietin-like 3
Dr.85174 CTSL.1 Cathepsin L.1 Dr.83376 ST3GAL3 ST3 beta-galactoside
alpha-2,3-sialyltransferase
3
Dr.47548 HOXD11A Homeo box D11a Dr.81274 SEMA3H Semaphorin 3h
Dr.122425 Transcribed locus Dr.28311 ZGC:152997 Hypothetical protein
LOC791544
Dr.77689 ZGC:153769 Zgc:153769 Dr.77272 E2F4 E2F transcription factor 4
Dr.75547 TRY Trypsin Dr.76353 TIAL1 TIA1 cytotoxic granule-
associated RNA binding
protein-like 1
Dr.79066 ACSL1 Acyl-CoA synthetase long-
chain family member 1
Dr.88583 FOXD1 Forkhead box D1
Dr.77961 ZGC:92765 Zgc:92765 Dr.88913 TH2 Tyrosine hydroxylase 2
Dr.84337 Transcribed locus Dr.83965 ZGC:103754 Zgc:103754
Dr.116102 ELA2L Elastase 2 like Dr.96078 ZGC:100836 Zgc:100836
Dr.76001 RPS18 Ribosomal protein S18 Dr.91026 LOC100006536 Hypothetical protein
LOC100006536
Dr.80969 LOC100004989 Hypothetical protein
LOC100004989
Dr.77992 MEIS4.1A Myeloid ecotropic viral in-
tegration site 4.1a
Dr.84618 ZGC:92762 Zgc:92762 Dr.133139 Transcribed locus
Dr.79471 CDNA clone IM-
AGE:7137180
Dr.86192 LOC559127 Similar to AWKS9372
Dr.84727 CHMP7 CHMP family, member 7 Dr.22416 Transcribed locus
Dr.7668 ZGC:158605 Zgc:158605 Dr.6703 CH211-106H4.12 Hypothetical LOC561742
Dr.88453 ZGC:77182 Zgc:77182 Dr.84960 GRTP1B Hypothetical protein
LOC791767
Dr.83978 ZGC:110755 Zgc:110755 Dr.74470 JAK1 Janus kinase 1
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Dr.85728 LOC557582 Hypothetical LOC557582
Dr.121574 Transcribed locus Dr.34348 LOC566646 Hypothetical LOC566646
Dr.32463 CTSC Cathepsin C
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Table 7: Genes that are enriched in S6
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.83251 Transcribed locus Dr.80057 ZGC:153984 Zgc:153984
Dr.122767 Transcribed locus Dr.106493 SHCBP1 Hypothetical LOC554973
Dr.13660 ZGC:101744 Hypothetical protein
LOC791489
Dr.80835 SI:CH73-13B6.3 Si:ch73-13b6.3
Dr.80773 RP2 Retinitis pigmentosa 2 (X-
linked recessive)
Dr.15182 ZGC:56596 Zgc:56596
Dr.105241 SCD Hypothetical protein
LOC792020
Dr.78671 ZGC:55888 Zgc:55888
Dr.106275 Transcribed locus Dr.47436 MCM7 Hypothetical LOC554619
Dr.123334 Transcribed locus Dr.12263 LOC402824 Hypothetical protein
LOC402824
Dr.79354 Transcribed locus Dr.77198 SERPINB1 Serpin peptidase inhibitor,
clade B (ovalbumin),
member 1
Dr.75384 ZGC:66430 Zgc:66430 Dr.75383 ZGC:110687 Zgc:110687
Dr.75792 HOXD9A Homeo box D9a Dr.105413 TPM1 Tropomyosin 1 (alpha)
Dr.77210 ZGC:112368 Hypothetical protein
LOC792169
Dr.75920 SMARCE1 SWI/SNF related, matrix
associated, actin depen-
dent regulator of chro-
matin, subfamily e, mem-
ber 1
Dr.143616 TPI1B Triosephosphate isomerase
1b
Dr.76710 Transcribed locus
Dr.123166 Transcribed locus Dr.76848 LOC798717 Hypothetical protein
LOC798717
Dr.132573 MT2 Metallothionein 2 Dr.105554 ZGC:173994 Zgc:173994
Dr.77514 ELA3L Elastase 3 like Dr.105858 ZGC:112971 Zgc:112971
Dr.78276 SI:DKEY-146N1.1 Si:dkey-146n1.1 Dr.45506 ZGC:112291 Zgc:112291
Dr.132866 ZGC:136551 Zgc:136551 Dr.75731 BTG4 B-cell translocation gene 4
Dr.82353 ELA2 Similar to Ela2 protein Dr.81117 ZGC:153243 Zgc:153243
Dr.77126 CTRB1 Chymotrypsinogen B1 Dr.123008 Transcribed locus
Dr.105901 FAM60AL Family with sequence sim-
ilarity 60, member A, like
Dr.13694 ZGC:163003 Zgc:163003
Dr.78419 MGC162288 Hypothetical LOC562365 Dr.15633 LOC570432 Hypothetical LOC570432
Dr.82877 LOC571645 Similar to sperm associ-
ated antigen 9
Dr.77534 ZGC:55702 Zgc:55702
Dr.77127 ZGC:66382 Zgc:66382 Dr.78385 HIC2 Hypermethylated in can-
cer 2
Dr.89216 Transcribed locus Dr.87643 ZGC:101827 Zgc:101827
Dr.32560 ZGC:113564 Zgc:113564 Dr.32320 LGMN Legumain
Dr.79871 DGAT1 Diacylglycerol O-
acyltransferase homolog 1
(mouse)
Dr.122870 Transcribed locus, mod-




Dr.157 NFYC Nuclear transcription fac-
tor Y, gamma
Dr.85513 WU:FC54A11 Wu:fc54a11
Dr.85873 EYA4 Eyes absent homolog 4
(Drosophila)
Dr.77771 SI:DKEY-252H13.6 Si:dkey-252h13.6
Dr.134285 DAO.2 D-amino-acid oxidase 2 Dr.114174 ZGC:63569 Hypothetical protein
LOC100000446
Dr.117291 WU:FD10H03 Wu:fd10h03 Dr.20974 ZGC:55943 Zgc:55943
Dr.84719 LOC795901 Hypothetical protein
LOC795901
Dr.81396 PPIL2 Peptidylprolyl isomerase
(cyclophilin)-like 2
Dr.106173 MYO1BL2 Myosin 1b-like 2 Dr.74466 SI:DKEY-264G21.1 Si:dkey-264g21.1
Dr.132203 HOXC6A Homeo box C6a Dr.78587 TSC1B Tuberous sclerosis 1b
Dr.31100 NUDT15 Hypothetical protein
LOC791620
Dr.78346 ZGC:152925 Zgc:152925
Dr.10201 SEPW1 Selenoprotein W, 1 Dr.79423 ZGC:114119 Zgc:114119





Dr.21063 NKX3.2 NK3 homeobox 2
Dr.75440 Transcribed locus Dr.75618 ZGC:171444 Zgc:171444
Dr.108202 ZGC:103514 Zgc:103514 Dr.29173 KLF2A Kruppel-like factor 2a
Dr.83156 Transcribed locus Dr.78271 ZGC:158414 Zgc:158414
Dr.61171 ALDOAA Aldolase a, fructose-
bisphosphate, a
Dr.13175 Transcribed locus









Dr.84876 LOC555985 Hypothetical LOC555985
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Dr.78850 Transcribed locus Dr.78830 SI:DKEY-267I17.5 Si:dkey-267i17.5








Dr.78272 C20ORF149L Chromosome 20 open
reading frame 149, like
Dr.81839 ZGC:77563 Zgc:77563
Dr.6725 Transcribed locus Dr.91044 LOC557719 Hypothetical LOC557719
Dr.8705 LOC794415 Hypothetical protein
LOC794415
Dr.121549 LOC798137 Similar to Secretory car-
rier membrane protein 2
Dr.76646 ZGC:165381 Zgc:165381 Dr.121988 Transcribed locus
Dr.89589 ZGC:101650 Zgc:101650 Dr.79037 ZGC:110259 Zgc:110259
Dr.79949 TM4SF5 Transmembrane 4 L six
family member 5
Dr.76979 ZGC:153225 Zgc:153225
Dr.76989 ABAT 4-aminobutyrate amino-
transferase
Dr.54293 Transcribed locus
Dr.47389 CEL.2 Hypothetical protein
LOC792128
Dr.14775 ZGC:91872 Zgc:91872
Dr.77027 KNTC2L Kinetochore associated 2-
like
Dr.105609 ZGC:110159 Zgc:110159
Dr.79878 DAB2 Disabled homolog 2
(Drosophila)
Dr.97360 ZGC:111826 Zgc:111826
Dr.105771 LOC100007704 Similar to Slc7a8-prov pro-
tein
Dr.22874 WU:FC21E07 Wu:fc21e07
Dr.75553 ZGC:112226 Zgc:112226 Dr.115707 PRKRI Hypothetical protein
LOC791666
Dr.78430 Transcribed locus,





Dr.23685 Transcribed locus Dr.75252 COL9A2 Procollagen, type IX, al-
pha 2
Dr.78704 ZGC:66317 Zgc:66317 Dr.76665 LOC566399 Hypothetical LOC566399






Dr.31691 LOC562438 Similar to LDLR dan Dr.83792 ZGC:158807 Zgc:158807
Dr.4044 ZGC:92139 Zgc:92139 Dr.76172 FUCA1 Fucosidase, alpha-L- 1, tis-
sue
Dr.85767 ZGC:92705 Zgc:92705 Dr.132876 ZGC:113984 Zgc:113984
Dr.86277 Transcribed locus Dr.117460 LOC792416 Hypothetical protein
LOC792416




Dr.7323 LOC571692 Hypothetical LOC571692 Dr.117593 LOC799087 Similar to Oip5 protein
Dr.76568 CLYBL Zgc:136594 Dr.26261 Transcribed locus
Dr.80597 TAF1B TATA box binding pro-
tein (Tbp)-associated fac-
tor, RNA polymerase I, B
Dr.80630 ZGC:73340 Zgc:73340




Dr.80471 ZGC:110537 Hypothetical protein
LOC791913
Dr.88420 ZGC:101803 Zgc:101803
Dr.12330 WDR33 WD repeat domain 33 Dr.76656 CAPN8 Calpain 8
Dr.78996 ZGC:55661 Zgc:55661 Dr.122289 Transcribed locus
Dr.122702 Transcribed locus Dr.80332 MCRS1 Microspherule protein 1
Dr.24323 ZGC:56608 Zgc:56608 Dr.29919 METT10D Methyltransferase 10 do-
main containing
Dr.81546 TRAPPC6BL Trafficking protein particle
complex 6b-like
Dr.3436 LOC100000870 Hypothetical protein
LOC100000870
Dr.75320 HSPD1 Heat shock 60kD protein 1
(chaperonin)
Dr.6975 ZGC:66107 Zgc:66107
Dr.76739 WU:FC44A11 Wu:fc44a11 Dr.75913 MAPK3 Mitogen-activated protein
kinase 3
Dr.144128 ZGC:109868 Zgc:109868 Dr.80454 WU:FI20G04 Wu:fi20g04
Dr.140543 Transcribed locus, mod-
erately similar to NP
775564.1 solute carrier
family 43, member 2 [Mus
musculus]
Dr.5461 LOC402880 Hypothetical protein
LOC402880
Dr.78624 Transcribed locus Dr.23039 Transcribed locus
230
Dr.6635 SH3BP5LA SH3-binding domain pro-
tein 5-like, a
Dr.80340 WU:FI04F09 Wu:fi04f09
Dr.17300 LOC559362 Hypothetical LOC559362 Dr.117507 ZGC:174575 Zgc:174575
Dr.80589 SCPEP1 Serine carboxypeptidase 1 Dr.79151 PXK PX domain containing ser-
ine/threonine kinase
Dr.81772 SI:BUSM1-241H12.4 Si:busm1-241h12.4 Dr.9174 ZGC:55673 Zgc:55673
Dr.26675 ZGC:55492 Hypothetical LOC554468 Dr.133159 Transcribed locus
Dr.132878 LOC100002850 Similar to Secretory car-
rier membrane protein 2,
like
Dr.77053 WU:FC18A08 Wu:fc18a08
Dr.76472 ZGC:110821 Zgc:110821 Dr.37018 ZGC:112003 Zgc:112003
Dr.82787 IM:7150662 Im:7150662 Dr.75558 SLC4A2 Solute carrier family 4, an-
ion exchanger, member 2
Dr.121617 Transcribed locus Dr.103297 LOC564151 Similar to Claspin




Dr.75131 FBL Fibrillarin Dr.113787 Transcribed locus,




Dr.29762 EFNA2 Non-POU domain contain-
ing, octamer-binding
Dr.143610 WDR43L WD repeat domain 43, like
Dr.76196 GSNB Gelsolin b Dr.82517 HMX3 Homeo box (H6 family) 3
Dr.107944 ABP1 Amiloride binding protein
1 (amine oxidase (copper-
containing))
Dr.78005 MPZ Sc:d0186
Dr.87101 ZGC:110143 Zgc:110143 Dr.132401 SENP3A SUMO1/sentrin/SMT3
specific peptidase 3a
Dr.77107 SCCPDHA Zgc:174379 Dr.80988 PAQR3 Progestin and adipoQ re-
ceptor family member III
Dr.79110 SUFU Suppressor of fused ho-
molog (Drosophila)
Dr.6651 PIAS4 Protein inhibitor of acti-
vated STAT, 4
Dr.76972 ZGC:110109 Zgc:110109 Dr.85714 Transcribed locus
Dr.9109 GLMNL Glomulin, like Dr.74197 ZGC:153452 Zgc:153452




Dr.4587 WDR82 WD repeat domain con-
taining 82




Dr.2657 GATS Opposite strand transcrip-
tion unit to Stag3






Dr.106780 ZGC:63486 Zgc:63486 Dr.80282 ZGC:110141 Zgc:110141
Dr.75949 Transcribed locus Dr.80187 ZGC:92035 Zgc:92035
Dr.81689 ZGC:55733 Zgc:55733 Dr.143654 ZGC:77183 Zgc:77183
Dr.81475 MMP13 Matrix metalloproteinase
13
Dr.91580 ZGC:171753 Zgc:171753
Dr.80438 VIL1L Villin 1 like Dr.82327 ZGC:153958 Zgc:153958
Dr.143630 Transcribed locus Dr.83069 Transcribed locus
Dr.84463 ZGC:101524 Zgc:101524 Dr.75215 ERG V-ets erythroblastosis
virus E26 oncogene like
(avian)
Dr.86029 LOC796017 Hypothetical protein
LOC796017
Dr.122141 Transcribed locus,
strongly similar to NP
955968.1 STIP1 homology
and U-box containing
protein 1 [Danio rerio]
Dr.82986 Transcribed locus Dr.122501 API5 Apoptosis inhibitor 5
Dr.107618 Transcribed locus Dr.77740 SETD2 SET domain containing 2
Dr.32732 INVS Inversin Dr.77595 Transcribed locus
Dr.20429 DLG7 Discs, large homolog 7
(Drosophila)
Dr.83417 BNIP2 BCL2/adenovirus E1B in-
teracting protein 2
Dr.109638 ZGC:114129 Im:7136473 Dr.140596 Transcribed locus
Dr.31849 ZGC:136380 Zgc:158165 Dr.80631 ZDHHC24 Zinc finger, DHHC-type
containing 24
Dr.82465 ZGC:63528 Zgc:63528 Dr.18206 Transcribed locus
Dr.5413 Transcribed locus, mod-






Dr.132825 ZGC:64095 Hypothetical protein
LOC792222
Dr.80871 Transcribed locus






Dr.39143 ZGC:112982 Zgc:112982 Dr.75730 ZGC:114123 Zgc:114123
Dr.81250 CBLN1 Cerebellin 1 precursor Dr.268 EPD Ependymin
Dr.122161 Transcribed locus,







(CaM kinase) II gamma 1
Dr.79523 ZGC:158289 Zgc:158289
Dr.76410 RAB20 RAB20, member RAS
oncogene family
Dr.14396 LOC572175 Similar to Muc2 protein
Dr.122707 Transcribed locus Dr.79193 MED12 Mediator of RNA poly-
merase II transcription,
subunit 12 homolog
Dr.43915 ZGC:175195 Zgc:175195 Dr.79368 SF3A3 Splicing factor 3a, subunit
3
Dr.79864 LOC556561 Similar to polyhomeotic
like 3 (Drosophila)
Dr.84914 ZGC:152928 Zgc:152928
Dr.82256 ZGC:153186 Zgc:153186 Dr.17244 ZGC:56533 Zgc:56533
Dr.84470 LOC797345 Zgc:163126 Dr.28305 HMMR Hyaluronan mediated
motility receptor
Dr.75521 TIMP2 Tissue inhibitor of metal-
loproteinase 2
Dr.79588 MAP4K5 Mitogen-activated protein
kinase kinase kinase kinase
5
Dr.48567 SI:BUSM1-234G15.1 Si:busm1-234g15.1 Dr.118849 ZGC:63958 Zgc:63958
Dr.143593 PCM1 Pericentriolar material 1 Dr.16985 ZGC:162290 Zgc:162290
Dr.26118 ARRDC2 Arrestin domain contain-
ing 2
Dr.76745 ZGC:56361 Zgc:56361
Dr.107727 IM:7142942 Im:7142942 Dr.32351 LGALS3L Lectin, galactoside-
binding, soluble, 3
(galectin 3)-like




Dr.76317 ZGC:112050 Zgc:112050 Dr.109966 Transcribed locus
Dr.76512 SEPT7A Septin 7a Dr.79390 ZGC:77868 Zgc:77868
Dr.3955 LOC798142 Hypothetical protein
LOC798142
Dr.120392 ADA Hypothetical protein
LOC792200
Dr.2976 SI:CH211-200O3.4 Si:ch211-200o3.4 Dr.39628 WU:FJ66B05 Wu:fj66b05
Dr.108624 ZGC:86716 Zgc:86716 Dr.133630 ZGC:110329 Zgc:110329
Dr.78373 Transcribed locus Dr.17340 HNMT Histamine N-
methyltransferase
Dr.76159 APRT Adenine phosphoribosyl
transferase
Dr.13798 Transcribed locus
Dr.83419 ZGC:153301 Hypothetical protein
LOC791996
Dr.26907 DND Dead end
Dr.76296 ZGC:56419 Zgc:56419 Dr.114009 Transcribed locus
Dr.74196 SI:DKEYP-87E7.4 Si:dkeyp-87e7.4 Dr.78599 GTF2B General transcription fac-
tor IIB
Dr.82468 TBC1D19 TBC1 domain family,
member 19
Dr.76816 SCNM1 Sodium channel modifier 1
Dr.75224 Transcribed locus Dr.83427 ZGC:91890 Zgc:91890
Dr.16810 LOC798400 Similar to N-
acetylgalactosaminyltransferase
Dr.132230 ZGC:101116 Zgc:101116
Dr.4955 Transcribed locus Dr.29995 WU:FI27C05 Wu:fi27c05
Dr.80059 ZGC:92732 Zgc:92732 Dr.75243 ZGC:113447 Zgc:113447
Dr.76732 GLDC Glycine dehydrogenase
(decarboxylating)
Dr.96932 ZGC:174234 Zgc:174234
Dr.84109 LOC796103 Similar to Chromosome
condensation protein G
Dr.107611 ZGC:110182 Zgc:110182
Dr.84250 LOC563634 Hypothetical LOC563634 Dr.116322 LOC795399 Hypothetical protein
LOC795399
Dr.81385 SI:DKEY-24P1.5 Si:dkey-24p1.5 Dr.31566 Transcribed locus
Dr.82345 ASZ1 Ankyrin repeat, SAM and
basic leucine zipper do-
main containing 1
Dr.83494 ZGC:110788 Zgc:110788
Dr.6973 WTAP Wilms tumor 1 associated
protein
Dr.79403 Transcribed locus
Dr.121668 Transcribed locus Dr.75369 DUS1L Dihydrouridine synthase
1-like (S. cerevisiae)




Dr.85634 S100A10A S100 calcium binding pro-
tein A10a
Dr.76427 Transcribed locus, mod-
erately similar to NP
071918.1 zinc finger pro-
tein 106 homolog [Homo
sapiens]
Dr.144133 LOC565165 Hypothetical LOC565165 Dr.76152 LOC560112 Hypothetical LOC560112
Dr.80441 ZGC:171298 Zgc:171298 Dr.78498 ZGC:77560 Zgc:77560
Dr.14153 ZGC:153434 Zgc:153434 Dr.80336 CYP11A1 Cytochrome P450, sub-
family XIA, polypeptide 1
Dr.80580 CCNB2 Cyclin B2 Dr.24755 PPP2R2D Protein phosphatase 2,
regulatory subunit B,
delta isoform
Dr.81345 LOC798299 Hypothetical protein
LOC798299
Dr.82334 ZGC:153929 Zgc:153929
Dr.85174 CTSL.1 Cathepsin L.1 Dr.84169 ZGC:175098 Zgc:175098
Dr.47548 HOXD11A Homeo box D11a Dr.3155 LOC100007780 Similar to putative RNA
methylase
Dr.132594 Transcribed locus Dr.122543 Transcribed locus
Dr.88756 ZGC:110238 Hypothetical protein
LOC791572
Dr.18504 NSMCE1 Non-SMC element 1 ho-
molog (S. cerevisiae)
Dr.36953 ASAH1 N-acylsphingosine amido-
hydrolase (acid cerami-
dase) 1
Dr.75844 IDH1 Isocitrate dehydrogenase 1
(NADP+), soluble
Dr.32947 NUPL1 Nucleoporin like 1 Dr.84313 ELP3 Elongation protein 3 ho-
molog (S. cerevisiae)
Dr.39108 ZGC:154168 Zgc:154168 Dr.80338 ZGC:66432 Zgc:66432
Dr.76852 ZGC:92643 Zgc:92643 Dr.122295 Transcribed locus
Dr.33734 ZGC:110008 Zgc:110008 Dr.67796 ICN Ictacalcin
Dr.76790 RPA1 Replication protein A1 Dr.75608 ESCO2 Establishment of cohesion
1 homolog 2 (S. cerevisiae)
Dr.6471 ZGC:172228 Zgc:172228 Dr.24234 SMC2 Structural maintenance of
chromosomes 2
Dr.117314 ZGC:101843 Zgc:101843 Dr.77600 SRL Sarcalumenin
Dr.52310 ZGC:123190 Zgc:123190 Dr.33521 KRCP Kelch repeat-containing
protein
Dr.111731 AQP10 Aquaporin 10 Dr.42971 ZGC:112455 Zgc:112455
Dr.76190 CFL1 Cofilin 1 (non-muscle) Dr.133660 Transcribed locus
Dr.75987 RPP40L Ribonuclease P 40 subunit
like
Dr.16380 ALDH8A1 Aldehyde dehydrogenase 8
family, member A1
Dr.85554 ZGC:112322 Zgc:112322 Dr.76784 SEPT8A Septin 8a
Dr.35904 ZGC:85729 Zgc:85729 Dr.106681 LOC569952 Hypothetical LOC569952
Dr.1499 TAF9 TAF9 RNA polymerase II,
TATA box binding protein
(TBP)-associated factor
Dr.79344 ZGC:56407 Zgc:56407
Dr.2713 CD82 Hypothetical protein
LOC792047
Dr.78676 SI:CH211-225P5.3 Si:ch211-225p5.3
Dr.35698 LOC100003669 Hypothetical protein
LOC100003669
Dr.80428 ZGC:66477 Zgc:66477
Dr.119277 ZGC:101026 Zgc:101026 Dr.77987 ZGC:113026 Zgc:113026
Dr.78736 WU:FC28F08 Wu:fc28f08 Dr.15534 LOC571197 Similar to Thrap4 protein
Dr.76207 AQP3 Aquaporin 3 Dr.132353 RNF14 Ring finger protein 14
Dr.80393 ZGC:66450 Zgc:66450 Dr.31086 RNF2 Ring finger protein 2
Dr.13965 Transcribed locus Dr.91373 DGAT2 Diacylglycerol O-
acyltransferase 2
Dr.122910 Transcribed locus, mod-
erately similar to NP
956523.1 COP9 signalo-
some subunit 8 [Danio
rerio]
Dr.77448 WDR21 WD repeat domain 21
Dr.84502 ZGC:103761 Zgc:103761 Dr.20969 FOXI1 Forkhead box I1
Dr.75392 AK3L1 Adenylate kinase 3-like 1 Dr.85037 CHRNE Cholinergic receptor, nico-
tinic, epsilon
Dr.81243 ZGC:86850 Wu:fj61b08 Dr.1823 SI:CH211-150C22.2 Si:ch211-150c22.2
Dr.75265 Transcribed locus Dr.77976 BYSL Bystin-like
Dr.88645 ZGC:86611 Zgc:86611 Dr.96184 ZGC:101095 Zgc:101095
Dr.118834 LOC566639 Similar to AHNAK nucleo-
protein
Dr.79271 ZGC:77294 Zgc:77294
Dr.104726 ZGC:114097 Zgc:114097 Dr.84790 UNG Uracil-DNA glycosylase
Dr.34097 PMP22B Peripheral myelin protein
22b
Dr.28227 IM:7148063 Im:7148063
Dr.77817 ZGC:77086 Hypothetical protein
LOC791995
Dr.7461 SI:DKEY-114G7.4 Si:dkey-114g7.4
Dr.83194 CYP1C1 Cytochrome P450, family
1, subfamily C, polypep-
tide 1
Dr.27090 DOCK8 Similar to dedicator of cy-
tokinesis 8
Dr.80192 ZGC:162158 Zgc:162158 Dr.84534 LOC100007999 Hypothetical protein
LOC100007999
233
Dr.82140 LOC100005813 Similar to sno, straw-
berry notch homolog 1
(Drosophila)
Dr.78222 ZGC:77529 Zgc:77529
Dr.114277 LOC794653 Similar to MGC84009 pro-
tein
Dr.122973 Transcribed locus







Dr.730 THOC7 THO complex 7 Dr.78487 SI:CH211-191I18.1 Si:ch211-191i18.1
Dr.77508 MAO Monoamine oxidase Dr.33564 IPO9 Importin 9
Dr.77582 LOC560453 Similar to KIAA1794 Dr.133114 LOC100000528 Hypothetical protein
LOC100000528
Dr.76907 PCBP2 Poly(rC) binding protein 2 Dr.84342 ZGC:92085 Zgc:92085
Dr.28430 SETX Senataxin Dr.77007 HIAT1A Hippocampus abundant
transcript 1a
Dr.83081 ZGC:153696 Zgc:153696 Dr.81733 RBBP5 Retinoblastoma binding
protein 5
Dr.123669 Transcribed locus,





Dr.32093 RAB30 RAB30, member RAS
oncogene family
Dr.32244 HSPB1 Heat shock protein, alpha-
crystallin-related, 1
Dr.75193 FAM76B Family with sequence sim-
ilarity 76, member B
Dr.34109 SI:DKEY-91F15.6 Si:dkey-91f15.6
Dr.52862 LIN7C Lin-7 homolog C (C. ele-
gans)
Dr.83993 NCBP2 Nuclear cap binding pro-
tein subunit 2
Dr.1956 Transcribed locus,





Dr.104406 ADRM1B Adhesion regulating
molecule 1b
Dr.37073 ZGC:101553 Zgc:101553
Dr.80692 UBE2Q1 Ubiquitin-conjugating en-
zyme E2Q (putative) 1
Dr.75129 ARGLU1A Arginine and glutamate
rich 1a
Dr.75468 ZGC:77304 Zgc:77304 Dr.117581 ZGC:154087 Zgc:154087
Dr.75753 NOTCH1A Notch homolog 1a Dr.86913 FABP6 Fatty acid binding protein
6, ileal (gastrotropin)
Dr.31752 HDAC1 Histone deacetylase 1 Dr.82719 DAP3 Death associated protein 3
Dr.75451 Transcribed locus Dr.106771 SI:DKEY-15J16.2 Si:dkey-15j16.2
Dr.77619 RUVBL1 RuvB-like 1 (E. coli) Dr.76650 ING4 Inhibitor of growth family,
member 4
Dr.1489 ZGC:136963 Zgc:136963 Dr.80063 RETSAT Retinol saturase (all-
trans-retinol 13,14-
reductase)
Dr.114062 STAP2A Signal transducing adap-
tor family member 2a
Dr.80000 SLC25A26 Solute carrier family 25,
member 26
Dr.117302 ZGC:92083 Zgc:92083 Dr.80524 WU:FI34B01 Wu:fi34b01
Dr.78703 RTKN2 Rhotekin 2 Dr.119738 SETB SET translocation
(myeloid leukemia-
associated) B
Dr.132305 ZGC:77439 Zgc:77439 Dr.78731 Transcribed locus
Dr.83273 ZGC:63960 Zgc:63960 Dr.78888 ZGC:77415 Zgc:77415
Dr.77306 UPB1 Ureidopropionase, beta Dr.43277 RAD21 RAD21 homolog (S.
pombe)
Dr.28948 TWF1B Twinfilin, actin-binding
protein, homolog 1b
Dr.80713 FSHR Follicle stimulating hor-
mone receptor
Dr.31639 ZGC:112095 Zgc:112095 Dr.140573 Transcribed locus, weakly
similar to NP 081830.2
ubiquitin specific pepti-
dase 38 [Mus musculus]
Dr.106380 PRDM8 PR domain containing 8 Dr.104286 Transcribed locus,





Dr.4479 SI:CH211-244O22.2 Si:ch211-244o22.2 Dr.37970 SI:RP71-1C10.3 Si:rp71-1c10.3
Dr.75141 ZGC:153228 DNA polymerase nu Dr.115188 SERINC5 Serine incorporator 5
Dr.100463 SMPD4 Sphingomyelin phosphodi-
esterase 4
Dr.82751 SSX2IP Synovial sarcoma, X
breakpoint 2 interacting
protein
Dr.77454 ZGC:73265 Zgc:73265 Dr.106021 SLC43A1 Solute carrier family 43,
member 1
234
Dr.121609 Transcribed locus Dr.132611 LOC793280 Hypothetical protein
LOC793280
Dr.75547 TRY Trypsin Dr.120800 ZGC:92512 Zgc:92512
Dr.105427 Transcribed locus Dr.41494 WU:FI46G11 Wu:fi46g11
Dr.95737 CCNH Cyclin H Dr.74211 TAKRP T-cell activation kelch re-
peat protein
Dr.79066 ACSL1 Acyl-CoA synthetase long-
chain family member 1
Dr.114283 WU:FD16E03 Wu:fd16e03
Dr.77961 ZGC:92765 Zgc:92765 Dr.75195 BTBD10B BTB (POZ) domain con-
taining 10b
Dr.82355 ZGC:171819 Zgc:171819 Dr.27305 ZGC:92111 Zgc:92111
Dr.80572 ZGC:103530 Zgc:103530 Dr.76783 PLA2G12B Phospholipase A2, group
XIIB
Dr.37643 ZGC:103509 Zgc:103509 Dr.78545 Transcribed locus
Dr.1786 ZGC:55292 Zgc:55292 Dr.78401 AATF Apoptosis antagonizing
transcription factor
Dr.79972 GOLGA5 Golgi autoantigen, golgin
subfamily a, 5
Dr.77471 Transcribed locus
Dr.75202 HDGFRP2 Hepatoma-derived growth
factor, related protein 2
Dr.80820 ZGC:85615 Zgc:85615
Dr.75603 H3F3A H3 histone, family 3A Dr.107659 ABI1 Abl-interactor 1
Dr.81899 ZGC:56699 Zgc:56699 Dr.31063 ZGC:86895 Zgc:86895
Dr.79720 ZGC:86839 Zgc:86839 Dr.84049 LOC556705 Hypothetical LOC556705
Dr.133457 CDNA clone IM-
AGE:7053246
Dr.132378 PLS3 Plastin 3 (T isoform)
Dr.116102 ELA2L Elastase 2 like Dr.81955 Transcribed locus
Dr.84043 ZGC:86635 Zgc:86635 Dr.81616 LOC569587 Similar to transcription
factor-like nuclear regula-
tor
Dr.5696 PRC1 Protein regulator of cy-
tokinesis 1
Dr.106367 PRPSAP2 Phosphoribosyl py-
rophosphate synthetase-
associated protein 2
Dr.14855 RAB35 RAB35, member RAS
oncogene family
Dr.78235 STK38L Serine/threonine kinase 38
like










Dr.14066 LOC565592 Similar to hCG32806
Dr.77649 MYST2 MYST histone acetyl-
transferase 2
Dr.78602 WU:FD14A01 Wu:fd14a01
Dr.106465 LOC799140 Hypothetical protein
LOC799140
Dr.122142 ATP1A3B ATPase, Na+/K+ trans-







Dr.118088 HNRNPL Heterogeneous nuclear ri-
bonucleoprotein L
Dr.75741 ZGC:100869 Zgc:100869 Dr.77174 C3A Similar to complement C3-
H1
Dr.83301 FOXC1B Forkhead box C1b Dr.82744 ZGC:92689 Zgc:92689
Dr.15573 RCOR2 REST corepressor 2 Dr.3585 AGT Angiotensinogen
Dr.82008 CDNA clone IM-
AGE:8128378
Dr.1291 SUMO3 SMT3 suppressor of mif
two 3 homolog 3 (yeast)
Dr.85085 PDLIM7 PDZ and LIM domain 7 Dr.122381 Transcribed locus




Dr.82521 ZGC:73144 Hypothetical protein
LOC792240
Dr.81780 PANE1 Proliferation associated
nuclear element
Dr.80659 WU:FI33G05 Wu:fi33g05 Dr.19947 LMBR1L Limb region 1 like
Dr.115711 LOC567858 Hypothetical LOC567858 Dr.15095 ZGC:113968 Hypothetical protein
LOC100001511
Dr.29092 Transcribed locus Dr.14778 ZGC:103752 Zgc:103752
Dr.75229 Transcribed locus Dr.76520 ST13 Suppression of tumori-
genicity 13 (colon carci-
noma) (Hsp70 interacting
protein)
Dr.1047 TYMS Thymidylate synthase Dr.76187 KRT15 Hypothetical protein
LOC791817
Dr.77760 PUS1 Hypothetical protein
LOC792133
Dr.132927 RAVER1 Hypothetical protein
LOC791538
235
Dr.88329 HIF1AL2 Hypoxia-inducible factor
1, alpha subunit, like 2
Dr.75458 ARNTL1A Aryl hydrocarbon recep-
tor nuclear translocator-
like 1a
Dr.50843 CD9L CD9 antigen, like Dr.78902 Transcribed locus
Dr.84307 ZGC:86870 Zgc:86870 Dr.132373 Transcribed locus
Dr.75748 ORC6L Origin recognition com-
plex, subunit 6 homolog-
like (yeast)
Dr.117056 ZGC:101030 Hypothetical protein
LOC791832
Dr.80266 ITM2C Integral membrane protein
2C
Dr.80821 SPAG6 Sperm associated antigen
6
Dr.114001 ZGC:110183 Zgc:110183 Dr.774 VDAC1 Voltage-dependent anion
channel 1
Dr.81511 ZGC:113156 Zgc:113156 Dr.67263 LOC561668 Hypothetical LOC561668
Dr.76676 LOC793260 Hypothetical protein
LOC793260
Dr.77751 Transcribed locus
Dr.79544 ING5B Inhibitor of growth family,
member 5b
Dr.91511 LCK Zgc:136695
Dr.81958 GNAT2 Guanine nucleotide bind-
ing protein (G protein),
alpha transducing activity
polypeptide 2
Dr.82260 LOC565205 Hypothetical LOC565205
Dr.75255 Transcribed locus Dr.79519 ATP5S ATP synthase, H+ trans-
porting, mitochondrial F0
complex, subunit s
Dr.105341 RACGAP1 Rac GTPase-activating
protein 1
Dr.119419 LOC572149 Similar to Dihydropyrimi-
dine dehydrogenase
Dr.23593 ZGC:56412 Zgc:56412 Dr.20705 ZGC:103537 Zgc:103537
Dr.106684 LOC799913 Similar to cell surface floc-
culin
Dr.13909 Transcribed locus
Dr.75152 CDK2 Cyclin-dependent kinase 2 Dr.5991 ZGC:101708 Zgc:101708
Dr.77280 Transcribed locus Dr.9528 PDK2 Pyruvate dehydrogenase
kinase, isoenzyme 2
Dr.7036 G3BP1 GTPase activating protein
(SH3 domain) binding pro-
tein 1
Dr.42600 LOC553397 Hypothetical protein
LOC553397
Dr.106515 LOC795458 Similar to EN-
SANGP00000022061
Dr.20155 SS18 Synovial sarcoma translo-
cation, chromosome 18 (H.
sapiens)
Dr.143647 POLD2 Polymerase (DNA di-
rected), delta 2, regulatory
subunit
Dr.84971 ZGC:153462 Zgc:153462
Dr.79840 ZGC:92006 Zgc:92006 Dr.82585 LOC562304 Similar to cytochrome
P450, family 2, subfamily
J, polypeptide 2
Dr.143804 TBX18 T-box 18 Dr.79823 ZGC:91926 Zgc:91926
Dr.79258 LOC100000846 Similar to PHD finger pro-
tein 12
Dr.16483 SLC39A6 Solute carrier family 39
(zinc transporter), mem-
ber 6
Dr.67738 ZGC:153795 Zgc:153795 Dr.76933 WU:FC31G06 Wu:fc31g06
Dr.84500 ZGC:92287 Zgc:92287 Dr.15227 Transcribed locus
Dr.85969 NDUFAF2 NADH dehydrogenase
(ubiquinone) 1 alpha sub-
complex, assembly factor
2
Dr.80564 RBM38 RNA binding motif protein
38
Dr.81062 PPM1D Protein phosphatase 1D
magnesium-dependent,
delta isoform
Dr.113485 LOC100002387 Hypothetical protein
LOC100002387
Dr.41866 CRYBB3 Crystallin, beta B3 Dr.75931 CKMT1 Creatine kinase, mitochon-
drial 1
Dr.36004 ZGC:153454 Zgc:153454 Dr.4757 WU:FB08G06 Wu:fb08g06
Dr.140737 Transcribed locus, mod-
erately similar to NP
957035.1 cysteine dioxy-
genase, type I [Danio
rerio]
Dr.78296 SI:CH211-147A11.3 Si:ch211-147a11.3
Dr.26481 EPS8L3 EPS8-like 3 Dr.83007 ZGC:110677 Zgc:110677
Dr.83578 LOC556669 Hypothetical LOC556669 Dr.121634 Transcribed locus
Dr.52170 Transcribed locus,
strongly similar to NP
001002726.1 WD repeat
and HMG-box DNA
binding protein 1 [Danio
rerio]
Dr.79728 LOC564287 Similar to MGC69156 pro-
tein




Dr.80609 KIF23 Kinesin family member 23 Dr.121431 LOC563410 Hypothetical LOC563410




Dr.77945 DNMT5 DNA (cytosine-5-)-
methyltransferase 5
Dr.79711 ZGC:158802 Zgc:158802
Dr.109592 ZGC:92151 Zgc:92151 Dr.99488 ZGC:171912 Zgc:171912
Dr.86190 ZGC:86715 Zgc:86715 Dr.39528 LOC100001396 Hypothetical protein
LOC100001396
Dr.82476 ZGC:112072 Zgc:112072 Dr.82458 DDX26B DEAD/H (Asp-Glu-Ala-
Asp/His) box polypeptide
26B
Dr.33507 ZGC:123170 Zgc:123170 Dr.86027 LOC100006639 Hypothetical protein
LOC100006639
Dr.67664 SI:DKEY-8L13.4 Si:dkey-8l13.4 Dr.2885 FTSJ1 FtsJ homolog 1 (E. coli)
Dr.78239 DDI2 DNA-damage inducible
protein 2
Dr.76280 ZGC:152779 Zgc:152779
Dr.119089 TOP2A Topoisomerase (DNA) II
alpha
Dr.75477 RTF1 Rtf1, Paf1/RNA poly-
merase II complex com-
ponent, homolog (S.
cerevisiae)
Dr.118182 ZGC:103681 Zgc:103681 Dr.18870 ZGC:86619 Zgc:86619
Dr.29859 IM:7142837 Im:7142837 Dr.40661 Transcribed locus












DICTED: similar to sreb2
isoform 1 [Danio rerio]
Dr.78166 PVALB7 Parvalbumin Dr.132872 ANKRD12 Ankyrin repeat domain 12
Dr.79083 TMEM57 Transmembrane protein 57 Dr.108840 RDH12L Retinol dehydrogenase 12,
like
Dr.4660 LOC100006592 Hypothetical protein
LOC100006592
Dr.9441 UTXL1 Ubiquitously transcribed
tetratricopeptide repeat,
X chromosome like 1






Dr.75815 FOXA Forkhead box A sequence Dr.80967 ZGC:112254 Zgc:112254








Dr.361 SEPH Selenoprotein H Dr.114161 ZGC:112397 Zgc:112397
Dr.87644 ZGC:113259 Zgc:113259 Dr.106470 ZGC:165536 Zgc:165536
Dr.132727 ALDH18A1 Aldehyde dehydrogenase
18 family, member A1
Dr.77969 LOC796797 Hypothetical protein
LOC796797
Dr.75779 PL10 Pl10 Dr.50820 LOC565671 Similar to MGC89155 pro-
tein
Dr.18376 ZGC:56538 Zgc:56538 Dr.89787 ZGC:113334 Zgc:113334
Dr.114177 DNAJA3A DnaJ (Hsp40) homolog,
subfamily A, member 3A
Dr.123739 Transcribed locus
Dr.9584 LOC567688 Similar to hCG28765 Dr.80660 PLK4 Polo-like kinase 4
(Drosophila)
Dr.77921 LOC564669 Similar to ARVCF Dr.83896 LOC100005060 Hypothetical protein
LOC100005060
Dr.83148 LOC556113 Similar to FLJ00281 pro-
tein
Dr.113808 PLS1 Plastin 1 (I isoform)
Dr.104975 ZGC:56513 Zgc:56513 Dr.77001 CDC42EP4 CDC42 effector protein
(Rho GTPase binding) 4
Dr.77407 SI:DKEY-190L1.1 Si:dkey-190l1.1 Dr.43919 ZGC:112954 Zgc:112954
Dr.78484 ZGC:85843 Hypothetical protein
LOC791495
Dr.82697 Transcribed locus, mod-




Dr.18312 U2AF1 U2(RNU2) small nuclear
RNA auxiliary factor 1
Dr.80478 ZGC:55308 Zgc:55308
Dr.27758 ZGC:85914 Zgc:85914 Dr.79117 SI:DKEY-97O5.1 Si:dkey-97o5.1
Dr.89328 Transcribed locus Dr.79876 LOC100002142 Hypothetical protein
LOC100002142
Dr.33530 SLC38A7 Solute carrier family 38,
member 7
Dr.88552 PNX Hypothetical protein
LOC791806
Dr.6442 ZGC:92875 Zgc:92875 Dr.18920 ZGC:136871 Zgc:136871
Dr.82342 DKEY-57A22.11 Similar to CG14692-PA Dr.8695 LOC793786 Hypothetical protein
LOC793786
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Dr.67167 SIAH2L Seven in absentia homolog
2 (Drosophila)-like
Dr.4322 DKEYP-94H10.2 Novel protein simi-




Dr.37828 ZGC:162025 Zgc:162025 Dr.105744 ZGC:175186 Zgc:175186
Dr.80456 Transcribed locus,




Dr.134087 C6ORF83 Hypothetical protein
LOC100004524
Dr.76462 RBB4 Retinoblastoma binding
protein 4
Dr.105605 WU:FJ98G07 Wu:fj98g07
Dr.81636 ZBTB2A Zinc finger and BTB do-
main containing 2a
Dr.143375 Transcribed locus
Dr.23036 ZGC:112282 Zgc:112282 Dr.82434 SLA/LPL Soluble liver antigen/liver
pancreas antigen (Homo
sapiens), like
Dr.67809 LOC558178 Similar to 19.9kD myosin
light chain
Dr.116962 LOC558028 Similar to exosome compo-
nent 10
Dr.115906 LOC799556 Similar to LOC553285 pro-
tein
Dr.120811 ZGC:65845 Zgc:65845
Dr.133627 ZGC:123209 Zgc:123209 Dr.36307 LOC562529 Hypothetical LOC562529
Dr.104586 LOC557328 Similar to XTimeless1 Dr.14549 ZGC:92307 Zgc:92307
Dr.120542 ZGC:63920 Zgc:63920 Dr.83661 GLE1L GLE1 RNA export
mediator-like







Dr.37659 BIN2 Bridging integrator 2 Dr.5040 CYB5A Cytochrome b5 type A
(microsomal)
Dr.70549 ARL8 ADP-ribosylation factor-
like 8
Dr.25277 AGR2 Anterior gradient homolog
2 (Xenopus laevis)
Dr.4206 ZGC:76977 Hypothetical protein
LOC792029
Dr.83536 ZGC:103540 Zgc:103540
Dr.77026 Transcribed locus Dr.120243 SI:CH211-197I12.2 Si:ch211-197i12.2
Dr.11520 SI:CH211-51E12.7 Si:ch211-51e12.7 Dr.15263 ZGC:73231 Zgc:73231
Dr.75704 PTGDS Prostaglandin D2 synthase Dr.140985 ZGC:112365 Zgc:112365
Dr.83502 ZGC:56310 Zgc:56310 Dr.16383 LOC564722 Similar to receptor associ-
ated protein 80
Dr.7668 ZGC:158605 Zgc:158605 Dr.79098 MBD1 Methyl-CpG binding do-
main protein 1
Dr.132734 LOC556271 Hypothetical LOC556271 Dr.133834 ZGC:66359 Zgc:66359
Dr.143646 ZGC:101616 Zgc:101616 Dr.33603 GPT2 Glutamic pyruvate
transaminase (alanine
aminotransferase) 2
Dr.77484 ZGC:110417 Zgc:110417 Dr.105736 Transcribed locus
Dr.75662 ZGC:114087 Zgc:114087 Dr.77272 E2F4 E2F transcription factor 4
Dr.110716 Transcribed locus Dr.76937 LOC570063 Similar to MGC115669
protein









strongly similar to NP
008855.1 splicing factor,
arginine/serine-rich 1
isoform 1 [Homo sapiens]
Dr.5024 PHF16 PHD finger protein 16
Dr.77985 ZGC:92279 Zgc:92279 Dr.113781 ZGC:85851 Zgc:85851
Dr.78765 ZGC:64130 Zgc:64130 Dr.14734 PUS7 Pseudouridylate synthase
7 homolog (S. cerevisiae)
Dr.36931 ZGC:103747 Zgc:103747 Dr.105040 ZGC:162119 Zgc:162119
Dr.90996 SNX33 Sorting nexin 33 Dr.80201 Transcribed locus
Dr.133388 Transcribed locus Dr.76675 ALDH3D1 Aldehyde dehydrogenase 3
family, member D1
Dr.4243 CX32.3 Connexin 32.3 Dr.77434 ZGC:56326 Zgc:56326
Dr.78916 ARHGEF7B Rho guanine nucleotide ex-
change factor (GEF) 7b
Dr.32820 ZGC:56597 Zgc:56597
Dr.86053 TBCCL Tubulin-specific chaperone
c-like
Dr.75970 FLNA Filamin A, alpha
Dr.36960 ZGC:91861 Zgc:91861 Dr.85904 IM:7143992 Im:7143992
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Dr.25142 WDR8 WD repeat domain 8 Dr.80627 B3GAT3 Beta3-
glucuronyltransferase
Dr.28229 BCL7A B-cell CLL/lymphoma 7A Dr.79578 EXT1A Exostoses (multiple) 1a
Dr.78604 ZGC:66488 Hypothetical LOC555138 Dr.30395 IRX3B Iroquois homeobox protein
3b
Dr.133796 ZGC:162319 Zgc:162319 Dr.83245 SKP1 S-phase kinase-associated
protein 1
Dr.30339 ZGC:85911 Zgc:85911 Dr.132343 ZGC:86722 Wu:fb65d05
Dr.75170 ACVR1B Activin A receptor, type
IB
Dr.123024 Transcribed locus
Dr.77853 SRPK1 Serine/arginine-rich pro-
tein specific kinase 1
Dr.83159 IM:7140357 Im:7140357
Dr.122443 Transcribed locus Dr.256 SEC61B SEC61, beta subunit
Dr.106626 LOC559414 Hypothetical LOC559414 Dr.84846 Transcribed locus,





Dr.117303 CRYGMX Crystallin, gamma MX Dr.36499 ZGC:101635 Zgc:101635
Dr.109645 ZGC:152986 Zgc:152986 Dr.75231 CHERP Calcium homeostasis en-
doplasmic reticulum pro-
tein
Dr.80703 ATXN7L2 Ataxin 7-like 2 Dr.31536 RCL1 RNA terminal phosphate
cyclase-like 1
Dr.81503 ZGC:112063 Zgc:112063 Dr.87304 ZGC:77234 Zgc:77234
Dr.75159 WU:FB25B09 Wu:fb25b09 Dr.81961 LOC100002864 Hypothetical protein
LOC100002864
Dr.33969 TNNI2B.2 Troponin I, skeletal, fast
2b.2
Dr.96078 ZGC:100836 Zgc:100836
Dr.140625 Transcribed locus, mod-





Dr.11480 RAP2IP Rap2 interacting protein Dr.36440 ABHD3 Abhydrolase domain con-
taining 3
Dr.79148 LOC565706 Similar to cyclic AMP spe-
cific phosphodiesterase
Dr.80055 Transcribed locus
Dr.140317 ZGC:110333 Zgc:110333 Dr.105425 ZGC:92164 Zgc:92164
Dr.83943 ZGC:113100 Zgc:113100 Dr.78702 ZGC:92326 Zgc:92326
Dr.75346 Transcribed locus Dr.76110 COX5AB Cytochrome c oxidase sub-
unit Vab
Dr.123514 Transcribed locus Dr.84795 ZGC:113293 Zgc:113293
Dr.79747 MYCL1A V-myc myelocytomatosis
viral oncogene homolog
1, lung carcinoma derived
(avian) a
Dr.77870 RNGTT RNA guanylyltransferase
and 5’-phosphatase
Dr.28823 Transcribed locus Dr.143376 ZGC:86753 Zgc:86753
Dr.13985 ZGC:152948 Hypothetical protein
LOC792228
Dr.115125 ZGC:77336 Zgc:77336




Dr.122845 Transcribed locus Dr.86126 Transcribed locus
Dr.76653 NET1 Neuroepithelial cell trans-
forming gene 1
Dr.77176 LOC571991 Hypothetical LOC571991
Dr.83945 BXDC5 Brix domain containing 5 Dr.45332 Transcribed locus
Dr.123021 Transcribed locus Dr.82411 SPTLC2 Serine palmitoyltrans-
ferase, long chain base
subunit 2
Dr.140590 CDNA clone MGC:173911
IMAGE:5915517
Dr.21044 Transcribed locus
Dr.132325 SOX19B SRY-box containing gene
19b
Dr.72465 ZGC:153103 Zgc:153103
Dr.22945 LOC795535 Hypothetical protein
LOC795535
Dr.91026 LOC100006536 Hypothetical protein
LOC100006536
Dr.31447 MBTPS2 Membrane-bound tran-
scription factor protease,
site 2
Dr.80532 DCP1A Decapping enzyme
Dr.7577 Transcribed locus,
strongly similar to XP
691993.2 PREDICTED:
similar to pogo transpos-
able element with ZNF
domain [Danio rerio]
Dr.104703 U2AF2A U2 small nuclear RNA
auxiliary factor 2a
Dr.143410 Transcribed locus Dr.38382 NBEA Neurobeachin
Dr.89100 ALLC Allantoicase Dr.85608 TBPL2 TATA box binding protein
like 2
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Dr.24325 ZGC:65780 Zgc:65780 Dr.77631 Transcribed locus
Dr.39930 UGT1AB Zgc:123097 Dr.81898 ZGC:110741 Zgc:110741
Dr.32463 CTSC Cathepsin C Dr.24546 ZGC:66327 Hypothetical protein
LOC791777
Dr.74638 LOC100007461 Hypothetical protein
LOC100007461
Dr.108054 SUPT3H Suppressor of Ty 3 ho-
molog (S. cerevisiae)
Dr.104982 WU:FB55E05 Wu:fb55e05 Dr.76556 ZGC:110112 Hypothetical protein
LOC792281
Dr.80745 Oogenesis-related protein Dr.80679 ZGC:112364 Zgc:112364
Dr.89609 LOC558120 Hypothetical LOC558120 Dr.86370 ZGC:77076 Zgc:173915
Dr.74222 SI:CH211-81I17.1 Si:ch211-81i17.1 Dr.83002 ZGC:101657 Zgc:101657
Dr.75117 CKMA Creatine kinase, muscle a Dr.85461 ZGC:56706 Zgc:56706
Dr.74031 SI:DKEY-202B22.2 Si:dkey-202b22.2 Dr.119008 LOC569427 Hypothetical LOC569427
Dr.82571 Transcribed locus Dr.16782 Transcribed locus
Dr.80488 PPP1R10 Protein phosphatase 1,
regulatory subunit 10
Dr.85829 CETN2 Centrin, EF-hand protein,
2
Dr.91347 ZGC:113381 Zgc:113381 Dr.132294 NOL14 Hypothetical protein
LOC792320
Dr.32625 STKA Wu:fa09g06 Dr.110726 LOC572168 Hypothetical LOC572168
Dr.82091 Transcribed locus Dr.86192 LOC559127 Similar to AWKS9372
Dr.7724 ZGC:154063 Zgc:154063 Dr.107641 LOC569277 Similar to ubiquitously
transcribed tetratricopep-
tide repeat, X chromosome
Dr.45587 ZGC:110611 Zgc:110611 Dr.80066 Transcribed locus
Dr.33127 IFRD2 Interferon-related develop-
mental regulator 2
Dr.82169 ZGC:123333 Zgc:123333
Dr.79190 ZGC:158607 Zgc:158607 Dr.82451 CDC42EP2 CDC42 effector protein
(Rho GTPase binding) 2
Dr.132448 Transcribed locus Dr.143590 ZGC:85948 Zgc:85948





Dr.105269 SUPT16H Suppressor of Ty 16 ho-
molog
Dr.6703 CH211-106H4.12 Hypothetical LOC561742
Dr.85496 FANCL Fanconi anemia, comple-
mentation group L
Dr.84866 LOC100005159 Hypothetical protein
LOC100005159
Dr.21244 UCP2 Uncoupling protein 2 Dr.2877 WU:FB08E07 Wu:fb08e07
Dr.82168 Transcribed locus,






Dr.84467 ZGC:56388 Zgc:56388 Dr.42866 MGST1 Microsomal glutathione S-
transferase 1
Dr.79437 ZGC:110299 Hypothetical LOC557968 Dr.123167 Transcribed locus
Dr.41980 ARID3B AT rich interactive domain
3B (Bright like)
Dr.76453 ARL4D ADP-ribosylation factor-
like 4D
Dr.80756 ZGC:77748 Zgc:77748 Dr.7628 ZGC:158611 Zgc:158611
Dr.115569 ATXN3 Ataxin 3 Dr.77441 ZGC:64148 Zgc:64148
Dr.81807 LOC100002531 Hypothetical protein
LOC100002531
Dr.82147 SI:DKEY-274C14.3 Si:dkey-274c14.3
Dr.9860 MDH1B Malate dehydrogenase 1b,
NAD (soluble)
Dr.78511 LOC559941 Similar to Rho-guanine
nucleotide exchange factor
Dr.75940 DEF Digestive-organ expansion
factor
Dr.43999 CGNL1 Cingulin-like 1
Dr.124001 Transcribed locus Dr.10250 TDH L-threonine dehydroge-
nase
Dr.3552 ZGC:136371 Zgc:136371 Dr.133306 CHM Choroideremia
Dr.122080 Transcribed locus Dr.16206 ZGC:153334 Zgc:153334
Dr.80074 POP4 Hypothetical LOC554559 Dr.105356 ZGC:92026 Zgc:92026
Dr.121869 Transcribed locus, mod-
erately similar to NP
001035095.1 transcription
elongation regulator 1
isoform 2 [Homo sapiens]
Dr.77776 SI:CH211-59D15.5 Si:ch211-59d15.5
Dr.14064 ZGC:55418 Zgc:55418 Dr.81544 Transcribed locus
Dr.51681 LOC799717 Hypothetical protein
LOC799717
Dr.116711 LOC561733 Hypothetical LOC561733
Dr.78991 LOC100006201 Hypothetical protein
LOC100006201
Dr.75239 WU:FB74B10 Wu:fb74b10
Dr.115855 TK2 Hypothetical protein
LOC791677
Dr.85728 LOC557582 Hypothetical LOC557582
Dr.114689 FAM116B Family with sequence sim-
ilarity 116, member B
Dr.28581 OPHN1 Oligophrenin 1
Dr.13689 ZGC:66449 Zgc:66449 Dr.121941 Transcribed locus
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Dr.4883 HSD17B4 Hydroxysteroid (17-beta)
dehydrogenase 4
Dr.76567 RGS7 Regulator of G-protein sig-
nalling 7
Dr.18318 SNRPC Small nuclear ribonucleo-
protein polypeptide C
Dr.76198 IM:7150932 Im:7150932
Dr.36457 PPP2R1B Protein phosphatase 2
(formerly 2A), regulatory




Table 8: Genes that are enriched in S7
Unigene GeneSym Desc Unigene GeneSym Desc
Dr.85699 ZGC:158130 Zgc:158130 Dr.76238 SC:D0144 Sc:d0144
Dr.104972 Transcribed locus,
strongly similar to NP
001001948.1 nucleoporin
54 [Danio rerio]
Dr.79262 FBXO5 F-box protein 5
Dr.83251 Transcribed locus Dr.121869 Transcribed locus, mod-
erately similar to NP
001035095.1 transcription
elongation regulator 1
isoform 2 [Homo sapiens]
Dr.122767 Transcribed locus Dr.51681 LOC799717 Hypothetical protein
LOC799717
Dr.13660 ZGC:101744 Hypothetical protein
LOC791489
Dr.78991 LOC100006201 Hypothetical protein
LOC100006201
Dr.77138 CPA2 Hypothetical protein
LOC792272
Dr.77310 ANXA11A Annexin A11a
Dr.80069 Transcribed locus Dr.76874 TEP1 Telomerase-associated
protein 1
Dr.105241 SCD Hypothetical protein
LOC792020
Dr.78320 ZGC:110281 Zgc:110281
Dr.132314 ZGC:91794 Zgc:91794 Dr.80638 WU:FE05B03 Wu:fe05b03
Dr.76148 ATP2B1A ATPase, Ca++ transport-
ing, plasma membrane 1a




Dr.106275 Transcribed locus Dr.80835 SI:CH73-13B6.3 Si:ch73-13b6.3
Dr.123334 Transcribed locus Dr.76339 UBE4B Ubiquitination factor E4B,
UFD2 homolog (S. cere-
visiae)
Dr.133403 Transcribed locus Dr.47436 MCM7 Hypothetical LOC554619
Dr.107097 WU:FK81D02 Wu:fk81d02 Dr.77198 SERPINB1 Serpin peptidase inhibitor,
clade B (ovalbumin),
member 1
Dr.75792 HOXD9A Homeo box D9a Dr.84455 ZGC:92240 Zgc:92240
Dr.123166 Transcribed locus Dr.75383 ZGC:110687 Zgc:110687
Dr.77514 ELA3L Elastase 3 like Dr.105413 TPM1 Tropomyosin 1 (alpha)
Dr.82353 ELA2 Similar to Ela2 protein Dr.75920 SMARCE1 SWI/SNF related, matrix
associated, actin depen-
dent regulator of chro-
matin, subfamily e, mem-
ber 1
Dr.77126 CTRB1 Chymotrypsinogen B1 Dr.122296 Transcribed locus
Dr.77127 ZGC:66382 Zgc:66382 Dr.105858 ZGC:112971 Zgc:112971
Dr.89216 Transcribed locus Dr.45506 ZGC:112291 Zgc:112291
Dr.115420 TH1L TH1-like (Drosophila) Dr.81117 ZGC:153243 Zgc:153243
Dr.32560 ZGC:113564 Zgc:113564 Dr.134857 ZGC:113294 Zgc:113294
Dr.85873 EYA4 Eyes absent homolog 4
(Drosophila)
Dr.13694 ZGC:163003 Zgc:163003
Dr.10050 ADIPOR2 Adiponectin receptor 2 Dr.80584 LOC560382 Hypothetical LOC560382
Dr.134285 DAO.2 D-amino-acid oxidase 2 Dr.15633 LOC570432 Hypothetical LOC570432
Dr.117291 WU:FD10H03 Wu:fd10h03 Dr.80071 Transcribed locus
Dr.75974 PDZK1L PDZ domain containing 1
like
Dr.77534 ZGC:55702 Zgc:55702





Dr.31100 NUDT15 Hypothetical protein
LOC791620
Dr.80398 ZGC:153079 Zgc:153079
Dr.10201 SEPW1 Selenoprotein W, 1 Dr.87643 ZGC:101827 Zgc:101827
Dr.79165 SB:CB14 Sb:cb14 Dr.81341 CAPRIN2 Caprin family member 2
Dr.76508 DIRC2 Disrupted in renal carci-
noma 2
Dr.32320 LGMN Legumain
Dr.1214 ARL6IP1 ADP-ribosylation factor-
like 6 interacting protein
1
Dr.85513 WU:FC54A11 Wu:fc54a11
Dr.21233 ZGC:103515 Zgc:103515 Dr.77771 SI:DKEY-252H13.6 Si:dkey-252h13.6





Dr.75440 Transcribed locus Dr.32415 Transcribed locus
Dr.83156 Transcribed locus Dr.6360 WU:FD16G01 Wu:fd16g01
Dr.78850 Transcribed locus Dr.78587 TSC1B Tuberous sclerosis 1b
Dr.44401 ZGC:153587 Zgc:153587 Dr.76985 CLDN10L Claudin 10 like




Dr.39134 SLC27A1 Solute carrier family 27
(fatty acid transporter),
member 1
Dr.76762 IHPK2 Inositol hexaphosphate ki-
nase 2
Dr.6725 Transcribed locus Dr.81863 ZGC:112466 Zgc:112466
Dr.76646 ZGC:165381 Zgc:165381 Dr.79423 ZGC:114119 Zgc:114119
Dr.82756 LOC402976 Hypothetical protein
LOC402976
Dr.113263 LOC793284 Similar to beta-
microseminoprotein
Dr.89589 ZGC:101650 Zgc:101650 Dr.21063 NKX3.2 NK3 homeobox 2
Dr.78050 ZGC:73324 Zgc:73324 Dr.133000 Transcribed locus
Dr.75549 ZGC:55420 Hypothetical protein
LOC792156
Dr.75618 ZGC:171444 Zgc:171444




strongly similar to NP
001018198.1 spermatogen-
esis associated 18 [Danio
rerio]
Dr.13175 Transcribed locus
Dr.119936 ZGC:92392 Zgc:92392 Dr.75449 Transcribed locus
Dr.83470 ZGC:123113 Zgc:123113 Dr.84876 LOC555985 Hypothetical LOC555985




Dr.32109 ZGC:91959 Zgc:91959 Dr.81839 ZGC:77563 Zgc:77563
Dr.77027 KNTC2L Kinetochore associated 2-
like
Dr.91044 LOC557719 Hypothetical LOC557719
Dr.31694 ZGC:56304 Zgc:56304 Dr.1692 ZBTB2B Zinc finger and BTB do-
main containing 2b
Dr.79878 DAB2 Disabled homolog 2
(Drosophila)
Dr.23725 Transcribed locus
Dr.77083 ZGC:86714 Zgc:86714 Dr.83279 ZGC:113070 Zgc:113070
Dr.78673 LOC571547 Hypothetical LOC571547 Dr.86083 Transcribed locus









Dr.74013 WU:FJ63D08 Wu:fj63d08 Dr.79037 ZGC:110259 Zgc:110259
Dr.23685 Transcribed locus Dr.76979 ZGC:153225 Zgc:153225





Solute carrier family 15
(oligopeptide transporter),
member 1 [Danio rerio]
Dr.105609 ZGC:110159 Zgc:110159
Dr.31691 LOC562438 Similar to LDLR dan Dr.97360 ZGC:111826 Zgc:111826
Dr.4044 ZGC:92139 Zgc:92139 Dr.22874 WU:FC21E07 Wu:fc21e07
Dr.85767 ZGC:92705 Zgc:92705 Dr.12595 HSF2 Heat shock factor 2
Dr.86277 Transcribed locus Dr.89596 ZGC:103559 Zgc:103559
Dr.11921 NR5A5 Nuclear receptor subfam-
ily 5, group A, member 5
Dr.75252 COL9A2 Procollagen, type IX, al-
pha 2
Dr.80597 TAF1B TATA box binding pro-
tein (Tbp)-associated fac-
tor, RNA polymerase I, B
Dr.77336 ZGC:113196 Zgc:113196
Dr.133716 ZGC:101841 Zgc:101841 Dr.10637 LOC797698 Similar to 5-3 exoribonu-
clease 2
Dr.19659 EZRL Ezrin like Dr.78358 LOC100000526 Hypothetical protein
LOC100000526
Dr.80471 ZGC:110537 Hypothetical protein
LOC791913
Dr.76665 LOC566399 Hypothetical LOC566399




Dr.122702 Transcribed locus Dr.76172 FUCA1 Fucosidase, alpha-L- 1, tis-
sue
Dr.24323 ZGC:56608 Zgc:56608 Dr.117460 LOC792416 Hypothetical protein
LOC792416
Dr.75320 HSPD1 Heat shock 60kD protein 1
(chaperonin)
Dr.85731 ZGC:162509 Zgc:162509
Dr.76739 WU:FC44A11 Wu:fc44a11 Dr.11991 CXXC1 CXXC finger 1 (PHD do-
main)
Dr.144128 ZGC:109868 Zgc:109868 Dr.81010 LOC795788 Similar to CC chemokine
SCYA103
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Dr.78624 Transcribed locus Dr.24983 POLR3F Polymerase (RNA) III
(DNA directed) polypep-
tide F
Dr.6635 SH3BP5LA SH3-binding domain pro-
tein 5-like, a
Dr.107744 Transcribed locus
Dr.87549 ZGC:112418 Zgc:112418 Dr.117593 LOC799087 Similar to Oip5 protein
Dr.17300 LOC559362 Hypothetical LOC559362 Dr.26261 Transcribed locus
Dr.80589 SCPEP1 Serine carboxypeptidase 1 Dr.80630 ZGC:73340 Zgc:73340
Dr.33597 LOC562370 Hypothetical LOC562370 Dr.132329 LOC100004607 Similar to Apoa4 protein
Dr.81772 SI:BUSM1-241H12.4 Si:busm1-241h12.4 Dr.110644 SI:DKEY-21K10.1 Si:dkey-21k10.1
Dr.79047 ZGC:113480 Zgc:113480 Dr.88420 ZGC:101803 Zgc:101803
Dr.132878 LOC100002850 Similar to Secretory car-
rier membrane protein 2,
like
Dr.45899 ZGC:113183 Zgc:113183
Dr.76472 ZGC:110821 Zgc:110821 Dr.26560 ELOVL5 ELOVL family member 5,
elongation of long chain
fatty acids (yeast)
Dr.82787 IM:7150662 Im:7150662 Dr.76656 CAPN8 Calpain 8
Dr.117801 SMAD5 MAD homolog 5
(Drosophila)
Dr.122289 Transcribed locus
Dr.121617 Transcribed locus Dr.80332 MCRS1 Microspherule protein 1
Dr.81288 MAF V-maf musculoaponeurotic
fibrosarcoma (avian) onco-
gene homolog
Dr.3436 LOC100000870 Hypothetical protein
LOC100000870
Dr.75131 FBL Fibrillarin Dr.14806 PPP2R3C Protein phosphatase 2,
regulatory subunit B”,
gamma
Dr.29762 EFNA2 Non-POU domain contain-
ing, octamer-binding
Dr.6975 ZGC:66107 Zgc:66107
Dr.75520 GATM Glycine amidinotrans-
ferase (L-arginine:glycine
amidinotransferase)
Dr.75913 MAPK3 Mitogen-activated protein
kinase 3
Dr.82671 SI:CH211-51L3.4 Si:ch211-51l3.4 Dr.5461 LOC402880 Hypothetical protein
LOC402880
Dr.85217 FLJ32675 Flj32675 Dr.23039 Transcribed locus
Dr.114529 LOC100003771 Similar to OT-
THUMP00000028706
Dr.116914 LOC100005579 Hypothetical protein
LOC100005579
Dr.78031 WHSC1 Wolf-Hirschhorn syndrome
candidate 1 protein
Dr.79733 SI:CH211-67E16.9 Si:ch211-67e16.9
Dr.75811 INS Preproinsulin Dr.117507 ZGC:174575 Zgc:174575
Dr.107944 ABP1 Amiloride binding protein
1 (amine oxidase (copper-
containing))
Dr.79151 PXK PX domain containing ser-
ine/threonine kinase
Dr.87101 ZGC:110143 Zgc:110143 Dr.9174 ZGC:55673 Zgc:55673
Dr.84019 ZGC:63614 Zgc:63614 Dr.133159 Transcribed locus




Dr.79110 SUFU Suppressor of fused ho-
molog (Drosophila)
Dr.75863 ZGC:77488 Zgc:77488
Dr.76972 ZGC:110109 Zgc:110109 Dr.75558 SLC4A2 Solute carrier family 4, an-
ion exchanger, member 2
Dr.9109 GLMNL Glomulin, like Dr.122732 Transcribed locus
Dr.121650 Transcribed locus Dr.1301 PRKAG1 Hypothetical protein
LOC791615
Dr.34301 ITGB5 Integrin, beta 5 Dr.105135 PPRC1 Peroxisome proliferator-
activated receptor gamma,
coactivator-related 1
Dr.38076 ZGC:158780 Zgc:158780 Dr.103297 LOC564151 Similar to Claspin








Dr.81478 SULT1ST3 Sulfotransferase family 1,
cytosolic sulfotransferase 3
Dr.82025 ZGC:112208 Zgc:112208 Dr.78005 MPZ Sc:d0186
Dr.77381 ZGC:92479 Zgc:92479 Dr.132401 SENP3A SUMO1/sentrin/SMT3
specific peptidase 3a
Dr.84521 LOC560369 Hypothetical LOC560369 Dr.132665 ZGC:153695 Zgc:153695
Dr.76489 ZGC:92763 Zgc:92763 Dr.80988 PAQR3 Progestin and adipoQ re-
ceptor family member III
Dr.104263 ZGC:92057 Zgc:92057 Dr.6651 PIAS4 Protein inhibitor of acti-
vated STAT, 4
Dr.78421 ZGC:163008 Zgc:163008 Dr.85714 Transcribed locus
Dr.75949 Transcribed locus Dr.6944 ZGC:100860 Zgc:100860
Dr.4742 ZGC:101121 Zgc:101121 Dr.133028 ADIPOR1A Adiponectin receptor 1a
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Dr.81689 ZGC:55733 Zgc:55733 Dr.80282 ZGC:110141 Zgc:110141
Dr.80558 ZGC:111879 Zgc:111879 Dr.80187 ZGC:92035 Zgc:92035
Dr.76364 ZGC:158773 Zgc:158773 Dr.75118 ZGC:112098 Zgc:112098
Dr.107618 Transcribed locus Dr.78675 CCNA1 Zgc:173602
Dr.20429 DLG7 Discs, large homolog 7
(Drosophila)
Dr.143654 ZGC:77183 Zgc:77183
Dr.109638 ZGC:114129 Im:7136473 Dr.46626 LOC100002480 Similar to A kinase
(PRKA) anchor protein 1
Dr.31849 ZGC:136380 Zgc:158165 Dr.91580 ZGC:171753 Zgc:171753
Dr.143234 Transcribed locus Dr.82327 ZGC:153958 Zgc:153958
Dr.82465 ZGC:63528 Zgc:63528 Dr.77563 WU:FB82H05 Wu:fb82h05
Dr.5413 Transcribed locus, mod-





Dr.84939 ST6GAL1 ST6 beta-galactosamide
alpha-2,6-sialyltranferase
1
Dr.75215 ERG V-ets erythroblastosis
virus E26 oncogene like
(avian)
Dr.132825 ZGC:64095 Hypothetical protein
LOC792222
Dr.76888 WU:FB37G07 Wu:fb37g07






Dr.80461 GNAI2 Guanine nucleotide bind-
ing protein (G protein),
alpha inhibiting activity
polypeptide 2
Dr.77740 SETD2 SET domain containing 2
Dr.39143 ZGC:112982 Zgc:112982 Dr.77595 Transcribed locus
Dr.76444 ZGC:172180 Zgc:172180 Dr.83417 BNIP2 BCL2/adenovirus E1B in-
teracting protein 2
Dr.78356 GATA6 GATA-binding protein 6 Dr.140596 Transcribed locus
Dr.122161 Transcribed locus,








(CaM kinase) II gamma 1
Dr.18206 Transcribed locus
Dr.76410 RAB20 RAB20, member RAS
oncogene family
Dr.5549 ZGC:66286 Zgc:66286
Dr.75714 WU:FD20A04 Wu:fd20a04 Dr.4573 LGALS9L1 Hypothetical protein
LOC791953
Dr.76827 Transcribed locus Dr.80871 Transcribed locus
Dr.79864 LOC556561 Similar to polyhomeotic
like 3 (Drosophila)
Dr.121558 Transcribed locus
Dr.105962 WU:FC50C06 Wu:fc50c06 Dr.80632 ZGC:73124 Zgc:73124
Dr.84470 LOC797345 Zgc:163126 Dr.77660 ZGC:100963 Zgc:100963
Dr.143593 PCM1 Pericentriolar material 1 Dr.75730 ZGC:114123 Zgc:114123
Dr.78701 ZGC:110212 Zgc:110212 Dr.268 EPD Ependymin
Dr.119225 LOC797428 Similar to Tubulin folding
cofactor B
Dr.14396 LOC572175 Similar to Muc2 protein
Dr.113556 UGDH UDP-glucose dehydroge-
nase
Dr.105738 WU:FI38H09 Wu:fi38h09
Dr.32211 ACIN1A Similar to Apoptotic
chromatin condensation
inducer in the nucleus
(Acinus)
Dr.79193 MED12 Mediator of RNA poly-
merase II transcription,
subunit 12 homolog
Dr.76240 FUBP1 Far upstream element
(FUSE) binding protein 1




Dr.79378 LOC561658 Hypothetical LOC561658 Dr.84914 ZGC:152928 Zgc:152928
Dr.76512 SEPT7A Septin 7a Dr.114873 GBGT1L3 Globoside alpha-1,3-N-
acetylgalactosaminyltransferase
1, like 3
Dr.79900 CX28.9 Connexin 28.9 Dr.118849 ZGC:63958 Zgc:63958
Dr.2976 SI:CH211-200O3.4 Si:ch211-200o3.4 Dr.16985 ZGC:162290 Zgc:162290
Dr.108624 ZGC:86716 Zgc:86716 Dr.132934 ZGC:63617 Zgc:63617
Dr.78373 Transcribed locus Dr.76745 ZGC:56361 Zgc:56361
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Dr.76296 ZGC:56419 Zgc:56419 Dr.32351 LGALS3L Lectin, galactoside-
binding, soluble, 3
(galectin 3)-like
Dr.82468 TBC1D19 TBC1 domain family,
member 19
Dr.120392 ADA Hypothetical protein
LOC792200
Dr.78711 ACSL4 Acyl-CoA synthetase long-
chain family member 4
Dr.133630 ZGC:110329 Zgc:110329
Dr.78921 ZGC:153420 Zgc:153420 Dr.13798 Transcribed locus
Dr.75224 Transcribed locus Dr.26907 DND Dead end
Dr.11428 LOC100001855 Similar to supervillin Dr.114009 Transcribed locus
Dr.80222 CASC3 Cancer susceptibility can-
didate 3
Dr.78779 Transcribed locus
Dr.16810 LOC798400 Similar to N-
acetylgalactosaminyltransferase
Dr.94519 ZGC:112296 Zgc:112296
Dr.9166 BLZF1 Hypothetical protein
LOC791432
Dr.83427 ZGC:91890 Zgc:91890
Dr.143598 CLDNI Claudin i Dr.75901 SI:DKEYP-117H8.4 Si:dkeyp-117h8.4
Dr.4955 Transcribed locus Dr.132230 ZGC:101116 Zgc:101116
Dr.76732 GLDC Glycine dehydrogenase
(decarboxylating)
Dr.29995 WU:FI27C05 Wu:fi27c05
Dr.84109 LOC796103 Similar to Chromosome
condensation protein G
Dr.75243 ZGC:113447 Zgc:113447
Dr.23391 SLC16A3 Hypothetical LOC554697 Dr.96932 ZGC:174234 Zgc:174234
Dr.81385 SI:DKEY-24P1.5 Si:dkey-24p1.5 Dr.31566 Transcribed locus
Dr.140471 Transcribed locus Dr.78758 GPD1 Hypothetical protein
LOC792059
Dr.4451 ZGC:55363 Zgc:55363 Dr.10580 NEK2 Hypothetical LOC554896
Dr.6973 WTAP Wilms tumor 1 associated
protein
Dr.83494 ZGC:110788 Zgc:110788
Dr.121668 Transcribed locus Dr.6833 SI:CH211-238N5.5 Si:ch211-238n5.5
Dr.83415 Transcribed locus Dr.25733 RDBP RD RNA binding protein
Dr.79634 LOC561231 Hypothetical LOC561231 Dr.75369 DUS1L Dihydrouridine synthase
1-like (S. cerevisiae)
Dr.132880 Transcribed locus Dr.135199 IL12A Interleukin 12a
Dr.85634 S100A10A S100 calcium binding pro-
tein A10a
Dr.87908 LIFRA Leukemia inhibitory factor
receptor alpha
Dr.144133 LOC565165 Hypothetical LOC565165 Dr.81832 LOC553407 Hypothetical protein
LOC100006308
Dr.123250 Transcribed locus Dr.76427 Transcribed locus, mod-
erately similar to NP
071918.1 zinc finger pro-
tein 106 homolog [Homo
sapiens]
Dr.80441 ZGC:171298 Zgc:171298 Dr.76152 LOC560112 Hypothetical LOC560112
Dr.14153 ZGC:153434 Zgc:153434 Dr.78498 ZGC:77560 Zgc:77560
Dr.81345 LOC798299 Hypothetical protein
LOC798299
Dr.80336 CYP11A1 Cytochrome P450, sub-
family XIA, polypeptide 1
Dr.90487 ZGC:172295 Zgc:172295 Dr.114385 ZGC:163023 Zgc:163023
Dr.85174 CTSL.1 Cathepsin L.1 Dr.77591 SI:DKEY-175G20.1 Si:dkey-175g20.1
Dr.77065 HMHA1 Histocompatibility (mi-
nor) HA-1
Dr.24755 PPP2R2D Protein phosphatase 2,
regulatory subunit B,
delta isoform
Dr.47548 HOXD11A Homeo box D11a Dr.82334 ZGC:153929 Zgc:153929
Dr.132594 Transcribed locus Dr.122543 Transcribed locus
Dr.88756 ZGC:110238 Hypothetical protein
LOC791572
Dr.18504 NSMCE1 Non-SMC element 1 ho-
molog (S. cerevisiae)
Dr.72371 WU:FB60G05 Wu:fb60g05 Dr.75844 IDH1 Isocitrate dehydrogenase 1
(NADP+), soluble
Dr.77547 ZGC:100868 Zgc:100868 Dr.84313 ELP3 Elongation protein 3 ho-
molog (S. cerevisiae)




Dr.118663 ZGC:64050 Hypothetical protein
LOC794885
Dr.75608 ESCO2 Establishment of cohesion
1 homolog 2 (S. cerevisiae)
Dr.32947 NUPL1 Nucleoporin like 1 Dr.24234 SMC2 Structural maintenance of
chromosomes 2
Dr.76852 ZGC:92643 Zgc:92643 Dr.77600 SRL Sarcalumenin
Dr.33734 ZGC:110008 Zgc:110008 Dr.42971 ZGC:112455 Zgc:112455
Dr.55498 WU:FO94F09 Wu:fo94f09 Dr.76547 ZGC:158323 Zgc:158323
Dr.76790 RPA1 Replication protein A1 Dr.133660 Transcribed locus
Dr.6471 ZGC:172228 Zgc:172228 Dr.16380 ALDH8A1 Aldehyde dehydrogenase 8
family, member A1
Dr.117314 ZGC:101843 Zgc:101843 Dr.76784 SEPT8A Septin 8a
Dr.111731 AQP10 Aquaporin 10 Dr.106681 LOC569952 Hypothetical LOC569952
Dr.76190 CFL1 Cofilin 1 (non-muscle) Dr.79287 ZGC:110077 Zgc:110077
Dr.2636 IMPDH2 IMP (inosine monophos-
phate) dehydrogenase 2
Dr.6291 Transcribed locus
Dr.85554 ZGC:112322 Zgc:112322 Dr.15534 LOC571197 Similar to Thrap4 protein
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Dr.19939 LOC555164 Hypothetical LOC555164 Dr.132353 RNF14 Ring finger protein 14
Dr.9988 WU:FD44F11 Wu:fd44f11 Dr.31086 RNF2 Ring finger protein 2
Dr.35904 ZGC:85729 Zgc:85729 Dr.91373 DGAT2 Diacylglycerol O-
acyltransferase 2
Dr.79955 ATL3 Atlastin 3 Dr.77448 WDR21 WD repeat domain 21
Dr.2713 CD82 Hypothetical protein
LOC792047
Dr.20969 FOXI1 Forkhead box I1
Dr.10893 SARA2 Hypothetical protein
LOC792159
Dr.85037 CHRNE Cholinergic receptor, nico-
tinic, epsilon
Dr.119277 ZGC:101026 Zgc:101026 Dr.1823 SI:CH211-150C22.2 Si:ch211-150c22.2
Dr.78736 WU:FC28F08 Wu:fc28f08 Dr.77932 SI:CH211-173P18.3 Si:ch211-173p18.3
Dr.76207 AQP3 Aquaporin 3 Dr.8200 SI:CH211-45M15.2 Si:ch211-45m15.2
Dr.80393 ZGC:66450 Zgc:66450 Dr.77976 BYSL Bystin-like
Dr.122910 Transcribed locus, mod-
erately similar to NP
956523.1 COP9 signalo-
some subunit 8 [Danio
rerio]
Dr.81932 GNB3 Guanine nucleotide bind-
ing protein (G protein),
beta polypeptide 3
Dr.84502 ZGC:103761 Zgc:103761 Dr.96184 ZGC:101095 Zgc:101095
Dr.39081 ZGC:110239 Zgc:110239 Dr.11569 OSBPL2 Oxysterol binding protein-
like 2
Dr.75392 AK3L1 Adenylate kinase 3-like 1 Dr.79271 ZGC:77294 Zgc:77294
Dr.75265 Transcribed locus Dr.84790 UNG Uracil-DNA glycosylase
Dr.117538 ZGC:77785 Zgc:77785 Dr.28227 IM:7148063 Im:7148063
Dr.88645 ZGC:86611 Zgc:86611 Dr.7461 SI:DKEY-114G7.4 Si:dkey-114g7.4
Dr.118834 LOC566639 Similar to AHNAK nucleo-
protein
Dr.27090 DOCK8 Similar to dedicator of cy-
tokinesis 8
Dr.34097 PMP22B Peripheral myelin protein
22b
Dr.84534 LOC100007999 Hypothetical protein
LOC100007999
Dr.83194 CYP1C1 Cytochrome P450, family
1, subfamily C, polypep-
tide 1
Dr.3168 SNUPN Snurportin 1
Dr.2532 PRKCI Protein kinase C, iota Dr.80082 LOC559441 Similar to E3 ubiquitin lig-
ase
Dr.114279 LOC555064 Hypothetical LOC555064 Dr.122973 Transcribed locus
Dr.80192 ZGC:162158 Zgc:162158 Dr.84465 ZGC:110718 Hypothetical protein
LOC791932
Dr.82140 LOC100005813 Similar to sno, straw-
berry notch homolog 1
(Drosophila)
Dr.76346 Transcribed locus
Dr.89720 LOC556114 Hypothetical LOC556114 Dr.116845 Transcribed locus,




Dr.77508 MAO Monoamine oxidase Dr.33564 IPO9 Importin 9
Dr.76643 HIBADHA 3-hydroxyisobutyrate de-
hydrogenase a
Dr.133114 LOC100000528 Hypothetical protein
LOC100000528
Dr.79774 CCDC98 Coiled-coil domain con-
taining 98
Dr.14824 Transcribed locus
Dr.78811 RNASEH2B Ribonuclease H2, subunit
B
Dr.84342 ZGC:92085 Zgc:92085
Dr.77582 LOC560453 Similar to KIAA1794 Dr.8058 GBAS Glioblastoma amplified se-
quence
Dr.76907 PCBP2 Poly(rC) binding protein 2 Dr.81733 RBBP5 Retinoblastoma binding
protein 5
Dr.77012 RCC1 Regulator of chromosome
condensation 1
Dr.141683 Transcribed locus, weakly




Dr.107710 LOC561086 Similar to putative adeny-
late cyclase
Dr.28300 ZGC:66024 Zgc:66024
Dr.84504 TRAIP TRAF-interacting protein Dr.82354 VLDLR Very low density lipopro-
tein receptor
Dr.121990 Transcribed locus Dr.79957 TMEM9B TMEM9 domain family,
member B
Dr.123669 Transcribed locus,




Dr.32244 HSPB1 Heat shock protein, alpha-
crystallin-related, 1
Dr.32093 RAB30 RAB30, member RAS
oncogene family
Dr.78113 ZGC:77390 Zgc:77390










Dr.32749 ZGC:91847 Zgc:91847 Dr.86913 FABP6 Fatty acid binding protein
6, ileal (gastrotropin)
Dr.104406 ADRM1B Adhesion regulating
molecule 1b
Dr.82719 DAP3 Death associated protein 3
Dr.75753 NOTCH1A Notch homolog 1a Dr.77391 UTP6 UTP6, small subunit
(SSU) processome compo-
nent, homolog (yeast)
Dr.31752 HDAC1 Histone deacetylase 1 Dr.76650 ING4 Inhibitor of growth family,
member 4
Dr.77619 RUVBL1 RuvB-like 1 (E. coli) Dr.77926 ZGC:63774 Zgc:109744
Dr.1489 ZGC:136963 Zgc:136963 Dr.80524 WU:FI34B01 Wu:fi34b01
Dr.78703 RTKN2 Rhotekin 2 Dr.119738 SETB SET translocation
(myeloid leukemia-
associated) B
Dr.132305 ZGC:77439 Zgc:77439 Dr.80032 ZGC:162976 Zgc:162976
Dr.80724 SULT1ST6 Sulfotransferase family,
cytosolic sulfotransferase
6
Dr.104887 LOC572121 Similar to XL-INCENP
Dr.122409 Transcribed locus Dr.134550 ZGC:77906 Zgc:77906
Dr.17174 ANKRD28 Ankyrin repeat domain 28 Dr.78888 ZGC:77415 Zgc:77415
Dr.31639 ZGC:112095 Zgc:112095 Dr.80713 FSHR Follicle stimulating hor-
mone receptor
Dr.77202 RDH1L Retinol dehydrogenase 1,
like
Dr.106217 C20ORF20 Chromosome 20 open
reading frame 20 (H.
sapiens)




Dr.140573 Transcribed locus, weakly
similar to NP 081830.2
ubiquitin specific pepti-
dase 38 [Mus musculus]
Dr.77343 Transcribed locus Dr.104286 Transcribed locus,





Dr.75547 TRY Trypsin Dr.37970 SI:RP71-1C10.3 Si:rp71-1c10.3
Dr.140810 Transcribed locus, weakly
similar to XP 690938.2
PREDICTED: hypotheti-
cal protein [Danio rerio]
Dr.79014 Transcribed locus
Dr.105427 Transcribed locus Dr.115188 SERINC5 Serine incorporator 5
Dr.37032 CYP2J30 Cytochrome P450, family
2, subfamily J, polypep-
tide 30
Dr.82751 SSX2IP Synovial sarcoma, X
breakpoint 2 interacting
protein
Dr.75843 CHPT1 Choline phosphotrans-
ferase 1
Dr.106021 SLC43A1 Solute carrier family 43,
member 1
Dr.79066 ACSL1 Acyl-CoA synthetase long-
chain family member 1
Dr.85700 NUP43 Nucleoporin 43
Dr.77961 ZGC:92765 Zgc:92765 Dr.132611 LOC793280 Hypothetical protein
LOC793280
Dr.40298 WU:FB58E08 Wu:fb58e08 Dr.120800 ZGC:92512 Zgc:92512
Dr.77610 ZGC:101667 Zgc:101667 Dr.41494 WU:FI46G11 Wu:fi46g11
Dr.80572 ZGC:103530 Zgc:103530 Dr.74211 TAKRP T-cell activation kelch re-
peat protein
Dr.37643 ZGC:103509 Zgc:103509 Dr.114283 WU:FD16E03 Wu:fd16e03
Dr.2274 STARD3 START domain containing
3
Dr.21958 LBR Lamin B receptor
Dr.1786 ZGC:55292 Zgc:55292 Dr.78401 AATF Apoptosis antagonizing
transcription factor
Dr.79972 GOLGA5 Golgi autoantigen, golgin
subfamily a, 5
Dr.77471 Transcribed locus
Dr.75202 HDGFRP2 Hepatoma-derived growth
factor, related protein 2
Dr.93960 Transcribed locus,




Dr.75603 H3F3A H3 histone, family 3A Dr.83735 HPRT1L Hypoxanthine phosphori-
bosyltransferase 1, like
Dr.76761 ZGC:91996 Zgc:91996 Dr.31063 ZGC:86895 Zgc:86895
Dr.2143 PRPF38B PRP38 pre-mRNA pro-
cessing factor 38 (yeast)
domain containing B
Dr.132378 PLS3 Plastin 3 (T isoform)
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Dr.132490 ZGC:77867 Zgc:77867 Dr.21094 Transcribed locus, weakly
similar to XP 001333287.1
PREDICTED: similar to
ENSANGP00000022061
isoform 1 [Danio rerio]
Dr.79720 ZGC:86839 Zgc:86839 Dr.81955 Transcribed locus
Dr.133457 CDNA clone IM-
AGE:7053246
Dr.81616 LOC569587 Similar to transcription
factor-like nuclear regula-
tor
Dr.24235 DDX18 DEAD (Asp-Glu-Ala-Asp)
box polypeptide 18
Dr.106367 PRPSAP2 Phosphoribosyl py-
rophosphate synthetase-
associated protein 2
Dr.7003 BMP15 Bone morphogenetic pro-
tein 15
Dr.78235 STK38L Serine/threonine kinase 38
like
Dr.116102 ELA2L Elastase 2 like Dr.4705 NOL10 Nucleolar protein 10
Dr.77703 UHRF1 Ubiquitin-like, containing
PHD and RING finger do-
mains, 1
Dr.119787 LOC554474 Similar to Protein phos-
phatase 1, regulatory (in-
hibitor) subunit 3B
Dr.84043 ZGC:86635 Zgc:86635 Dr.78602 WU:FD14A01 Wu:fd14a01
Dr.5696 PRC1 Protein regulator of cy-
tokinesis 1
Dr.122142 ATP1A3B ATPase, Na+/K+ trans-
porting, alpha 3b polypep-
tide
Dr.32573 RPL11 Ribosomal protein L11 Dr.135679 Transcribed locus, mod-




Dr.82263 LOC796453 Hypothetical protein
LOC796453
Dr.118088 HNRNPL Heterogeneous nuclear ri-
bonucleoprotein L




strongly similar to NP
956291.1 TAR (HIV) RNA
binding protein 2 [Danio
rerio]











Dr.81780 PANE1 Proliferation associated
nuclear element
Dr.77649 MYST2 MYST histone acetyl-
transferase 2
Dr.120681 ZGC:171428 Zgc:171428









Dr.75741 ZGC:100869 Zgc:100869 Dr.76520 ST13 Suppression of tumori-
genicity 13 (colon carci-
noma) (Hsp70 interacting
protein)
Dr.83301 FOXC1B Forkhead box C1b Dr.80701 Transcribed locus
Dr.75260 C2ORF24 Chromosome 2 open read-
ing frame 24
Dr.12565 VAT1 Vesicle amine transport
protein 1 homolog (T cali-
fornica)
Dr.85085 PDLIM7 PDZ and LIM domain 7 Dr.121512 LOC100004500 Hypothetical protein
LOC100004500
Dr.80637 ITGA5 Integrin, alpha 5 (fi-
bronectin receptor, alpha
polypeptide)
Dr.75458 ARNTL1A Aryl hydrocarbon recep-
tor nuclear translocator-
like 1a
Dr.81184 ZGC:92818 Zgc:92818 Dr.78902 Transcribed locus
Dr.82521 ZGC:73144 Hypothetical protein
LOC792240
Dr.82999 INTS6 Integrator complex sub-
unit 6
Dr.80659 WU:FI33G05 Wu:fi33g05 Dr.132373 Transcribed locus
Dr.75229 Transcribed locus Dr.80821 SPAG6 Sperm associated antigen
6
Dr.77760 PUS1 Hypothetical protein
LOC792133
Dr.17457 ZGC:63667 Hypothetical protein
LOC100005281
Dr.88329 HIF1AL2 Hypoxia-inducible factor
1, alpha subunit, like 2
Dr.75286 CKAP5 Cytoskeleton associated
protein 5
Dr.75372 STARD3NL STARD3 N-terminal like Dr.116678 ZGC:110200 Zgc:110200
Dr.75748 ORC6L Origin recognition com-
plex, subunit 6 homolog-
like (yeast)
Dr.67263 LOC561668 Hypothetical LOC561668
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Dr.80266 ITM2C Integral membrane protein
2C
Dr.77751 Transcribed locus
Dr.85627 ANXA3A Hypothetical protein
LOC791593
Dr.82056 LHX8 LIM homeobox 8
Dr.118555 LOC567390 Hypothetical LOC567390 Dr.79519 ATP5S ATP synthase, H+ trans-
porting, mitochondrial F0
complex, subunit s
Dr.114001 ZGC:110183 Zgc:110183 Dr.119419 LOC572149 Similar to Dihydropyrimi-
dine dehydrogenase
Dr.79757 ZGC:77112 Zgc:77112 Dr.13909 Transcribed locus
Dr.81511 ZGC:113156 Zgc:113156 Dr.59 ANXA1A Annexin A1a
Dr.76676 LOC793260 Hypothetical protein
LOC793260
Dr.75602 TRIM71 Tripartite motif-
containing 71
Dr.133005 LOC100001846 Hypothetical protein
LOC100001846
Dr.42600 LOC553397 Hypothetical protein
LOC553397
Dr.79544 ING5B Inhibitor of growth family,
member 5b
Dr.20155 SS18 Synovial sarcoma translo-
cation, chromosome 18 (H.
sapiens)
Dr.75255 Transcribed locus Dr.82585 LOC562304 Similar to cytochrome
P450, family 2, subfamily
J, polypeptide 2
Dr.79169 PAPOLG Poly(A) polymerase
gamma
Dr.79823 ZGC:91926 Zgc:91926
Dr.105341 RACGAP1 Rac GTPase-activating
protein 1
Dr.16483 SLC39A6 Solute carrier family 39
(zinc transporter), mem-
ber 6
Dr.23593 ZGC:56412 Zgc:56412 Dr.15227 Transcribed locus
Dr.106684 LOC799913 Similar to cell surface floc-
culin
Dr.80564 RBM38 RNA binding motif protein
38
Dr.74227 ANLN-LIKE Anillin, actin binding
protein-like
Dr.114476 ZGC:92161 Hypothetical protein
LOC791539
Dr.40624 LOC569148 Hypothetical LOC569148 Dr.80447 ZGC:55983 Zgc:55983




Dr.7036 G3BP1 GTPase activating protein
(SH3 domain) binding pro-
tein 1
Dr.121634 Transcribed locus
Dr.106515 LOC795458 Similar to EN-
SANGP00000022061
Dr.79728 LOC564287 Similar to MGC69156 pro-
tein
Dr.79840 ZGC:92006 Zgc:92006 Dr.106024 WU:FC46H12 Wu:fc46h12
Dr.79258 LOC100000846 Similar to PHD finger pro-
tein 12
Dr.17275 WU:FI75F03 Wu:fi75f03
Dr.67738 ZGC:153795 Zgc:153795 Dr.80157 ZGC:56161 Zgc:56161
Dr.41866 CRYBB3 Crystallin, beta B3 Dr.79711 ZGC:158802 Zgc:158802
Dr.15775 DKEY-151P17.3 Plasma membrane prote-
olipid
Dr.82376 ZGC:63863 Hypothetical protein
LOC797468
Dr.75966 THOC1 THO complex 1 Dr.99488 ZGC:171912 Zgc:171912
Dr.83578 LOC556669 Hypothetical LOC556669 Dr.39528 LOC100001396 Hypothetical protein
LOC100001396
Dr.52170 Transcribed locus,
strongly similar to NP
001002726.1 WD repeat
and HMG-box DNA
binding protein 1 [Danio
rerio]
Dr.7489 Transcribed locus, weakly
similar to NP 001034277.1
ras responsive element
binding protein 1 isoform
2 [Mus musculus]
Dr.78694 UTP15 Utp15, U3 small nucleo-
lar ribonucleoprotein, ho-
molog
Dr.2195 TNPO3 Transportin 3
Dr.13960 S100A1 S100 calcium binding pro-
tein A1
Dr.120175 HSD11B3 Hydroxysteroid (11-beta)
dehydrogenase 3
Dr.118684 LOC100002310 Hypothetical protein
LOC100002310
Dr.82458 DDX26B DEAD/H (Asp-Glu-Ala-
Asp/His) box polypeptide
26B
Dr.77945 DNMT5 DNA (cytosine-5-)-
methyltransferase 5
Dr.74706 Transcribed locus, mod-
erately similar to NP
775564.1 solute carrier
family 43, member 2 [Mus
musculus]
Dr.109592 ZGC:92151 Zgc:92151 Dr.116738 LOC794025 Hypothetical protein
LOC794025
Dr.86190 ZGC:86715 Zgc:86715 Dr.8749 WBP2 WW domain binding pro-
tein 2
Dr.80969 LOC100004989 Hypothetical protein
LOC100004989
Dr.117431 SI:CH211-51N14.2 Si:ch211-51n14.2
Dr.80848 ZGC:100856 Zgc:100856 Dr.86027 LOC100006639 Hypothetical protein
LOC100006639
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Dr.77864 PHC2 Polyhomeotic-like 2
(Drosophila)
Dr.2885 FTSJ1 FtsJ homolog 1 (E. coli)
Dr.82476 ZGC:112072 Zgc:112072 Dr.76280 ZGC:152779 Zgc:152779
Dr.33507 ZGC:123170 Zgc:123170 Dr.87817 DNAJC5 DnaJ (Hsp40) homolog,
subfamily C, member 5
Dr.67664 SI:DKEY-8L13.4 Si:dkey-8l13.4 Dr.25529 PHEX Phosphate regulating gene
with homologues to en-
dopeptidases on the X
chromosome
Dr.78239 DDI2 DNA-damage inducible
protein 2
Dr.132507 ZGC:85696 Zgc:85696
Dr.47041 ZGC:92126 Zgc:92126 Dr.75477 RTF1 Rtf1, Paf1/RNA poly-
merase II complex com-
ponent, homolog (S.
cerevisiae)
Dr.67618 USP25 Ubiquitin specific protease
25
Dr.29744 SP8L Sp8 transcription factor-
like
Dr.29859 IM:7142837 Im:7142837 Dr.40661 Transcribed locus








Dr.32297 CAHZ Carbonic anhydrase
Dr.78166 PVALB7 Parvalbumin Dr.81229 Transcribed locus,
strongly similar to
XP 001332444.1 PRE-
DICTED: similar to sreb2
isoform 1 [Danio rerio]
Dr.79083 TMEM57 Transmembrane protein 57 Dr.132872 ANKRD12 Ankyrin repeat domain 12
Dr.4660 LOC100006592 Hypothetical protein
LOC100006592
Dr.9441 UTXL1 Ubiquitously transcribed
tetratricopeptide repeat,
X chromosome like 1
Dr.32436 ZGC:101883 Hypothetical protein
LOC792171
Dr.89166 Transcribed locus










Dr.86041 ZGC:92277 Zgc:92277 Dr.77969 LOC796797 Hypothetical protein
LOC796797
Dr.75815 FOXA Forkhead box A sequence Dr.50820 LOC565671 Similar to MGC89155 pro-
tein
Dr.78299 PHF17 PHD finger protein 17 Dr.89787 ZGC:113334 Zgc:113334
Dr.80537 ZGC:55621 Zgc:55621 Dr.123739 Transcribed locus
Dr.30247 ZGC:77118 Zgc:113969 Dr.80660 PLK4 Polo-like kinase 4
(Drosophila)







Dr.83896 LOC100005060 Hypothetical protein
LOC100005060
Dr.81259 DAZL Daz-like gene Dr.121806 Transcribed locus
Dr.82958 MCEE Methylmalonyl CoA
epimerase
Dr.113808 PLS1 Plastin 1 (I isoform)
Dr.76154 ZGC:77241 Zgc:77241 Dr.77001 CDC42EP4 CDC42 effector protein
(Rho GTPase binding) 4
Dr.87644 ZGC:113259 Zgc:113259 Dr.82697 Transcribed locus, mod-




Dr.84074 SB:CB157 Sb:cb157 Dr.115947 LOC563252 Similar to MTG16a
Dr.36081 KIF11 Kinesin family member 11 Dr.80478 ZGC:55308 Zgc:55308
Dr.78997 Transcribed locus Dr.79117 SI:DKEY-97O5.1 Si:dkey-97o5.1
Dr.75779 PL10 Pl10 Dr.37370 ZGC:103562 Zgc:103562
Dr.15518 ZGC:113343 Zgc:113343 Dr.4322 DKEYP-94H10.2 Novel protein simi-





Dr.114177 DNAJA3A DnaJ (Hsp40) homolog,
subfamily A, member 3A
Dr.105744 ZGC:175186 Zgc:175186
Dr.47266 SNIP1 Smad nuclear interacting
protein
Dr.143375 Transcribed locus
Dr.52195 SI:CH211-152C12.2 Si:ch211-152c12.2 Dr.82434 SLA/LPL Soluble liver antigen/liver
pancreas antigen (Homo
sapiens), like
Dr.77921 LOC564669 Similar to ARVCF Dr.77353 ZGC:101663 Hypothetical protein
LOC792193
Dr.83148 LOC556113 Similar to FLJ00281 pro-
tein
Dr.116962 LOC558028 Similar to exosome compo-
nent 10
Dr.76348 ZGC:63504 Zgc:63504 Dr.133285 ZGC:153878 Hypothetical protein
LOC795094
Dr.104975 ZGC:56513 Zgc:56513 Dr.83484 EED Embryonic ectoderm de-
velopment
Dr.18312 U2AF1 U2(RNU2) small nuclear
RNA auxiliary factor 1
Dr.120811 ZGC:65845 Zgc:65845
Dr.6442 ZGC:92875 Zgc:92875 Dr.36307 LOC562529 Hypothetical LOC562529
Dr.82342 DKEY-57A22.11 Similar to CG14692-PA Dr.14549 ZGC:92307 Zgc:92307
Dr.80456 Transcribed locus,




Dr.25277 AGR2 Anterior gradient homolog
2 (Xenopus laevis)
Dr.76462 RBB4 Retinoblastoma binding
protein 4
Dr.83536 ZGC:103540 Zgc:103540
Dr.107002 Transcribed locus Dr.120243 SI:CH211-197I12.2 Si:ch211-197i12.2
Dr.106921 ZGC:110586 Zgc:110586 Dr.114355 Transcribed locus,
strongly similar to NP
999931.1 mediator of RNA
polymerase II transcrip-
tion, subunit 25 [Danio
rerio]
Dr.35596 TPP1 Tripeptidyl peptidase I Dr.78105 ZGC:56518 Zgc:56518
Dr.115906 LOC799556 Similar to LOC553285 pro-
tein
Dr.15263 ZGC:73231 Zgc:73231
Dr.75192 ZGC:109901 Zgc:109901 Dr.140985 ZGC:112365 Zgc:112365
Dr.120542 ZGC:63920 Zgc:63920 Dr.16383 LOC564722 Similar to receptor associ-
ated protein 80
Dr.113957 LOC100007887 Similar to LOC559853 pro-
tein
Dr.79098 MBD1 Methyl-CpG binding do-
main protein 1
Dr.37659 BIN2 Bridging integrator 2 Dr.6354 CNOT3 CCR4-NOT transcription
complex, subunit 3






Adenylate kinase 3-like 1
[Danio rerio]
Dr.4206 ZGC:76977 Hypothetical protein
LOC792029
Dr.133834 ZGC:66359 Zgc:66359
Dr.29879 Transcribed locus Dr.78519 SPAG1 Sperm associated antigen
1
Dr.77026 Transcribed locus Dr.77928 SCYL3 SCY1-like 3 (S. cerevisiae)
Dr.11520 SI:CH211-51E12.7 Si:ch211-51e12.7 Dr.6680 MKNK2A MAP kinase-interacting
serine/threonine kinase 2a
Dr.75704 PTGDS Prostaglandin D2 synthase Dr.76983 ZGC:110286 Hypothetical protein
LOC791833
Dr.83502 ZGC:56310 Zgc:56310 Dr.80737 ZGC:110307 Hypothetical protein
LOC791571
Dr.23244 Transcribed locus Dr.43244 Transcribed locus,




Dr.132340 Transcribed locus Dr.77272 E2F4 E2F transcription factor 4
Dr.77971 LOC798926 Hypothetical protein
LOC798926
Dr.24982 ZGC:56585 Hypothetical protein
LOC792146





Dr.77484 ZGC:110417 Zgc:110417 Dr.76573 SPNS1 Spinster homolog 1
(Drosophila)
Dr.75662 ZGC:114087 Zgc:114087 Dr.76353 TIAL1 TIA1 cytotoxic granule-
associated RNA binding
protein-like 1
Dr.77172 ZGC:153968 Zgc:153968 Dr.5024 PHF16 PHD finger protein 16
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Dr.83525 ZGC:162268 Zgc:162268 Dr.14734 PUS7 Pseudouridylate synthase
7 homolog (S. cerevisiae)
Dr.78256 IVNS1ABPA Influenza virus NS1A
binding protein a
Dr.90256 DSCC1 Zgc:103507
Dr.105855 ZGC:171818 Zgc:171818 Dr.80201 Transcribed locus
Dr.77985 ZGC:92279 Zgc:92279 Dr.76675 ALDH3D1 Aldehyde dehydrogenase 3
family, member D1
Dr.78765 ZGC:64130 Zgc:64130 Dr.47567 SI:DKEY-30H14.2 Si:dkey-30h14.2
Dr.36931 ZGC:103747 Zgc:103747 Dr.132384 SULT1ST1 Sulfotransferase family,
cytosolic sulfotransferase
1
Dr.90996 SNX33 Sorting nexin 33 Dr.81681 ZGC:55557 Zgc:55557
Dr.133388 Transcribed locus Dr.122970 Transcribed locus
Dr.78823 LOC572451 Similar to zona pellucida
glycoprotein ZPB
Dr.77434 ZGC:56326 Zgc:56326
Dr.116371 ZGC:171776 Zgc:171776 Dr.32820 ZGC:56597 Zgc:56597
Dr.75241 PCID2 Hypothetical protein
LOC791435
Dr.75970 FLNA Filamin A, alpha
Dr.116223 ZGC:55879 Zgc:55879 Dr.85904 IM:7143992 Im:7143992
Dr.78916 ARHGEF7B Rho guanine nucleotide ex-
change factor (GEF) 7b
Dr.39952 VPS33A Vacuolar protein sorting
33A
Dr.28229 BCL7A B-cell CLL/lymphoma 7A Dr.79340 ZGC:56653 Zgc:56653
Dr.78604 ZGC:66488 Hypothetical LOC555138 Dr.80627 B3GAT3 Beta3-
glucuronyltransferase
Dr.133796 ZGC:162319 Zgc:162319 Dr.35822 ZGC:92425 Zgc:92425
Dr.30339 ZGC:85911 Zgc:85911 Dr.83245 SKP1 S-phase kinase-associated
protein 1
Dr.77853 SRPK1 Serine/arginine-rich pro-
tein specific kinase 1
Dr.80551 ZGC:110655 Zgc:110655
Dr.104630 MBD3A Methyl-CpG binding do-
main protein 3a
Dr.83159 IM:7140357 Im:7140357
Dr.88388 NEDD8L Neural precursor cell ex-
pressed, developmentally
down-regulated 8, like
Dr.256 SEC61B SEC61, beta subunit
Dr.117303 CRYGMX Crystallin, gamma MX Dr.75185 ZGC:110767 Zgc:110767
Dr.109645 ZGC:152986 Zgc:152986 Dr.36499 ZGC:101635 Zgc:101635
Dr.80703 ATXN7L2 Ataxin 7-like 2 Dr.75231 CHERP Calcium homeostasis en-
doplasmic reticulum pro-
tein
Dr.81104 LOC568795 Similar to Anaphase pro-
moting complex subunit 1
Dr.31536 RCL1 RNA terminal phosphate
cyclase-like 1
Dr.79516 ZGC:92027 Zgc:92027 Dr.87304 ZGC:77234 Zgc:77234
Dr.106451 ZGC:113828 Hypothetical protein
LOC797940
Dr.81961 LOC100002864 Hypothetical protein
LOC100002864
Dr.78406 ZGC:66448 Zgc:66448 Dr.72357 ZGC:153136 Zgc:153136
Dr.117779 ZGC:110128 Hypothetical protein
LOC791907
Dr.117029 ZGC:112265 Zgc:112265
Dr.75159 WU:FB25B09 Wu:fb25b09 Dr.122414 Transcribed locus
Dr.11480 RAP2IP Rap2 interacting protein Dr.118526 LOC556210 S100 calcium binding pro-
tein V1
Dr.78825 ELOVL1 Hypothetical protein
LOC791805
Dr.96078 ZGC:100836 Zgc:100836
Dr.13043 TPST1L Tyrosylprotein sulfotrans-
ferase 1, like
Dr.122815 Transcribed locus
Dr.140317 ZGC:110333 Zgc:110333 Dr.77086 ZGC:92664 Zgc:92664
Dr.83943 ZGC:113100 Zgc:113100 Dr.105425 ZGC:92164 Zgc:92164
Dr.79979 Transcribed locus Dr.12491 LOC562579 Similar to complement C4-
2
Dr.75346 Transcribed locus Dr.77870 RNGTT RNA guanylyltransferase
and 5’-phosphatase
Dr.123514 Transcribed locus Dr.118097 LOC566888 Hypothetical LOC566888
Dr.80056 DHDDS Dehydrodolichyl diphos-
phate synthase
Dr.143376 ZGC:86753 Zgc:86753
Dr.51813 CDNA clone IM-
AGE:7897837
Dr.115125 ZGC:77336 Zgc:77336
Dr.119113 SUV420H1 Suppressor of variega-
tion 4-20 homolog 1
(Drosophila)
Dr.77116 ZGC:101540 Zgc:101540




Dr.85121 ZGC:56259 Zgc:56259 Dr.45962 LOC792966 Similar to cathepsin A
Dr.122845 Transcribed locus Dr.45332 Transcribed locus
Dr.83945 BXDC5 Brix domain containing 5 Dr.82411 SPTLC2 Serine palmitoyltrans-
ferase, long chain base
subunit 2
Dr.78482 IM:7158730 Im:7158730 Dr.72465 ZGC:153103 Zgc:153103
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Dr.121695 Transcribed locus, mod-
erately similar to NP
001117721.1 glucokinase
[Oncorhynchus mykiss]
Dr.91026 LOC100006536 Hypothetical protein
LOC100006536
Dr.123021 Transcribed locus Dr.80532 DCP1A Decapping enzyme
Dr.140590 CDNA clone MGC:173911
IMAGE:5915517
Dr.85930 ZGC:66419 Hypothetical protein
LOC791547
Dr.22945 LOC795535 Hypothetical protein
LOC795535
Dr.104703 U2AF2A U2 small nuclear RNA
auxiliary factor 2a




Dr.29035 CTNNB2 Catenin, beta 2 Dr.85608 TBPL2 TATA box binding protein
like 2
Dr.7577 Transcribed locus,
strongly similar to XP
691993.2 PREDICTED:
similar to pogo transpos-
able element with ZNF
domain [Danio rerio]
Dr.81537 ZGC:101021 Zgc:101021
Dr.77837 LOC100005775 Similar to MGC53357 pro-
tein
Dr.81898 ZGC:110741 Zgc:110741
Dr.20277 ACTA2 Actin, alpha 2, smooth
muscle, aorta
Dr.24546 ZGC:66327 Hypothetical protein
LOC791777
Dr.133827 ZGC:63676 Zgc:63676 Dr.87085 ZGC:92113 Zgc:92113
Dr.24325 ZGC:65780 Zgc:65780 Dr.108054 SUPT3H Suppressor of Ty 3 ho-
molog (S. cerevisiae)
Dr.32463 CTSC Cathepsin C Dr.80679 ZGC:112364 Zgc:112364
Dr.115301 LOC567840 Similar to KIAA1573 pro-
tein
Dr.84245 CUL4A Cullin 4A
Dr.80745 Oogenesis-related protein Dr.31762 WU:FI12A09 Wu:fi12a09
Dr.143767 ZGC:152922 Zgc:152922 Dr.86370 ZGC:77076 Zgc:173915
Dr.14063 EML2 Echinoderm microtubule
associated protein like 2
Dr.36480 ZGC:103645 Zgc:103645
Dr.74222 SI:CH211-81I17.1 Si:ch211-81i17.1 Dr.77910 FAM46C Family with sequence sim-
ilarity 46, member C
Dr.82571 Transcribed locus Dr.31094 RBKS Hypothetical protein
LOC792027
Dr.76341 LOC100002247 Hypothetical protein
LOC100002247
Dr.119008 LOC569427 Hypothetical LOC569427
Dr.80488 PPP1R10 Protein phosphatase 1,
regulatory subunit 10
Dr.531 DCPS MRNA decapping enzyme
Dr.75902 ZGC:158387 Zgc:158387 Dr.16782 Transcribed locus
Dr.91347 ZGC:113381 Zgc:113381 Dr.85829 CETN2 Centrin, EF-hand protein,
2
Dr.32625 STKA Wu:fa09g06 Dr.132294 NOL14 Hypothetical protein
LOC792320
Dr.82091 Transcribed locus Dr.13677 ZGC:55317 Zgc:55317
Dr.45587 ZGC:110611 Zgc:110611 Dr.110726 LOC572168 Hypothetical LOC572168
Dr.85340 MRPL14 Mitochondrial ribosomal
protein L14
Dr.86192 LOC559127 Similar to AWKS9372
Dr.33127 IFRD2 Interferon-related develop-
mental regulator 2
Dr.107641 LOC569277 Similar to ubiquitously
transcribed tetratricopep-
tide repeat, X chromosome
Dr.83423 LOC569187 Similar to PHD finger pro-
tein 6
Dr.82169 ZGC:123333 Zgc:123333
Dr.1220 ZGC:64155 Zgc:64155 Dr.82451 CDC42EP2 CDC42 effector protein
(Rho GTPase binding) 2
Dr.122884 Transcribed locus Dr.143590 ZGC:85948 Zgc:85948
Dr.75665 MYLIP Myosin regulatory light
chain interacting protein
Dr.84866 LOC100005159 Hypothetical protein
LOC100005159
Dr.85496 FANCL Fanconi anemia, comple-
mentation group L
Dr.123167 Transcribed locus
Dr.21244 UCP2 Uncoupling protein 2 Dr.76453 ARL4D ADP-ribosylation factor-
like 4D
Dr.82168 Transcribed locus,






Dr.79437 ZGC:110299 Hypothetical LOC557968 Dr.7628 ZGC:158611 Zgc:158611
Dr.3855 PRMT7 Protein arginine N-
methyltransferase 7
Dr.77441 ZGC:64148 Zgc:64148
Dr.41980 ARID3B AT rich interactive domain
3B (Bright like)
Dr.82147 SI:DKEY-274C14.3 Si:dkey-274c14.3
Dr.80756 ZGC:77748 Zgc:77748 Dr.78511 LOC559941 Similar to Rho-guanine
nucleotide exchange factor
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Dr.27180 PPARB2 Peroxisome proliferator
activated receptor beta 2
Dr.43999 CGNL1 Cingulin-like 1
Dr.86792 DT1P1A10L Hypothetical protein
DT1P1A10 (human) - like
Dr.84960 GRTP1B Hypothetical protein
LOC791767
Dr.115569 ATXN3 Ataxin 3 Dr.133306 CHM Choroideremia
Dr.81807 LOC100002531 Hypothetical protein
LOC100002531
Dr.81558 SI:DKEY-98F17.2 Si:dkey-98f17.2
Dr.53929 SNF1LK2B SNF1-like kinase 2b Dr.27946 Transcribed locus
Dr.75940 DEF Digestive-organ expansion
factor
Dr.28581 OPHN1 Oligophrenin 1
Dr.124001 Transcribed locus Dr.14931 ZGC:153327 Zgc:153327
Dr.122080 Transcribed locus Dr.81311 DRL Hypothetical protein
LOC791603
Dr.80074 POP4 Hypothetical LOC554559 Dr.76198 IM:7150932 Im:7150932
Dr.132767 ZGC:77051 Zgc:77051 Dr.75142 SI:CH211-197G15.1 Si:ch211-197g15.1
Dr.33631 SI:CH211-124K10.2 Si:ch211-124k10.2 Dr.86287 ZGC:63651 Zgc:63651
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